10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2019

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-16244

VEECO INSTRUMENTS INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	11-2989601
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

Terminal Drive
Plainview, New York	11803
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code:

(516) 677-0200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	VECO	The NASDAQ Global Select Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ☒ No

The aggregate market value of the common stock held by non-affiliates of the registrant at June 28, 2019 (the last business day of the registrant’s most recently completed second quarter) was $584,427,830 based on the closing price of $12.22 on the NASDAQ Global Select Market on that date.

As of February 14, 2020, there were 49,000,023 shares of the registrant’s common stock, par value $0.01 per share, outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of the definitive Proxy Statement to be used in connection with the Registrant’s 2020 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K.

VEECO INSTRUMENTS INC.

INDEX

PART I	3
Item 1. Business	3
Item 1A. Risk Factors	9
Item 1B. Unresolved Staff Comments	24
Item 2. Properties	25
Item 3. Legal Proceedings	25
Item 4. Mine Safety Disclosures	25
PART II	26
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	26
Stock Performance Graph	27
Item 6. Selected Financial Data	28
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations	29
Item 7A. Quantitative and Qualitative Disclosures about Market Risk	38
Item 8. Financial Statements and Supplementary Data	38
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	38
Item 9A. Controls and Procedures	39
Item 9B. Other Information	42
PART III	42
Item 10. Directors, Executive Officers and Corporate Governance	42
Item 11. Executive Compensation	42
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	42
Item 13. Certain Relationships and Related Transactions, and Director Independence	42
Item 14. Principal Accounting Fees and Services	42
PART IV	43
Item 15. Exhibits, Financial Statement Schedules	43
SIGNATURES	46

2

This Annual Report on Form 10-K (“Form 10-K”) contains certain forward-looking information relating to Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” the “Company,” “Registrant,” “we,” “our,” or “us,” unless the context indicates otherwise) that is based on the beliefs of, and assumptions made by, our management as well as information currently available to management. When used in this Form 10-K, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions relating to the future are intended to identify forward-looking information. Discussions containing such forward-looking statements may be found in Part I, Items 1 and 3, Part II, Items 7 and 7A hereof, as well as within this Form 10-K generally. This forward-looking information reflects our current views with respect to future events and is subject to certain risks, uncertainties, and assumptions, some of which are described under the caption “Risk Factors” in Part I, Item 1A, and elsewhere in this Form 10-K. Should one or more of these risks or uncertainties occur, or should our assumptions prove incorrect, actual results may vary materially from the forward-looking information described in this Form 10-K as believed, anticipated, expected, estimated, targeted, planned, or similarly identified. We do not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.

PART I

Item 1. Business

Business Description and Overview

Headquartered in Plainview, New York, we were organized as a Delaware corporation in 1989. We are an innovative manufacturer of semiconductor process equipment which solve an array of challenging materials engineering problems for our customers. Our comprehensive collection of ion beam, laser annealing, lithography, MOCVD (metal organic chemical vapor deposition), MBE (molecular beam epitaxy), ALD (atomic layer deposition) and single wafer wet etch and clean technologies play an integral role in the fabrication of key devices that are enabling the 4^th industrial revolution of all things connected. Such devices include leading node application processors for mobile devices, thin film magnetic heads for hard disk drives in data storage, photonics devices for 3D sensing, advanced displays and high-speed communications, radio frequency (“RF”) filters and power amplifiers for fifth generation (“5G”) networks and mobile electronics. In close partnership with our customers, we combine decades of applications and materials know-how with leading-edge systems engineering to deliver high-volume manufacturing solutions with superior cost of ownership. Serving a global and highly interconnected customer base, we have comprehensive sales and service operations across the Asia-Pacific region, Europe, and North America to directly address our customers’ needs and maximize our system uptime.

Our priorities are:

● Focus on our products - Innovate by providing differentiated semiconductor and thin film process equipment to address our customers’ challenging materials engineering problems for current production requirements and next generation product development roadmaps; Invest in focused research and development in markets that we believe provide significant growth opportunities or are at an inflection point, including compound semiconductor, leading edge front-end semiconductor, and advanced packaging; Maintain strength in our foundational businesses, including our data storage and service offerings, and sales to universities and research institutions;

● Extend our core technologies - Penetrate new markets by leveraging our sales channel and local process applications support teams to build strong strategic relationships with leading customers; Expanding our services portfolio to improve the performance of our systems, reduce our customers’ cost of ownership, and improve customer satisfaction; Cross-selling our diverse product portfolio across our broad customer base and into new markets, such as front-end semiconductor, photonics, and 5G RF;

● Strengthen – Improve profitability by selectively reducing operating expenses and delivering improved gross margins, resulting from optimizing manufacturing costs and improving product mix.

3

Our products are purchased by semiconductor and thin film process equipment customers in the following four markets: 1) Front-End Semiconductor; 2) Advanced Packaging, MEMS & RF Filters; 3) LED Lighting, Display & Compound Semiconductor; and 4) Scientific & Industrial.

Markets

Our array of process equipment systems are used in the production of a broad range of microelectronic components, including RF filters and amplifiers, power electronics, thin film magnetic heads, laser diodes, 3D NAND, DRAM, logic, LEDs (including mini- and micro-LEDs), micro-electro mechanical systems (“MEMS”), and other semiconductor devices. Many of our systems are used to directly deposit advanced materials critical to the operation of the device and some of our systems are used in cleaning and surface preparation as well as the precision removal of critical materials. We are also a leader in systems used in the advanced packaging process flow of microelectronic components such as flip chip, Fan-Out Wafer Level Packaging (“FOWLP”), and other wafer level packaging approaches used in the modern integration of diverse semiconductor products, especially used in consumer electronics. In general, our customers purchase our systems to both produce current-generation devices in volume and to develop next-generation products which deliver more efficient, cost-effective, and advanced technological solutions. We operate in several highly cyclical business environments, and our customers’ buying patterns are dependent upon industry trends and consumer buying patterns for consumer electronics. As our products are sold into multiple markets, the following discussion focuses on the trends that most influence our business within each of those markets.

Front-End Semiconductor

Front-End Semiconductor refers to early process steps where transistors are formed directly on silicon. There are many different process steps in forming integrated circuits, such as Deposition, Etching, Masking, and Doping, where the microchips are created but still remain on the silicon wafer. As device architecture continue to shrink with advanced nodes, more precise process control is paramount to achieving high yields and competitive cost. Our Laser Spike Annealing (“LSA”) systems enable precision doping of materials at a controlled temperature in the semiconductor manufacturing process and is qualified and deployed in several advanced node applications. Our Ion Beam Etch (“IBE”) for front-end semiconductor has been demonstrated in Spin Torque Transfer Magnetic Random Access Memory (“STT-MRAM”) applications. STT-MRAM has many benefits over traditional random access memory such as its non-volatility, speed, endurance, and power consumption. Our Ion Beam Deposition (“IBD”) products have been adopted for the manufacturing of Extreme Ultraviolet (“EUV”) mask blanks. Our ability to precisely deposit high quality films with extremely low particulate levels make our IBD technology ideal for manufacturing defect-free EUV photomask blanks. The front-end semiconductor industry is in the process of adopting EUV lithography to meet leading edge device requirements. Future growth will depend on overall adoption of EUV lithography by Independent Device Manufacturers (“IDMs”) and Semiconductor Foundries (“Foundries”).

Advanced Packaging, MEMS & RF Filters

Advanced Packaging includes a portfolio of wafer-level assembly technologies that enable improved performance of electronic products, such as smartphones, high-end servers, and graphical processors.

Demand for higher performance, increased functionality, smaller form factors, and lower power consumption in applications such as Artificial Intelligence in mobile devices, consumer electronics, and high-performance computing is driving the adoption of advanced packaging technologies. Foundries, IDMs, and Outsourced Semiconductor Assembly and Test (“OSATs”) companies are implementing multiple advanced packaging approaches including FOWLP, which has been deployed in high-volume manufacturing, and copper-pillar to enable stacked memory devices. These demand drivers in Advanced Packaging are encouraging as our Lithography and wet etch and clean systems enable several process steps for Advanced Packaging.

MEMS devices are used for an increasing number of applications, including accelerometers for automobile airbags, pressure sensors for medical uses, and gyroscopes for a variety of consumer products, such as gaming consoles and mobile devices.

4

One of the fastest growing MEMS applications has been RF filters for mobile devices, driven by increasingly complex wireless standards, the proliferation of an increasing number of communication bands, the exponential growth of mobile data, and carrier aggregation. These trends are positive for us, particularly for our wet etch and clean products, where our technology is enabling some of the most challenging process steps, as well as our IBE and MBE systems, which are used to create Bulk Acoustic Wave (“BAW”) and Surface Acoustic Wave (“SAW”) RF filters.

LED Lighting, Display & Compound Semiconductor

MOCVD technology is important in the manufacturing of GaN based LEDs for general lighting and for red, orange, and yellow (“ROY”) LEDs, which are used increasingly for fine-pitch digital signage and automotive applications. For these applications, our MOCVD technology is used to deposit highly uniform Arsenides and Phosphides (“As/P”) films which create amber and red output colors.

The Display market refers to LEDs, mini-LEDs, or micro-LEDs used for displays. Mini-LEDs are larger than micro-LEDs and a recent trend for manufacturers has been to use mini-LEDs to backlight LCD displays in a similar but more effective manner than traditionally LED-backlit LCD displays, requiring many more mini-LEDs per display. A micro-LED display is a new approach which uses an array of red, blue, and green micro-LEDs to directly display an image without motion blur or image retention, and with improved brightness, darker blacks, and wider viewing angles. Manufacturing requirements for micro-LEDs are more stringent than normal LEDs. There are many manufacturing challenges for our customers to produce micro-LED displays, however, we believe our MOCVD systems are well suited to serve this market.

The Compound Semiconductor market broadly refers to the deposition of GaN or As/P based thin film compounds on a variety of substrates including Silicon, Gallium Arsenide (“GaAs”), Indium Phosphide (“InP”), and Silicon Carbide (“SiC”) to enable a variety of power electronics, RF, and photonics devices. Future growth is anticipated in this market driven by optical communication and industrial applications requiring laser diodes, 3D sensing and world facing vertical cavity surface emitting lasers (“VCSELs”), 5G RF infrastructure adoption, and power electronics.

Demand for RF power amplifiers in mobile devices drives the RF device portion of the Compound Semiconductor market. Our GaN and As/P technologies are used to deposit critical thin film layers for the production of RF amplifiers. Our wet etch and clean systems are used for process steps such as metal lift off and photo resist strip for devices such as heterojunction bipolar transistors (“HBTs”) used in smartphones. We believe GaN and As/P based devices will enable the evolution of wireless technology to 5G. It is expected that the transition to 5G will take several years to become fully adopted.

Scientific & Industrial

The Scientific and Industrial market includes advanced materials research and a broad range of manufacturing applications including high-power fiber lasers, infrared detectors, thin film magnetic heads on hard disk drives (“HDDs”), and optical coatings.

Our MBE systems are used by scientific research organizations and universities to drive new discoveries in the areas of materials science. MBE enables precise epitaxial crystal growth for a very wide variety of materials, which supports the development of new performance materials used for emerging technologies. MBE technology is also used in the manufacturing of specialized, lower volume products such as high-power lasers and infrared sensors. Our fully automated process equipment systems create highly uniform, and high purity GaAs or InP film layers, which are critical to the performance of these devices. Our wet etch and clean systems are also used in the manufacture of infrared sensors.

Our IBD, IBE, Physical Vapor Deposition (“PVD”), and lapping and dicing tools are used in data storage applications, including HDDs that will continue to provide significant value for mass storage and will remain an important part of large capacity storage applications. This is especially true for data center applications where large volumes of data storage are required to serve an increasingly mobile population. In addition, our IBD tools are used to produce high quality optical films for multiple applications including laser mirrors, optical filters, and anti-reflective coatings. Our tools deposit thin layers of advanced materials on various substrates to alter how light is reflected and transmitted.

5

Our atomic layer deposition (“ALD”) systems are sold into a variety of Scientific & Industrial market applications including optical, semi/nano-electronics, MEMS, nanostructures, and biomedical.

System Products

Ion Beam Deposition and Etch Systems

Our NEXUS^® IBD systems use ion beam technology to deposit precise layers of thin films. IBD systems deposit high purity thin film layers and provide excellent uniformity and repeatability. Our NEXUS IBE systems utilize a charged particle beam consisting of ions to etch precise, complex features. The NEXUS systems may be included on our cluster system platform to allow either parallel or sequential deposition/etch processes. These systems are used primarily by data storage, semiconductor, and telecommunications device manufacturers in the fabrication of discrete and integrated microelectronic devices.

Our IBD technology has also been adapted to deposit precise layers in the manufacture of EUV lithography mask blanks. The semiconductor industry has been collectively working toward using extreme ultraviolet light in the lithography process to enable shrinking feature sizes in advanced node semiconductor manufacturing. We have been involved for many years in applying our technology, so our customers can produce mask blanks with low defect density.

Our SPECTOR^® Ion Beam Sputtering system was developed for high precision optical coatings and offers manufacturers state of the art optical thickness monitoring, improved productivity, and target material utilization, for cutting-edge optical interference coating applications. We also provide a broad array of ion beam sources. These technologies are applicable in the HDD industry as well as for optical coatings and other end markets.

Laser Annealing Systems

The progression of Moore’s law has led semiconductor manufacturers to implement a variety of material and process changes to overcome the technical hurdles related to shrinking of feature sizes in integrated circuits. Along with new materials and smaller dimensions have come new process challenges. One such challenge has been new constraints on thermal annealing processes. One example is the thermal annealing of dopants for activation, in order to form the transistor junction, critical to the function and performance of a complementary metal-oxide semiconductor (“CMOS”) logic integrated circuit. In this and other thermal process steps, traditional lamp-based annealing techniques have challenges meeting the thermal budget (time/temperature regime) required by new materials and designs. Our LSA systems meet the industry demand for millisecond time-scale annealing, heating the wafer up to temperatures just below the silicon melting point over a range of ultra-short timeframes (microseconds to milliseconds), enabling thermal annealing solutions at the most advanced processing nodes. This unique annealing technology provides the solution to the difficult challenge of fabricating ultra-shallow junctions and highly activated source/drain contacts at these advanced logic nodes. In addition, our proprietary hardware design enables outstanding temperature uniformity across the wafer and die, by minimizing the pattern-density effect, thus reducing absorption variations.

We have also developed a next generation melt anneal technology (“MELT”) targeted for annealing advanced logic devices at advanced nodes. As devices scale, achieving the performance targets has become a challenge. To continue the roadmap, the industry is looking at new materials and the use of thermal processes that require nanosecond time-scale thermal annealing with temperatures exceeding the melting point. It is believed that nanosecond annealing will be required to meet the device targets at future nodes; the initial application being explored by customers is contact annealing aimed to improve source/drain contact resistance, which has become a performance bottleneck at the most advanced FinFET nodes, and as devices continue to scale, we see the application space for our melt product expanding.

Metal Organic Chemical Vapor Deposition Systems

MOCVD production systems are used to make GaN-based devices (such as blue and green LEDs) and As/P-based devices (such as ROY LEDs), which are used in television and computer display backlighting, general illumination, large area signage, specialty illumination, power electronics, and many other applications. Our proven TurboDisc^®

6

technology is at the heart of our MOCVD systems and it the key to enabling best-in-class deposition uniformity and yield performance and cost per wafer savings for our customers with a combined advantage of best operating uptime and low maintenance costs. In February of 2020, we introduced the Lumina platform for As/P deposition, based on Veeco’s industry leading MOCVD TurboDisc® technology. It features long campaigns and low defectivity for exceptional yield and flexibility. Our Propel™ series of MOCVD Systems (“Propel”) enables the development of highly-efficient GaN-based power electronic and RF devices. The Propel system offers 200mm and fully-automated 300mm technology and incorporates single-wafer reactor technology for outstanding film uniformity, yield, and device performance.

Advanced Packaging Lithography

We have a leading position in the Advanced Packaging lithography equipment market. The Advanced Packaging market is driven by the need for improved performance, reduced power consumption, and the ability to image smaller geometries for mobile and automotive applications. These applications continue to demand increasingly complex packaging techniques and heterogeneous device integration from IDMs, Foundries, and OSATs. Our Advanced Packaging tools are designed to optimize productivity for leading-edge 200mm and 300mm Advanced Packaging applications by delivering proven reliability and low cost of ownership in high-volume manufacturing environments. Our best-in-class yield coupled with outstanding resolution and depth of focus addresses all leading-edge requirements for Advanced Packaging applications such as redistribution layers (“RDLs”), Copper Pillar, Micro-Bump, FOWLP, interposers, and TSVs.

Single Wafer Wet Etch and Clean Systems

We offer single wafer wet etch and clean, and surface preparation systems which target high-growth segments in advanced packaging, MEMS, LEDs, and compound semiconductor markets. The WaferStorm^® platform is based on our unique ImmJET™ technology, which provides improved performance at a lower cost of ownership than conventional wet bench-only or spray-only approaches. This highly flexible platform targets solvent-based cleaning applications that require a significant level of process control and flexibility. The WaferEtch^® platform provides highly uniform, selective etching with onboard end-point detection for improved process control and yield in bumping applications. In addition, we have developed a state-of-the-art solution with the WaferEtch^® platform to address the requirements of wafer thinning.

Molecular Beam Epitaxy Systems

Molecular beam epitaxy is the process of precisely depositing epitaxially-aligned atomically-thin crystalline layers, or epilayers, of elemental materials onto a substrate in an ultra-high vacuum environment. We are a leading supplier of MBE systems worldwide.

Our MBE systems, sources, and components are used to develop and manufacture compound semiconductor devices in a wide variety of applications such as high-power fiber lasers, infrared detectors, mobile phones, radar systems, high efficiency solar cells, and basic materials science research. For many compound semiconductors, MBE is the critical step of the fabrication process, ultimately determining device functionality and overall performance. We offer a full complement of MBE systems customized for the specific end application depositing on single 3” substrates up to fully automated production systems that can deposit on seven 6” substrates simultaneously. The GENxplor^® MBE system creates high quality epitaxial layers and is ideal for cutting-edge research on a wide variety of materials including GaAs, antimonides, nitrides, and oxides on 3” diameter substrates. The GENxcel^® MBE system extends the same performance of the GENxplor to 4” diameter substrates.

Atomic Layer Deposition and Other Deposition Systems

ALD is a thin-film deposition method in which a film is deposited on a substrate uniformly with precise control down to the atomic scale. Veeco offers a full suite of ALD systems for non-semiconductor front-end production applications across a wide range of markets and applications such as energy, optical, electronics, MEMS, nanostructures, and biomedical. We have recently developed a fully automated tool capable of managing fragile wafers in a continuous

7

operational sequence. Other deposition systems include Physical Vapor Deposition, Diamond-Like Carbon Deposition, and Chemical Vapor Deposition Systems.

Sales and Service

We sell our products and services worldwide through various strategically located facilities in the United States, Europe, and the Asia-Pacific region. We believe that our customer service organization is a significant factor in our success. We provide service and support on a warranty, service contract, and an individual service-call basis. We believe that offering timely support creates stronger relationships with customers. Revenue from the sales of parts, upgrades, service, and support represented approximately 26%, 28%, and 27% of our net sales for the years ended December 31, 2019, 2018, and 2017, respectively. Parts and upgrade sales represented approximately 19%, 23%, and 22% of our net sales for those years, respectively, and service and support sales were 7%, 5%, and 5% respectively.

Customers

We sell our products to many of the world’s semiconductor, HDD, OSAT, LED, and MEMS manufacturers, as well as research centers and universities. We rely on certain principal customers for a significant portion of our sales. Sales to Seagate Technology accounted for more than 10% of our total net sales in 2019; sales to Focus Lighting Tech Co. accounted for more than 10% of our total net sales in 2018; and sales to OSRAM Opto Semiconductors accounted for more than 10% of our total net sales for 2017. If any principal customer discontinues its relationship with us or suffers economic difficulties, our business prospects, financial condition, and operating results could be materially and adversely affected.

Research and Development

Our research and development functions are focused on the timely creation of new products and enhancements to existing products, both of which are necessary to maintain our competitive position. We collaborate with our customers to align our technology and product roadmaps to customer requirements. Our research and development activities take place at our facilities in San Jose, California; Waltham, Massachusetts; St. Paul, Minnesota; Somerset, New Jersey; Plainview, New York; and Horsham, Pennsylvania.

Suppliers

We outsource certain functions to third parties, including the manufacture of several of our systems. While we rely on our outsourcing partners to perform their contracted functions, we maintain some level of internal manufacturing capability for these systems. Refer to Item 1A, “Risk Factors,” for a description of risks associated with our reliance on suppliers and outsourcing partners.

Backlog

Our backlog consists of orders for which we received a firm purchase order, a customer-confirmed shipment date within twelve months, and a deposit when required. Our backlog decreased to $267.6 million at December 31, 2019 from $288.3 million at December 31, 2018. During the year ended December 31, 2019, we decreased backlog by approximately $5.7 million relating to orders that no longer met our bookings criteria, as well as decreased backlog by approximately $6.7 million relating to a product line that was classified as held for sale at December 31, 2019.

Competition

In each of the markets that we serve, we face competition from established competitors, some of which have greater financial, engineering, and marketing resources than we do, as well as from smaller competitors. In addition, many of our products face competition from alternative technologies, some of which are more established than those used in our products. Significant factors for customer selection of our tools include system performance, accuracy, repeatability, ease of use, reliability, cost of ownership, and technical service and support. None of our competitors compete with us across all of our product lines.

8

Our principal competitors include: Advanced Micro-Fabrication Equipment (AMEC); Aixtron; Applied Materials; Canon; Grand Plastics Technology Corporation; Leybold Optics; Mattson Technology; Onto Innovation; Riber; Scientech; Screen Semiconductor Solutions; and Shanghai Micro Electronics Equipment.

Intellectual Property

Our success depends in part on our proprietary technology, and we have over 1,000 patents and pending applications in the United States and other countries.

We have patents and exclusive and non-exclusive licenses to patents owned by others covering certain of our products, which we believe provide us with a competitive advantage. We have a policy of seeking patents on inventions concerning new products and improvements as part of our ongoing research, development, and manufacturing activities. We believe that there is no single patent or exclusive or non-exclusive license to patents owned by others that is critical to our operations, as the success of our business depends primarily on the technical expertise, innovation, customer satisfaction, and experience of our employees. Refer to Item 1A, “Risk Factors,” for a description of risks associated with intellectual property.

Employees

At December 31, 2019 we had 954 employees, of which there were 279 in manufacturing and testing, 86 in sales and marketing, 218 in service and product support, 240 in engineering and research and development, and 131 in information technology, general administration, and finance. The success of our future operations depends on our ability to recruit and retain engineers, technicians, and other highly skilled professionals who are in considerable demand. We feel that we have adequate programs in place to attract, motivate, and retain our employees. We monitor industry practices to make sure that our compensation and employee benefits remain competitive. We believe that our employee relations are good. Refer to Item 1A, “Risk Factors,” for a description of risks associated with employee retention and recruitment.

Available Information

Our corporate website address is www.veeco.com. All filings we make with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K, our proxy statements and any amendments thereto filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, are available for free in the Investor Relations section of our website as soon as reasonably practicable after they are filed with or furnished to the SEC. The reference to our website address does not constitute inclusion or incorporation by reference of the information contained on our website in this Form 10-K or other filings with the SEC, and the information contained on our website is not part of this document.

Item 1A. Risk Factors

Key Risk Factors That May Impact Future Results

Stockholders should carefully consider the risk factors described below. Any of these factors, many of which are beyond our control, could materially and adversely affect our business, financial condition, operating results, cash flow, and stock price.

Unfavorable market conditions have adversely affected, and may continue to adversely affect, our operating results.

Conditions of the markets in which we operate are volatile and have experienced, and may in the future continue to experience, significant deterioration. Demand for our equipment and services can change depending on several factors, including the nature and timing of technology inflections, the emergence of new technologies and competitors, production capacity and end-user demand, international trade barriers, access to affordable capital, and general economic conditions (including, for example, a prolonged U.S. government shutdown). Changing market conditions require that we continuously monitor and reassess our strategic resource allocation decisions. If we fail to properly adapt to changing business

9

environments, we may lack the infrastructure and resources necessary to scale up our businesses to successfully compete during periods of growth, or we may incur excess fixed costs during periods of decreasing demand. Adverse market conditions relative to our products have resulted in, and may continue to result in:

● reduced demand for our products;

● rescheduling and cancellations of orders for our products, resulting in negative backlog adjustments;

● asset impairments, including the impairment of goodwill and other intangible assets;

● unfavorable changes in customer mix and product mix;

● increased price competition leading to lower margin for our products;

● increased competition from sellers of used equipment or lower-priced alternatives to our products;

● increased inventory obsolescence;

● disruptions in our supply chain as we reduce our purchasing volumes and limit our contract manufacturing operations;

● higher operating costs as a percentage of revenues; and

● an increase in uncollectable amounts due from our customers resulting in increased reserves for doubtful accounts and write-offs of accounts receivable.

If the markets in which we participate continue to experience deteriorations or downturns, this could negatively impact our sales and revenue generation, margins, operating expenses, and profitability.

We are exposed to the risks of operating a global business.

Most of our sales are to customers located outside of the United States, and we expect sales from non-U.S. markets to continue to represent a significant portion of our sales in the future. Our non-U.S. sales and operations are subject to risks inherent in conducting business outside the United States, many of which are beyond our control including:

● political and social attitudes, laws, rules, regulations, and policies within countries that favor local companies over U.S. companies, including government-supported efforts to promote the development and growth of local competitors;

● global trade issues and uncertainties with respect to trade policies, including tariffs, trade sanctions, and international trade disputes, and the ability to obtain required import and export licenses;

● differing legal systems and standards of trade which may not honor our intellectual property rights and which may place us at a competitive disadvantage;

● pressures from foreign customers and foreign governments for us to increase our operations and sourcing in the foreign country, which may necessitate the sharing of sensitive information and intellectual property rights;

● multiple conflicting and changing governmental laws and regulations, including varying labor laws and tax regulations;

● reliance on various information systems and information technology to conduct our business, making us vulnerable to additional cyberattacks by third parties or breaches due to employee error, misuse, or other causes, that could result in further business disruptions, loss of or damage to our intellectual property and confidential information (and that of our customers and other business partners), reputational harm, transaction errors, processing inefficiencies, or other adverse consequences;

● regional economic downturns, varying foreign government support, unstable political environments, and other changes in foreign economic conditions (such as the United Kingdom’s planned departure from the European Union, commonly referred to as Brexit);

10

● the impact of public health epidemics on employees, suppliers, customers and the global economy, such as the recent outbreak of a novel strain of coronavirus first identified in Wuhan, Hubei Province, China;

● difficulties in managing a global enterprise, including staffing, managing distributors and representatives, and repatriating cash;

● longer sales cycles and difficulties in collecting accounts receivable; and

● different customs and ways of doing business.

These challenges, many of which are associated with sales into the Asia-Pacific region, have had and may continue to have a material adverse effect on our business.

Changes in U.S. trade policy and export controls and ongoing trade disputes between the U.S. and China have adversely affected, and may continue to adversely affect, our business, results of operations, and financial condition.

The U.S. government has recently enacted changes in trade policy, including the imposition of tariffs on certain items, proposed tariffs on additional items, and new export controls. On May 15, 2019, the President of the United States issued an Executive Order that authorized the creation and implementation of controls over transactions involving Chinese and possibly other entities involving threats to U.S. national security. On the same day, the U.S. Commerce Department added Huawei (a multinational technology company with its headquarters in China) and many of its affiliates to the Entity List, which essentially requires U.S. companies and others to obtain licenses before providing commodities, software, and technology subject to the regulations. Further, the Trump Administration has expressed an intent to implement new regulations designed to address concerns about the export of emerging and foundational technologies to China, and additional controls on the export of items to China and other countries may be forthcoming. While the United States and China signed a preliminary “Phase One” trade agreement in January 2020, many uncertainties remain.

These new tariffs, and other changes in U.S. trade policy and export controls, as well as sanctions imposed by the U.S. against certain Chinese companies, have triggered retaliatory action by China and could trigger further retaliation. For example, China has instituted trade sanctions on certain U.S. goods, as well as other sanctions designed to deny U.S. companies access to critical raw materials. Also, China has provided, and is expected to continue to provide, significant assistance, financial and otherwise, to their domestic industries, including some of our competitors, and to intervene in support of national industries and/or competitors. We face increasing competition as a result of significant investment in the semiconductor industry by the Chinese government and various state-owned or affiliated entities that is intended to advance China's stated national policy objectives. In addition, the Chinese government may restrict us from participating in the China market or may prevent us from competing effectively with Chinese companies.

A “trade war” of this nature or other governmental action related to tariffs or international trade agreements or policies has the potential to adversely affect demand for our products, our costs, customers, suppliers, and/or the U.S. economy or certain sectors thereof and, in turn, may have a material adverse effect on our business, results of operations and financial condition.

Further, we hold inventory of products affected by the recent U.S. government actions and there is uncertainty relating to the disposition of this inventory. While we continue to take steps to mitigate our exposure to this developing situation, if the sale of these products is delayed or we are unable to return or dispose of our inventory on favorable economic terms, we may experience order cancellations, incur additional carrying costs for the inventory or otherwise record losses associated with the inventory.

In addition, we have experienced increasing difficulty and uncertainty in obtaining export licenses required to sell products to certain foreign customers. Further, the U.S. Bureau of Industry and Security (BIS) has indicated its intention to eliminate license exception CIV, which we utilize to facilitate the shipment of many of our products to customers in China. Without this license exception, we will be required to obtain export licenses from BIS prior to shipment. This would likely create delay and uncertainty, which would make our products less attractive to customers in China than competing products from suppliers in Europe and elsewhere which do not require an export license for shipment to China. This difficulty and uncertainty has adversely affected our ability to compete for and win business from customers in these foreign jurisdictions.

11

Foreign customers affected by these and future U.S. government sanctions or threats of sanctions may respond by developing their own solutions to replace our products or by utilizing our foreign competitors’ products.

Tariff and trade policy discussions between the U.S., China and its other trading partners are ongoing and fluid. These tariffs and other policy changes are subject to a number of uncertainties as they are implemented. The ultimate reaction of other countries and the individuals in each of these countries may have an adverse impact on the U.S. and global economies, and our business, results of operations and financial condition.

Disruptions in our information technology systems or data security incidents could result in significant financial, legal, regulatory, business, and reputational harm to us.

We are increasingly dependent on information technology systems and infrastructure, including mobile technologies, to operate our business. In the ordinary course of our business, we collect, store, process and transmit significant amounts of sensitive information, including intellectual property, proprietary business information, personally-identifiable information of individuals, and other confidential information, including that of our customers and other business partners. It is critical that we do so in a secure manner to maintain the confidentiality, integrity, and availability of this sensitive information. We have also outsourced elements of our operations (including elements of our information technology infrastructure) to third parties, and as a result, we manage a number of third-party vendors who have access to our computer networks and our confidential information.

All information systems are subject to disruption, breach, or failure. Potential vulnerabilities can be exploited from inadvertent or intentional actions of our employees, third-party vendors, business partners, or by malicious third parties. Attacks of this nature are increasing in their frequency, levels of persistence, sophistication, and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of expertise and motives (including industrial espionage), including organized criminal groups, nation states, and others. In addition to the extraction of sensitive information, attacks could include the deployment of harmful malware, ransomware, or other means which could affect service reliability and threaten the confidentiality, integrity, and availability of information. Significant disruptions in our, or our third-party vendors’, information technology systems or other data security incidents could adversely affect our business operations and result in the loss or misappropriation of, and unauthorized access to, sensitive information, which could result in financial, legal, regulatory, business, and reputational harm to us.

On November 1, 2018, we announced the discovery of an attack on our computer system by a highly-sophisticated actor. We notified law enforcement of the attack and retained forensic experts to assist with the investigation. It currently remains unclear whether we will be able to determine the extent of the breach or the potential impact on our operations. Also unclear is whether we will be able to identify who is responsible for the attack, or whether we will be able to pursue legal action or other remedies. The attack, including the expenses incurred to address it, may have an adverse effect on our results of operations and financial condition, may result in litigation, and may cause reputational harm.

While we are engaged in remediation and have implemented, and are continuing to implement, security measures intended to protect our information technology systems and infrastructure, there can be no assurance that such remediation and security measures will successfully prevent further security incidents. Additional information technology system disruptions, whether from attacks on our technology environment or from computer viruses, natural disasters, terrorism, war or other causes, could result in a material disruption in our business operations, force us to incur significant costs and engage in litigation, harm our reputation, and subject us to liability under laws, regulations, and contractual obligations.

We may be unable to effectively enforce and protect our intellectual property rights.

Our success as a company depends in part upon the protection of our intellectual property rights. We rely primarily on patent, copyright, trademark, and trade secret laws, as well as nondisclosure and confidentiality agreements and other methods, to protect our proprietary information, technologies, processes, and brand identity. We own various U.S. and international patents and have additional pending patent applications relating to certain of our products and technologies. The process of seeking patent protection is lengthy and expensive, and we cannot be certain that pending or future applications will actually result in issued patents or that issued patents will be of sufficient scope or strength to provide meaningful protection or commercial advantage. In addition, our intellectual property rights may be circumvented,

12

invalidated, or rendered obsolete by the rapid pace of technological change, or through efforts by others to reverse engineer our products or design around patents that we own. Policing unauthorized use of our products and technologies is difficult and time consuming and the laws of other countries may not protect our proprietary rights as fully or as readily as U.S. laws. Given these limitations, our success will depend in part upon our ability to innovate ahead of our competitors.

In addition, our outsourcing efforts require that we share certain portions of our technology with our outsourcing partners, which poses additional risks of infringement and trade secret misappropriation. Infringement of our rights by a third party, possibly for purposes of developing and selling competing products, could result in uncompensated lost market and revenue opportunities. Similar exposure could result in the event that former employees seek to compete with us through their unauthorized use of our intellectual property and proprietary information. We cannot be certain that the protective steps and measures we have taken will prevent the misappropriation or unauthorized use of our proprietary information and technologies, nor can we be certain that applicable intellectual property laws, regulations, and policies will not be changed in a manner detrimental to the sale or use of our products.

Litigation has been required in the past, is currently ongoing, and may be required in the future, to enforce our intellectual property rights, protect our trade secrets, and to determine the validity and scope of proprietary rights of others. As a result of any such litigation, we could lose our ability to enforce one or more patents, incur substantial costs, and jeopardize relationships with current or prospective customers or suppliers. Any action we take to enforce or defend our intellectual property rights could absorb significant management time and attention, and could otherwise negatively impact our operating results.

We may be subject to claims of intellectual property infringement by others.

We receive communications from time to time from other parties asserting the existence of patent or other rights which they believe cover certain of our products. We also periodically receive notices from customers who believe that we are required to indemnify them for damages they may incur related to infringement claims made against these customers by third parties. Our customary practice is to evaluate such assertions and to consider the available alternatives, including whether to seek a license, if appropriate. However, we cannot ensure that licenses can be obtained or, if obtained, will be on acceptable terms or that costly litigation or other administrative proceedings will not occur. If we are not able to resolve a claim, negotiate a settlement of the matter, obtain necessary licenses on commercially reasonable terms, or successfully prosecute and defend our position, our business, financial condition, and results of operations could be materially and adversely affected.

We face significant competition.

We face significant competition throughout the world, which may increase as certain markets in which we operate continue to evolve. Some of our competitors have greater financial, engineering, manufacturing, and marketing resources than us. Other competitors are located in regions with lower labor costs and other reduced costs of operation. In addition, our ability to compete in foreign countries against local manufacturers may be hampered by nationalism, social attitudes, laws, regulations, and policies within such countries that favor local companies over U.S. companies or that are otherwise designed to promote the development and growth of local competitors. Furthermore, we face competition from smaller emerging equipment companies whose strategy is to provide a portion of the products and services we offer, with a focused approach on innovative technology for specialized markets. New product introductions or enhancements by us or our competitors could cause a decline in sales or loss of market acceptance of our existing or prior generation products. Increased competitive pressure could also lead to intensified price competition resulting in lower margins.

To remain competitive, we may enter into strategic alliances with customers, suppliers, and other third parties to explore new market opportunities and possible technological advancements. These alliances may require significant investments of capital and other resources and often involve the exchange of sensitive confidential information. The success of these alliances may depend on factors over which we have limited control and will likely require ongoing cooperation and good faith efforts from our strategic partners. Strategic alliances are inherently subject to significant risks, and the inability to effectively manage these risks could materially and adversely affect our business and operating results.

13

We operate in industries characterized by rapid technological change.

Each of the industries in which we operate is subject to rapid technological change. Our ability to remain competitive depends on our ability to enhance existing products and develop and manufacture new products in a timely and cost effective manner and to accurately predict technology transitions. New product development commitments must be made well in advance of sales, and we must anticipate the future demand for products when selecting which development programs to fund and pursue. Our financial results depend on the successful introduction of new products, many of which require the achievement of increasingly stringent technical specifications. We may not be successful in selecting, developing, manufacturing, and marketing new products and new technologies or in enhancing our existing products. Our performance may be adversely affected if we are unable to accurately predict evolving market trends and related customer needs and to effectively allocate our resources among new and existing products and technologies.

We are also exposed to potential risks associated with unexpected product performance issues. Our product designs and manufacturing processes are complex and could contain unexpected product defects, especially when products are first introduced. Unexpected product performance issues could result in significant costs and damages, including increased service and warranty expenses, the need to provide product replacements or modifications, reimbursement for damages caused by our products, product recalls, related litigation, product write-offs, and disposal costs. Product defects could also result in personal injury or property damage, claims for which may exceed our existing insurance coverages. These and other costs could be substantial and our reputation could be harmed, resulting in a reduced demand for our products and a negative effect on our business, financial condition, and results of operations.

Certain of our sales are dependent on the demand for consumer electronics, which can experience significant volatility due to seasonal and other factors.

The demand for semiconductors, LEDs, HDDs and other devices is highly dependent on sales of consumer electronics, such as televisions, computers, tablets, digital video recorders, smartphones, cell phones, and other mobile devices. Factors that could influence the levels of spending on consumer electronic products include consumer confidence, access to credit, volatility in fuel and other energy costs, conditions in the residential real estate and mortgage markets, labor and healthcare costs, and other macroeconomic factors affecting consumer spending behavior. These and other economic factors have had and could continue to have a material adverse effect on the demand for our customers’ products and, in turn, on our customers’ demand for our products and services. Furthermore, in the past, some of our customers have overestimated their potential for market share growth. If this growth is overestimated, we may experience cancellations of orders in backlog, rescheduling of customer deliveries, obsolete inventory, and liabilities to our suppliers for products no longer needed.

In addition, the demand for our customers’ products can be even more volatile and unpredictable due to the possibility of competing technologies, such as flash memory as an alternative to HDDs. Unpredictable fluctuations in demand for our customers’ products or rapid shifts in demand from our customers’ products to alternative technologies could materially and adversely impact our future results of operations.

We have a concentrated customer base, located primarily in a limited number of regions, which operates in highly concentrated industries.

Our customer base continues to be highly concentrated. Orders from a relatively limited number of customers have accounted for, and likely will continue to account for, a substantial portion of our net sales, which may allow customers to demand pricing and other terms less favorable to us (including extended warranties, indemnification commitments, and the obligation to continue production of older products). Customer consolidation activity involving some of our largest customers could result in an even greater concentration of our sales in the future. Management changes at key customer accounts could result in a loss of future sales due to vendor preferences or other reasons and may introduce new challenges in managing customer relationships.

If a principal customer discontinues its relationship with us or suffers economic setbacks, our business, financial condition, and operating results could be materially and adversely affected. Our ability to increase sales in the future will depend in part upon our ability to obtain orders from new customers and we cannot be certain that we will be successful in these

14

efforts. In addition, because a relatively small number of large manufacturers, many of whom are our customers, dominate the industries in which they operate, it may be especially difficult for us to replace these customers if we lose their business. A significant portion of orders in our backlog are orders from our principal customers.

In addition, a substantial investment is required by customers to install and integrate capital equipment into a production line. As a result, once a manufacturer has selected a particular vendor to supply capital equipment, the manufacturer will often attempt to consolidate its other capital equipment requirements with the same vendor. Accordingly, if a customer selects a competitor’s product over ours, we could experience difficulty selling to that customer for a significant period of time.

Furthermore, we do not have long-term contracts with our customers. As a result, our agreements with our customers do not provide assurance of future sales, and we are exposed to competitive price pressures on new orders we attempt to obtain.

Our customer base is also highly concentrated in terms of geography, and the majority of our sales are to customers located in a limited number of countries. Dependence upon sales emanating from a limited number of regions increases our risk of exposure to local difficulties and challenges, such as those associated with regional economic downturns, political instability, trade wars and other trade disruptions, fluctuating currency exchange rates, natural disasters, social unrest, pandemics, terrorism, and acts of war. Our reliance upon customer demand arising primarily from a limited number of countries could materially and adversely impact our future results of operations.

The cyclicality of the industries we serve directly affects our business.

Our business depends in large part upon the capital expenditures of manufacturers in our four key markets: Front-End Semiconductor; Advanced Packaging, MEMS & RF Filters; LED Lighting, Display & Compound Semiconductor; and Scientific & Industrial. We are subject to the business cycles of these industries, the timing, length, and volatility of which are difficult to predict. These industries have historically been highly cyclical and have experienced significant economic downturns in the last decade. As a capital equipment provider, our revenue depends in large part on the spending patterns of these customers, who often delay expenditures or cancel or reschedule orders in reaction to variations in their businesses or general economic conditions. In downturns, we must be able to quickly and effectively align our costs with prevailing market conditions, as well as motivate and retain key employees. However, because a portion of our costs are fixed, our ability to reduce expenses quickly in response to revenue shortfalls may be limited. Downturns in one or more of these industries have had, and will likely have, a material adverse effect on our business, financial condition, and operating results. Alternatively, during periods of rapid growth, we must be able to acquire and develop sufficient manufacturing capacity to meet customer demand and attract, hire, assimilate, and retain a sufficient number of qualified people. Our net sales and operating results may be negatively affected if our customers experience economic downturns or slowdowns in their businesses.

The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly.

We derive a substantial portion of our net sales in any fiscal period from the sale of a relatively small number of high-priced systems. As a result, the timing of recognition of revenue for a single transaction could have a material effect on our sales and operating results for a particular fiscal period. As is typical in our industry, orders and shipments often occur during the last few weeks of a quarter. As a result, a delay of only a week or two can impact which period revenue is reported and can cause volatility in our revenue for a given reporting period. Our quarterly results have fluctuated significantly in the past and we expect this trend to continue. If our orders, shipments, net sales, or operating results in a particular quarter do not meet expectations, our stock price may be adversely affected as well.

Our sales cycle is long and unpredictable.

Historically, we have experienced long and unpredictable sales cycles (the period between our initial contact with a potential customer and the time that we recognize revenue for resulting sales to that customer). It is not uncommon for our sales cycle to exceed twelve months. The timing of an order often depends on our customer’s capital expenditure budget, over which we have no control. In addition, the time it takes us to build a product to customer specifications typically

15

ranges from three to six months. When coupled with the fluctuating amount of time required for shipment, installation, and final acceptance, our sales cycles often vary widely, and these variations can cause fluctuations in our operating results. As a result of our lengthy sales cycles, we may incur significant research, development, selling, general, and administrative expenses before we generate revenue for these products. We may never generate the anticipated revenue if a customer cancels or otherwise changes its purchase plans, which could have an adverse effect on our business.

We are now confronting many of these risks as we gain traction in the front-end semiconductor market, which is often characterized by long customer qualification times, typically twelve to eighteen months. Once qualified, the ramp to volume production can take an additional extended period of time, often twelve to twenty-four months. During these periods, little to no revenue will be recognized by us, while we will continue to incur research and development costs. Despite our efforts, our products may never be qualified and may never achieve design-tool-of-record (“DTOR”) or production-tool-of-record (“PTOR”) status, and our business, financial condition, and results of operations may be materially and adversely affected.

Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and liabilities to our suppliers for products no longer needed.

Customer purchase orders may be cancelled or rescheduled by the customer, sometimes with limited or no penalties, which may result in increased or unrecoverable costs for the Company. We adjust our backlog for such cancellations, contract modifications, and delivery delays that result in a delivery period in excess of one year, among other items. A downturn in one or more of our businesses could result in an increase in order cancellations and postponements.

We write-off excess and obsolete inventory based on historical trends, future usage forecasts, and other factors including the amount of backlog we have on hand. If our backlog is canceled or modified, our estimates of future product demand may prove to be inaccurate, in which case we may have understated the write-off required for excess and obsolete inventory. In the future, if we determine that our inventory is overvalued, we will be required to recognize associated costs in our financial statements at the time of such determination. In addition, we place orders with our suppliers based on our customers’ orders. If our customers cancel their orders with us, we may not be able to cancel our orders with our suppliers. Any such charges could be materially adverse to our results of operations and financial condition.

We may be unable to obtain required export licenses for the sale of our products.

Products which are either manufactured in the United States or based on U.S. technology are subject to the U.S. Export Administration Regulations (“EAR”) when exported to and re-exported from international jurisdictions, in addition to the local jurisdiction’s export regulations applicable to individual shipments. Currently, our MOCVD, MBE, and certain other systems and products are controlled for export under the EAR. Licenses or proper license exceptions may be required for the shipment of our products to certain customers or countries (and, as noted above, the U.S. Bureau of Industry and Security has indicated its intention to eliminate license exception CIV, which we currently utilize to facilitate the shipment of many of our products to customers in China). Obtaining an export license or determining whether an export license exception exists often requires considerable effort by us and cooperation from the customer, which can add time to the order fulfillment process. We may be unable to obtain required export licenses or unable to qualify for export license exceptions and, as a result, we may be unable to export products to our customers and/or meet their servicing needs. The administrative processing, potential delay and risk of ultimately not obtaining required export approvals pose a particular disadvantage to us relative to our non-U.S. competitors who are not required to comply with U.S. export controls. Non-compliance with the EAR or other applicable export regulations could result in a wide range of penalties including the denial of export privileges, fines, criminal penalties, and the seizure of commodities. In the event that an export regulatory body determines that any of our shipments violate applicable export regulations, we could be fined significant sums and our export capabilities could be restricted, which could have a material adverse impact on our business.

Our operating results may be adversely affected by tightening credit markets.

As a global company with worldwide operations, we are subject to volatility and adverse consequences associated with economic downturns in different parts of the world. In the event of a downturn, many of our customers may delay or reduce their purchases of our products and services. If negative conditions in the credit markets prevent our customers from obtaining credit or necessary financing, product orders in these channels may decrease, which could result in lower revenue.

16

In addition, we may experience cancellations of orders in backlog, rescheduling of customer deliveries, and attendant pricing pressures. If our suppliers face challenges in obtaining credit, in selling their products, or otherwise in operating their businesses, their ability to continue to supply materials to us may be negatively affected.

In addition, we finance some of our sales through trade credit. In addition to ongoing credit evaluations of our customers’ financial condition, we seek to mitigate our credit risk by obtaining deposits and letters of credit on certain of our sales arrangements. We could suffer significant losses if a customer whose accounts receivable we have not secured fails or is otherwise unable to pay us, or if financial institutions providing letters of credit become insolvent. A loss in collections on our accounts receivable would have a negative impact on our financial condition and results of operations.

Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and manufacturing interruptions or delays which could affect our ability to meet customer demand.

The success of our business depends in part on our ability to accurately forecast and supply equipment and services that meet the rapidly changing technical and volume requirements of our customers. To meet these demands, we depend on the timely delivery of parts, components, and subassemblies from our suppliers. Uncertain worldwide economic conditions and market instabilities make it difficult for us (and our customers) to accurately forecast future product demand. If actual demand for our products is different than expected, we may purchase more or fewer parts than necessary or incur costs for canceling, postponing, or expediting delivery of parts. If we overestimate the demand for our products, excess inventory could result which could be subject to heavy price discounting, which could become obsolete, and which could subject us to liabilities to our suppliers for products no longer needed. Similarly, we may be harmed in the event that our competitors overestimate the demand for their products and engage in heavy price discounting practices as a result. In addition, the volatility of demand for capital equipment poses risks for companies in our supply chain, including challenges associated with inventory management and fluctuating working capital requirements.

Furthermore, certain key parts may be subject to long lead-times or may be obtainable only from a single supplier or limited group of suppliers, and some sourcing and assembly is provided by suppliers located in countries other than the United States. We may experience significant interruptions in our manufacturing operations, delays in our ability to timely deliver products or services, increased costs, or customer order cancellations as a result of:

● the failure or inability of our suppliers to timely deliver quality parts;

● volatility in the availability and cost of materials;

● difficulties or delays in obtaining required import or export approvals;

● information technology or infrastructure failures;

● natural disasters such as earthquakes, tsunamis, floods, or storms; or

● other causes such as regional economic downturns, international trade disruptions, pandemics, political instability, terrorism, or acts of war, which could result in delayed deliveries, manufacturing inefficiencies, increased costs, or order cancellations.

In addition, in the event of an unanticipated increase in demand for our products, our need to rapidly increase our business and manufacturing capacity may be limited by our working capital constraints and those of our suppliers, which may cause or exacerbate interruptions in our manufacturing and supply chain operations. Any or all of these factors could materially and adversely affect our business, financial condition, and results of operations.

Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations.

To better align our costs with market conditions, increase the percentage of variable costs relative to total costs, and to increase productivity and operational efficiency, we have outsourced certain functions to third parties, including the manufacture of several of our systems. While we maintain some level of internal manufacturing capability for these systems, we rely on our outsourcing partners to perform their contracted functions to allow us flexibility to adapt to

17

changing market conditions, including periods of significantly diminished order volumes. If our outsourcing partners do not perform as required, or if our outsourcing efforts do not allow us to realize the intended cost savings and flexibility, our results of operations (and those of our third-party providers) may be adversely affected. Disputes and possibly litigation involving third party providers could result and we could suffer damage to our reputation. Dependence on contract manufacturing and outsourcing may also adversely affect our ability to bring new products to market. Although we attempt to select reputable providers, one or more of these providers could fail to perform as we expect. If we do not effectively manage our outsourcing efforts or if third party providers do not perform as anticipated, we may not realize the benefits of productivity improvements and we may experience operational difficulties, increased costs, manufacturing and installation interruptions or delays, inefficiencies in the structure and operation of our supply chain, loss of intellectual property rights, quality issues, increased product time-to-market, and an inefficient allocation of our human resources, any or all of which could materially and adversely affect our business, financial condition, and results of operations.

We rely on a limited number of suppliers, some of whom are our sole source for particular components.

Certain of the parts, components, and sub-assemblies included in our products are obtained from a single source or a limited group of suppliers. Our inability to develop alternative sources, as necessary, could result in a prolonged interruption in our ability to supply related products, a failure on our part to meet the demands our customers, and a significant increase in the price of related products, which could adversely affect our business, financial condition, and results of operations.

The price of our common shares is volatile and could decrease.

The stock market in general and the market for technology stocks in particular has experienced significant volatility. The trading price of our common shares has fluctuated significantly and could decline independent of the overall market, and shareholders could lose all or a substantial part of their investment. The market price of our common shares could continue to fluctuate in response to several factors, including among others:

● difficult macroeconomic conditions, international trade disputes, unfavorable geopolitical events, and general stock market uncertainties, such as those occasioned by a global liquidity crisis and a failure of large financial institutions;

● the emergence of competitors and competing technologies;

● receipt of large orders or cancellations of orders for our products;

● issues associated with the performance of our products, or the performance of our internal systems such as our customer relationship management (“CRM”) system or our enterprise resource planning (“ERP”) system;

● actual or anticipated variations in our results of operations;

● announcements of financial developments or technological innovations;

● our failure to meet the performance estimates of investment research analysts;

● changes in recommendations and financial estimates by investment research analysts, and decisions by investment research analysts to cease coverage of our company;

● strategic transactions, such as acquisitions, divestitures, and spin-offs, and the results of our investment decisions;

● our failure to successfully and timely implement cost reduction initiatives and restructuring activities, if and when required;

● the commencement of, and rulings on, litigation and legal proceedings;

● the dilutive impact of our Convertible Senior Notes; and

● the occurrence of major catastrophic events.

Securities class action litigation is often brought against a company following periods of volatility in the market price of its securities. We have defended security class actions lawsuits in the past, and are currently defending such a lawsuit now.

18

These lawsuits, if and when brought, can result in substantial costs and a diversion of management’s attention and resources, which can adversely affect our financial condition, results of operations, and liquidity.

We may be required to take impairment charges on assets.

We are required to assess goodwill and indefinite-lived intangible assets annually for impairment, or on an interim basis whenever certain events occur or circumstances change, such as an adverse change in business climate or a decline in the overall industry, that would more likely than not reduce the fair value below its carrying amount. We maintain a single reporting unit, and as such, if our stock price decreases to the point where our fair value, as determined by our adjusted market capitalization, is less than the carrying value of our single reporting unit, this would also indicate a potential impairment, and we may be required to record an impairment charge in that period, which could adversely affect our results of operations. Such an impairment charge was taken by the Company during the fourth quarter of 2018, in the amount of $122.8 million.

As part of our long term strategy, we may pursue future acquisitions of, or investments in, other companies or assets which could potentially increase our assets. We are required to test certain of our assets, including acquired intangible assets, property, plant, and equipment, and equity investments without readily observable market prices, for recoverability and impairment whenever there are indicators of impairment such as an adverse change in business climate. Adverse changes in business conditions or worse-than-expected performance by these acquired companies could negatively impact our estimates of future operations and result in impairment charges to these assets. For example, during the second quarter of 2018, we recorded an asset impairment charge of $252.3 million related to the intangible assets acquired as part of our acquisition of Ultratech, Inc. In addition, in the fourth quarter of 2019 we recorded asset impairment charges of $25.0 million, primarily related to our equity investments without readily observable market prices. If our assets are further impaired, our financial condition and results of operations could be materially and adversely affected.

Our inability to attract, retain, and motivate employees could have a material adverse effect on our business.

Our success depends in part upon our ability to attract, retain, and motivate employees, including those in executive, managerial, engineering and marketing positions, as well as highly skilled and qualified technical personnel. Attracting, retaining, and motivating such qualified personnel may be difficult due to challenging industry conditions, competition for such personnel by other technology companies, consolidations and relocations of operations, and workforce reductions, and there can be no assurance that we will be successful in recruiting or retaining key personnel. We have entered into employment agreements with certain key personnel but our inability to attract, retain, and motivate key personnel could have a material adverse effect on our business, financial condition, and results of operations.

We are exposed to risks associated with business combinations, acquisitions, strategic investments and divestitures.

We have completed several significant acquisitions and investments in the past and we will consider new opportunities in the future. Acquisitions and investments involve numerous risks, many of which are unpredictable and beyond our control, including the following:

● difficulties and increased costs in integrating the personnel, operations, technologies, and products of acquired companies;

● diversion of management’s attention and disruption of ongoing businesses;

● the inability to complete proposed transactions as anticipated, resulting in obligations to pay professional and other expenses, including any applicable termination fees;

● potential loss of key employees of acquired companies, especially if a relocation or change in responsibilities is involved;

● difficulties in managing geographically dispersed operations in a cost effective manner;

● the failure to realize expected synergies;

● unknown, underestimated, and undisclosed commitments or liabilities;

19

● increased amortization expenses relating to intangible assets; and

● other adverse effects on our business, including the potential impairment and write-down of amounts capitalized as intangible assets and goodwill as part of the acquisition, as a result of such matters as technological advancements or worse-than-expected performance by the acquired company.

If we issue equity securities to pay for an acquisition or investment, the ownership percentage of our then-current shareholders would be reduced and the value of the shares held by these shareholders could be diluted, which could adversely affect the price of our stock. If we use cash to pay for an acquisition or investment, the payment could significantly reduce the cash that would be available to fund our operations, pay our indebtedness, or be used for other purposes, which could have a negative effect on our business.

In addition, we continually assess the strategic fit of our businesses and may from time to time seek to divest portions of our business that no longer fit our strategic plan, such as the potential sale of a non-core product line that was classified as held for sale as of December 31, 2019. Divestitures involve significant risks and uncertainties, including the ability to sell such businesses at satisfactory prices, on acceptable terms, and in a timely manner. Divestitures may also disrupt other parts of our businesses, distract the attention of our management, result in a loss of key employees or customers, and require that we allocate internal resources that would otherwise be devoted to operating our existing businesses. Divestitures may expose us to unanticipated liabilities (including those arising from representations and warranties made to a buyer regarding the businesses) and to ongoing obligations to support the businesses following such divestitures, any and all of which could adversely affect our business, financial condition, and results of operations.

We are subject to internal control evaluations and attestation requirements of Section 404 of the Sarbanes-Oxley Act and any delays or difficulties in satisfying these requirements or negative reports concerning our internal controls could adversely affect our future results of operations and our stock price.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we must include in our Annual Report on Form 10-K a report by management on the effectiveness of our internal control over financial reporting. Ongoing compliance with this requirement is complex, costly, time-consuming, and is subject to significant judgment. If our internal controls are ineffective or if our management does not timely assess the adequacy of such internal controls, our ability to file timely and accurate periodic reports may be impeded. Any delays in filing may cause us to face the following risks and concerns, among others:

● concern on the part of our customers, partners, investors, and employees about our financial condition and filing delay status, including the potential loss of business opportunities;

● significant time and expense required to complete delayed filings and the distraction of our senior management team and board of directors as we work to complete delayed filings;

● investigations by the SEC and other regulatory authorities of the Company and our management;

● limitations on our ability to raise capital or possible violations of existing debt covenants;

● suspension or termination of our stock listing on The NASDAQ Global Select Market and the removal of our stock as a component of certain stock market indices; and

● general reputational harm.

Any or all of the foregoing could result in the commencement of stockholder lawsuits against the Company. Any such litigation, as well as any proceedings that could arise as a result of a filing delay and the circumstances which gave rise to it, may be time consuming and expensive, may divert management attention from the conduct of our business, could have a material adverse effect on our business, financial condition, and results of operations, and may expose us to costly indemnification obligations to current or former officers, directors, or other personnel, regardless of the outcome of such matters, which may not be adequately covered by insurance.

20

Changes in accounting pronouncements or taxation rules or practices may adversely affect our financial results.

Changes in accounting pronouncements or taxation rules or practices can have a significant effect on our reported results. New accounting pronouncements and taxation rules can have a material impact on revenue recognition practices, effective tax rates, results of operations, and our financial condition. In addition, varying interpretations of accounting pronouncements or taxation practices, and the questioning of our current or past practices (such as those associated with our transfer pricing), may adversely affect our reported financial results.

Our income taxes may change.

We are subject to income tax on a jurisdictional or legal entity basis and significant judgment is required in certain instances to allocate our taxable income to a jurisdiction and to determine the related income tax expense and benefits. Losses in one jurisdiction generally may not be used to offset profits in other jurisdictions. As a result, changes in the mix of our earnings (or losses) between jurisdictions, among other factors, could alter our overall effective income tax rate, possibly resulting in significant tax rate increases.

We are regularly audited by various tax authorities. Income tax audit assessments or changes in tax laws, regulations, or other interpretations may result in increased tax provisions which could materially affect our operating results in the period or periods in which such determinations are made or changes occur.

In addition, our effective tax rate could increase if we determine that it is no longer more likely than not that we are able to realize our remaining net deferred tax assets, if we are unable to generate sufficient future taxable income in certain jurisdictions, or if we are otherwise required to increase our valuation allowances against our deferred tax assets.

We have indebtedness in the form of convertible senior notes which could adversely affect our financial position, prevent us from implementing our strategy, and dilute the ownership interest of our existing shareholders.

In January of 2017, we issued $345 million of 2.70% Convertible Senior Notes due 2023 (“Convertible Senior Notes”). The Convertible Senior Notes are convertible into Company common stock at an initial conversion rate of 24.98 shares of Company common stock per $1,000 principal amount of the Convertible Senior Notes. The Company is obligated to repurchase the Convertible Senior Notes upon the occurrence of certain events described in the indenture relating to the Convertible Senior Notes. The degree to which we are leveraged could have negative consequences, including but not limited to the following:

● we may be more vulnerable to economic downturns, less able to withstand competitive pressures, and less flexible in responding to changing business and economic conditions;

● our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate, and other purposes may be limited;

● a substantial portion of our cash flows from operations in the future may be required for the payment of the principal amount of our existing indebtedness when it becomes due; and

● we may elect to make cash payments upon any conversion of the Convertible Senior Notes, which would reduce our cash on hand.

Our ability to meet our payment obligations under the Convertible Senior Notes depends on our ability to generate significant cash flow in the future. This, to some extent, is subject to general economic, financial, competitive, legislative, regulatory, and other factors that are beyond our control. There can be no assurance that our business will generate cash flow from operations, or that additional capital will be available to us, in an amount sufficient for us to meet our debt payment obligations and to fund other liquidity needs. If we are unable to generate sufficient cash flow to service our debt obligations, we may need to refinance or restructure our debt, sell assets, reduce or delay capital investments, or seek to raise additional capital. If we are unable to implement one or more of these alternatives, we may be unable to meet our debt payment obligations, which could have a material adverse effect on our business, results of operations, and financial condition.

21

Furthermore, if the Convertible Senior Notes are converted into shares of Company common stock, the issuance of additional shares of Company common stock would dilute the ownership interest of our existing shareholders and could have a dilutive effect on our net income per share to the extent that the price of our common stock exceeds the conversion price of the Convertible Senior Notes. In addition, any sales in the public market of our common stock issuable upon conversion of the Convertible Senior Notes could adversely affect prevailing market prices of our common stock.

The accounting method for convertible debt securities that may be settled in cash, such as the Convertible Senior Notes, could have a material effect on our reported financial results.

Under Accounting Standards Codification 470-20, Debt with Conversion and Other Options (“ASC 470-20”), an entity must separately account for the liability and equity components of certain convertible debt instruments (such as the Convertible Senior Notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer’s economic interest cost. The effect of ASC 470-20 on the accounting for the Convertible Senior Notes is that the equity component is required to be included in the additional paid-in capital section of stockholders’ equity on our consolidated balance sheet, and the value of the equity component would be treated as original issue discount for purposes of accounting for the debt component of the Convertible Senior Notes. As a result, we will be required to record a greater amount of non-cash interest expense in current periods presented as a result of the amortization of the discounted carrying value of the Convertible Senior Notes to their face amount over the term of the Convertible Senior Notes. We will report lower net income in our financial results because ASC 470-20 will require interest to include both the current period’s amortization of the debt discount and the instrument’s coupon interest, which could adversely affect our financial results, the trading price of our common stock, and the trading price of the Convertible Senior Notes.

In addition, under certain circumstances, including our ability and intent to settle the convertible debt instruments in cash, convertible debt instruments (such as the Convertible Senior Notes) that may be settled entirely or partly in cash can be accounted for utilizing the treasury stock method, the effect of which is that the shares issuable upon conversion of the Convertible Senior Notes are not included in the calculation of diluted income per share except to the extent that the conversion value of the Convertible Senior Notes exceeds their principal amount. Under the treasury stock method, for diluted income per share purposes, the transaction is accounted for as if the number of shares of common stock that would be necessary to settle such excess, if we elected to settle such excess in shares, are issued. We cannot be sure that we will meet the criteria to utilize the treasury stock method in the future. If we are unable to utilize the treasury stock method, we would be required to apply the if-converted method. Under that method, diluted income per share would generally be calculated assuming that all the Convertible Senior Notes were converted solely into shares of our common stock at the beginning of the reporting period, unless the result would be anti-dilutive. If we are unable or otherwise elect not to use the treasury stock method in accounting for the shares issuable upon conversion of the Convertible Senior Notes, then our diluted income per share would be adversely affected.

In July 2019, the FASB issued an exposure draft that proposes to change the accounting for convertible debt instruments, such as the Convertible Senior Notes. Under the exposure draft, an entity may no longer be required to separately account for the liability and equity components of convertible debt instruments. This could have the impact of reducing non-cash interest expense, and thereby increasing net income. Additionally, as currently proposed, the treasury stock method for calculating earnings per share will no longer be allowed for convertible debt instruments whose principal amount may be settled using shares. Rather, the if-converted method may be required, which would adversely affect our diluted net income per share. We cannot be sure that the proposed changes in this exposure draft will be adopted, or will be adopted in their current format. We also cannot be sure whether other changes may be made to the current accounting standards related to the Convertible Senior Notes, or otherwise, that could have an adverse impact on our financial statements.

We are subject to foreign currency exchange risks.

We are exposed to foreign currency exchange rate risks that are inherent in our anticipated sales, sales and purchase commitments, and assets and liabilities that are denominated in currencies other than the U.S. dollar. Although we attempt to mitigate our exposure to fluctuations in currency exchange rates, hedging activities may not always be available or adequate to mitigate the impact of our exchange rate exposure. Failure to sufficiently hedge or otherwise manage foreign currency risks properly could materially and adversely affect our financial condition, results of operations, and liquidity.

22

We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult.

We have adopted, and may in the future adopt, certain measures that may have the effect of delaying, deferring, or preventing a takeover or other change in control of our Company, which a holder of our common stock might not consider to be in the holder’s best interest. These measures include:

● “blank check” preferred stock;

● a classified board of directors; and

● certain other provisions appearing in our certificate of incorporation and bylaws.

Our board of directors has the authority to issue up to 500,000 shares of preferred stock and to fix the rights (including voting rights), preferences and privileges of these shares (“blank check” preferred). Such preferred stock may have rights, including economic rights, senior to our common stock. As a result, the issuance of the preferred stock could have a material adverse effect on the price of our common stock and could make it more difficult for a third party to acquire a majority of our outstanding common stock.

Our board of directors is divided into three classes with each class serving a staggered three-year term. The existence of a classified board makes it more difficult for our shareholders to change the composition of our board of directors, and therefore the Company’s policies, in a relatively short period of time.

We have adopted certain certificate of incorporation and bylaws provisions which have anti-takeover effects. These include: (a) requiring certain actions to be taken at a meeting of shareholders rather than by written consent, (b) requiring a super-majority of shareholders to approve certain amendments to our bylaws, (c) limiting the maximum number of directors, and (d) providing that directors may be removed only for cause. These measures and those described above may have the effect of delaying, deferring, or preventing a takeover or other change in control of our Company that a holder of our common stock may not consider to be in the holder’s best interest.

In addition, we are subject to the provisions of Section 203 of the General Corporation Law of the State of Delaware, which prohibits a Delaware corporation from engaging in any business combination, including mergers and asset sales, with an interested stockholder (generally, a 15% or greater stockholder) for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. The operation of Section 203 may have anti-takeover effects, which could delay, defer, or prevent a takeover attempt that a holder of our common stock may not consider to be in the holder’s best interest.

Despite the above measures, an activist shareholder could undertake action to implement governance, strategic, or other changes to the Company which a holder of our common stock may not consider to be in the holder’s best interest. Such activities could interfere with our ability to execute our strategic plans, be costly and time consuming, disrupt our operations, and divert the attention of management and our employees.

We are exposed to various risks associated with global regulatory requirements.

As a public company with global operations, we are subject to the laws of the United States and multiple foreign jurisdictions, and the rules and regulations of various governing bodies, which may differ among jurisdictions. We are required to comply with legal and regulatory requirements pertaining to such matters as data privacy (including, for example, the European Union General Data Protection Regulation and similar laws), labor laws, immigration, customs, trade, taxes, corporate governance, conflict minerals and other social responsibility legislation, and antitrust regulations, among others. These laws and regulations, which are ever-evolving and at times complex and inconsistent, impose costs on our business and divert management time and attention from revenue-generating activities. Changes to or ambiguities in these laws and regulations may create uncertainty regarding our compliance requirements. While we intend to invest the required resources to comply with these regulatory requirements, if we are found by a court or regulatory agency to have failed in these efforts, our business, financial condition, and results of operations could be adversely affected.

23

We may be exposed to liabilities under the Foreign Corrupt Practices Act and other similar laws.

We are subject to the Foreign Corrupt Practices Act of 1977 (“FCPA”) and other laws that prohibit improper payments or offers of payments to foreign government officials, as defined by the statute, for the purpose of obtaining or retaining business. In addition, many of our customers have policies limiting or prohibiting us from providing certain types or amounts of entertainment, meals, or gifts to their employees. It is our policy to implement safeguards to discourage these practices by our employees and representatives. However, our safeguards may prove to be ineffective and our employees, consultants, sales agents, or distributors may engage in conduct for which we may be held responsible. In addition, we may acquire a company that has engaged in unlawful conduct in the past, and be held responsible for this conduct through successor liability principles. Violations of the FCPA or similar laws or similar customer policies may result in severe criminal or civil sanctions or the loss of supplier privileges to a customer and we may be subject to other liabilities, which could negatively affect our business, financial condition, and results of operations.

We are subject to risks of non-compliance with environmental, health, and safety regulations.

From a corporate governance perspective, there is an increasing focus on reducing energy usage and improving the environmental impact and sustainability associated with manufacturing operations. In addition, we are subject to environmental, health, and safety regulations in connection with our business operations, including but not limited to regulations related to the development, manufacture and use of our products, recycling and disposal of related materials, and the operation and use of our facilities and real property. Failure or inability to comply with existing or future environmental, safety and sustainability standards and regulations could result in significant remediation liabilities, the imposition of fines, the suspension or termination of research, development, or use of certain of our products, and other harm to the Company, which could have a material adverse effect on our business, financial condition, and results of operations. Furthermore, some of our operations involve the storage, handling, and use of hazardous materials that may pose a risk of fire, explosion, or environmental release. Such events could result from acts of terrorism, natural disasters, or operational failures and may result in injury or loss of life to our employees and others, local environmental contamination, and property damage. These events may cause a temporary shutdown of an affected facility, or portion thereof, and we could be subject to penalties or claims as a result. Each of these events could have a material adverse effect on our business, financial condition, and results of operations.

We have significant operations in locations which could be materially and adversely impacted in the event of a natural disaster, an act of terrorism, or other significant disruption.

Our operations in the United States, in the Asia-Pacific region, and in other areas could be subject to natural disasters or other significant disruptions, including earthquakes, tsunamis, fires, hurricanes, floods, water shortages, other extreme weather conditions, medical epidemics and severe outbreaks (such as coronavirus), power shortages and blackouts, telecommunications failures, and other natural and manmade disasters or disruptions. In the event of such a natural disaster or other disruption, we could experience disruptions or interruptions to our operations and to the operations of our suppliers, distributors, resellers and customers, destruction of facilities and loss of life, all of which could materially increase our costs and expenses and materially and adversely affect our business, financial condition, and results of operations. In addition, various regions of the world in which we do business are subject to the threat of terrorism and acts of war. Any act of terrorism or war that affects the economy or the industries in which we operate could result in significant harm to us, including the loss of life and property, manufacturing and transportation delays, disruptions in our supply chain, the need to comply with enhanced security measures, and other increased costs.

Item 1B. Unresolved Staff Comments

None.

24

Item 2. Properties

Our corporate headquarters and principal research and development, manufacturing, and sales and service facilities are:

	Approximate
Owned Facilities Location	Size (sq. ft.)	Use
Plainview, NY	80,000	Corporate Headquarters; R&D; Sales & Service; Administration
Somerset, NJ	80,000	R&D; Manufacturing; Sales & Service; Administration
St. Paul, MN	43,000	R&D; Manufacturing; Sales & Service; Administration
Somerset, NJ	38,000	R&D; Sales & Service; Administration

	Approximate		Lease
Leased Facilities Location	Size (sq. ft.)	Use	Expires
San Jose, CA	100,000	R&D; Manufacturing; Sales & Service; Administration	2023
Somerset, NJ	57,000	Warehouse	2022
Horsham, PA	49,000	R&D; Manufacturing; Sales & Service; Administration	2024
Singapore	23,000	Sales & Service; Administration	2023
Waltham, MA	19,000	R&D; Sales & Service; Administration	2023

In addition to the above, we lease a small office in Malta, New York for sales and service and our foreign sales and service subsidiaries lease office space in China, Germany, Japan, Malaysia, Philippines, South Korea, Thailand, Taiwan and the United Kingdom. We believe our facilities are adequate to meet our current needs.

Item 3. Legal Proceedings

On June 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed on behalf of different plaintiffs in the same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the Securities Act of 1933 for, among other things, alleged false/misleading statements in the registration statement and prospectus relating to the Ultratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. Veeco is defending this matter vigorously.

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the Superior Court of the State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Item 4. Mine Safety Disclosures

Not Applicable.

25

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock is quoted on The NASDAQ Global Select Market under the symbol “VECO.” As of February 14, 2020, there were approximately 131 stockholders of record of our common stock. Because many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders. We have not paid dividends on our common stock. The Board of Directors will determine future dividend policy based on our consolidated results of operations, financial condition, capital requirements, and other circumstances.

Issuer Purchases of Equity Securities

On December 11, 2017, our Board of Directors authorized a program to repurchase up to $100 million of the Company’s outstanding common stock to be completed through December 11, 2019, after completion of the previous program on October 28, 2017. During fiscal years 2018 and 2017, we repurchased 1.0 million shares and 0.2 million shares of our common stock for $11.3 million and $3.0 million, respectively, through our share repurchase programs. We did not purchase any shares during the fiscal year 2019. At the end of the program, $14.3 million of the $100 million had been utilized.

26

Stock Performance Graph

ASSUMES $100 INVESTED ON DEC. 31, 2014

ASSUMES DIVIDENDS REINVESTED

FISCAL YEAR ENDING DEC. 31

	2014	2015	2016	2017	2018	2019
Veeco Instruments Inc.	100.00	58.94	83.57	42.57	21.24	42.10
S&P Smallcap 600	100.00	98.03	124.06	140.48	128.56	157.85
RDG MidCap Technology	100.00	90.54	91.63	95.17	80.39	96.51

27

Item 6. Selected Financial Data

The information set forth below should be read in conjunction with the “Results of Operations” section included in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

	Year ended December 31,
	2019		2018		2017 (1)(2)		2016 (1)		2015 (1)
	(in thousands, except per share data)
Statement of Operations Data:
Net sales	$	419,349	$	542,082	$	475,686	$	331,702	$	477,038
Operating income (loss)		(39,578)		(415,502)		(71,868)		(120,162)		(23,232)
Net income (loss)		(78,733)		(407,088)		(51,396)		(122,027)		(31,978)
Basic income (loss) per common share		(1.66)		(8.63)		(1.16)		(3.10)		(0.80)
Diluted income (loss) per common share		(1.66)		(8.63)		(1.16)		(3.10)		(0.80)

(1) Effective January 1, 2018, the Company adopted the new revenue accounting standard (“ASC 606”). The results of operations for 2017 and 2016 have been recast for the new standard, while prior years have not. Refer to Note 1, “Significant Accounting Policies” for additional information.

(2) During the second quarter of 2017, the Company acquired Ultratech. The results of operations of Ultratech have been included in the consolidated financial statements since that date.

	December 31,
	2019 (1)		2018		2017 (2)		2016 (2)		2015
	(in thousands)
Balance Sheet Data:
Cash and cash equivalents	$	129,294	$	212,273	$	279,736	$	277,444	$	269,232
Short-term investments		115,252		48,189		47,780		66,787		116,050
Working capital		357,654		360,027		372,822		365,374		379,904
Total assets		818,088		900,816		1,387,475		763,988		890,789
Long-term debt (less current installments)		300,068		287,392		275,630		826		1,193
Total equity		374,512		437,775		840,093		601,704		714,615

(1) Effective January 1, 2019, the Company adopted the new lease accounting standard (“ASC 842”). The balance sheet and results of operations for prior periods have not been recast for the new standard. Refer to Note 1, “Significant Accounting Policies” for additional information.

(2) Effective January 1, 2018, the Company adopted the new revenue accounting standard (“ASC 606”). The results of operations for 2017 and 2016 have been recast for the new standard, while prior years have not. Refer to Note 1, “Significant Accounting Policies” for additional information.

28

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Executive Summary

We are an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in many of the markets we serve.

We categorize our revenue by the key market segments into which we sell. Our four key markets are: Front-End Semiconductor; Advanced Packaging, MEMS & RF Filters; LED Lighting, Display & Compound Semiconductor; and Scientific & Industrial.

Sales in the Front-End Semiconductor market were driven by Laser Annealing systems and Low Defect Density Ion Beam Deposition (“LDD-IBD”) systems for Extreme Ultraviolet (“EUV”) Mask Blank Production. We continue to build momentum in the Front-End Semiconductor market with shipments and additional orders for our EUV mask blank systems as well as advanced node penetration with our Laser Annealing systems. The ongoing adoption of EUV Lithography for advanced node, front-end semiconductor manufacturing is a good trend for us, as is our Laser Annealing progress and opportunity with current advanced nodes and future nodes.

Sales in the Advanced Packaging, MEMS & RF Filter market were driven by Lithography and wet etch and clean systems. Advanced Packaging opportunities remained soft in 2019 as mobile supply chains were dealing with excess capacity due to weak mobile device forecasts. We remain well positioned for future growth in these markets, supported by trends such as artificial intelligence, mobile connectivity, automotive electronics, big data processing, and 5G infrastructure deployment, as well as the longer term growth of FOWLP and other Advanced Packaging applications.

Sales in the LED Lighting, Display & Compound Semiconductor market were very weak in 2019 with limited system shipments of MOCVD systems. More recently, we have been focused on compound semiconductor applications such as 3D sensors, VCSELs, laser diodes, and RF devices. Our broad portfolio of MOCVD and wet etch and clean technologies have been developed to support these industry applications. During 2019, we shipped our first Lumina evaluation system. This As/P-based system was developed to meet our customers’ requirements for the photonics market which includes specialty LEDs, edge emitting lasers and VCSELs. Additionally, in 2019 we shipped and received acceptance on our fully automated, 300mm single wafer MOCVD cluster system to a major front-end fab. This GaN based system is ideal for power and 5G RF applications.

Sales in the Scientific & Industrial market were supported by shipments of Ion Beam systems for data storage applications and optical coatings as well as shipments of MBE systems to universities and laboratories. Demand for our Ion Beam products for Data Storage is being driven by big data and cloud-based storage growth. In order to be successful, hard disk drive manufacturers are required to improve areal density of magnetic heads for hard disk drives and are manufacturing drives with an increasing number of thin film magnetic heads. These two factors taken together along with new innovations by HDD manufacturers such as heat assisted magnetic recording (“HAMR”) and microwave assisted magnetic recording (“MAMR”) are driving additional capacity and equipment upgrades. While equipment demand from each individual market may fluctuate quarter to quarter, the diverse customer base has historically provided a relatively stable revenue stream for the Company.

29

Results of Operations

Years Ended December 31, 2019 and 2018

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 2019 and 2018 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment. See Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the SEC on February 25, 2019, as amended by Amendment No. 1 to such Annual Report on Form 10-K, filed with the SEC on May 1, 2019, for Management’s Discussions and Analysis of Financial Condition and Results of Operations for the fiscal year ended December 31, 2017.

	For the year ended December 31,								Change
	2019				2018				Period to Period
	(dollars in thousands)
Net sales	$	419,349	100	%	$	542,082	100	%	$	(122,733)	(23)	%
Cost of sales		261,155	62	%		348,363	64	%		(87,208)	(25)	%
Gross profit		158,194	38	%		193,719	36	%		(35,525)	(18)	%
Operating expenses, net:
Research and development		90,557	22	%		97,755	18	%		(7,198)	(7)	%
Selling, general, and administrative		79,749	19	%		92,060	17	%		(12,311)	(13)	%
Amortization of intangible assets		17,085	4	%		32,351	6	%		(15,266)	(47)	%
Restructuring		6,403	2	%		8,556	2	%		(2,153)	(25)	%
Acquisition costs		—	—			2,959	1	%		(2,959)	(100)	%
Asset impairment		4,020	1	%		375,172	69	%		(371,152)	*
Other operating expense (income), net		(42)	—			368	—			(410)	*
Total operating expenses, net		197,772	47	%		609,221	112	%		(411,449)	(68)	%
Operating income (loss)		(39,578)	(9)	%		(415,502)	(77)	%		375,924	*
Interest income (expense), net		(17,405)	(4)	%		(18,332)	(3)	%		927	(5)	%
Other income (expense), net		(20,973)	(5)	%		—	—			(20,973)	*
Income (loss) before income taxes		(77,956)	(19)	%		(433,834)	(80)	%		355,878	*
Income tax expense (benefit)		777	—			(26,746)	(5)	%		27,523	*
Net income (loss)	$	(78,733)	(19)	%	$	(407,088)	(75)	%	$	328,355	*

* Not meaningful

Net Sales

The following is an analysis of sales by market and by region:

	Year ended December 31,								Change
	2019				2018				Period to Period
	(dollars in thousands)
Sales by market
Front-End Semiconductor	$	120,128	29	%	$	62,582	12	%	$	57,546	92	%
Advanced Packaging, MEMS & RF Filters		66,909	16	%		90,775	17	%		(23,866)	(26)	%
LED Lighting, Display & Compound Semiconductor		72,791	17	%		249,974	46	%		(177,183)	(71)	%
Scientific & Industrial		159,521	38	%		138,751	25	%		20,770	15	%
Total	$	419,349	100	%	$	542,082	100	%	$	(122,733)	(23)	%
Sales by geographic region
United States	$	126,160	30	%	$	125,659	23	%	$	501	—
China		71,078	17	%		194,032	36	%		(122,954)	(63)	%
EMEA		57,351	14	%		89,102	16	%		(31,751)	(36)	%
Rest of World		164,760	39	%		133,289	25	%		31,471	24	%
Total	$	419,349	100	%	$	542,082	100	%	$	(122,733)	(23)	%

30

Total sales decreased for the year ended December 31, 2019 against the comparable prior year period in the LED Lighting, Display & Compound Semiconductor and Advanced Packaging, MEMS & RF Filters markets, partially offset by increases in the Front-End Semiconductor and Scientific & Industrial markets. Pricing did not have a significant impact on the change in total sales. By geography, sales decreased in the China and EMEA regions, partially offset by an increase in the Rest of World region. The most significant decrease occurred in the China region, which was largely attributable to the decreased sales in the LED Lighting, Display & Compound Semiconductor market. We do not expect significant new orders in China for the LED Lighting, Display & Compound Semiconductor market in the near future. Sales increased in Rest of World due to an increase of sales in the Front-End Semiconductor market in Japan for our EUV mask blank systems. Sales in Japan and Taiwan were $48.1 million and $48.8 million, respectively, for the year ended December 31, 2019. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies.

Gross Profit

In 2019, gross profit decreased compared to 2018 primarily due to a decrease in sales volume, partially offset by increased gross margins. Gross margins increased principally due to product and region mix of sales in the periods, which included an exit out of the low margin commoditized LED market in China, partially offset by an increase in inventory reserves.

Research and Development

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses decreased in 2019 compared to 2018 primarily related to personnel-related expenses and professional fees as a result of our initiative to streamline operations, enhance efficiency, and reduce costs.

Selling, General, and Administrative

Selling, general, and administrative expenses decreased in 2019 compared to 2018 primarily related to personnel-related expenses and professional fees as a result of our initiative to streamline operations, enhance efficiency, and reduce costs.

Amortization Expense

Amortization expense decreased in 2019 compared to 2018 primarily as a result of the impairment of intangible assets during the second quarter of 2018.

Restructuring Expense

During the second quarter of 2018, we initiated plans to reduce excess capacity associated with the manufacture and support of our advanced packaging lithography and 3D wafer inspection systems by consolidating these operations into our San Jose, California facility. As a result of this and other cost saving initiatives, we announced headcount reductions of approximately 40 employees.

We continued to record restructuring charges in 2019 as a result of our efforts to further streamline operations, enhance efficiencies, and reduce costs. In the second half of 2019, we executed an initiative to reorganize various functions along product lines and created a central research and development organization to better allocate our resources to our highest priority projects. In addition, we delayered the organization while preserving our ability to execute. Collectively, these actions impacted approximately 60 employees.

Acquisition Costs

Acquisition costs incurred during 2018 are non-recurring charges incurred in connection with the acquisition of the Ultratech business, as well as legal and professional fees incurred in connection with certain integration activities.

31

Asset Impairment

During the fourth quarter of 2019, we determined that one of our product lines met the criteria for held for sale accounting treatment and recorded a non-cash impairment charge of $4.0 million to reduce these assets to their expected fair value upon sale.

During the second quarter of 2018, we lowered our projected results for the Ultratech asset group, which were significantly below the projected results at the time of the acquisition. The reduced projections were based on lower than expected unit volume of certain smartphones, which incorporate advanced packaging methods such as FOWLP, and a delay in the adoption of FOWLP advanced packaging by other electronics manufacturers, both of which slowed orders and reduced revenue projections for our advanced packaging lithography systems. In addition, there was a delay in the build out of 28nm facilities by companies in China who were expected to purchase our LSA systems. Taken together, the reduced projections identified during the second quarter of 2018 required us to assess the Ultratech asset group for impairment. As a result of the analysis, during the second quarter of 2018 we recorded a $252.3 million non-cash intangible asset impairment charge.

Additionally, as a result of a significant decline in our stock price during the fourth quarter of 2018, we concluded it was appropriate to perform an interim goodwill impairment test as of the end of fiscal 2018. The fair value of our reporting unit was determined using an adjusted market capitalization approach, which is calculated by multiplying our stock price by the number of outstanding shares and adding a control premium. The fair value of our reporting unit was determined to be below the carrying value, and we recorded an impairment charge equal to the excess of carrying value over fair value, or $122.8 million, for the year ended December 31, 2018. The valuation of goodwill will continue to be subject to changes in our market capitalization and observable market control premiums. 

Interest Income (Expense)

For the year ended December 31, 2019, we recorded net interest expense of $17.4 million, compared to $18.3 million for the comparable prior period. Included in interest expense for the year ended December 31, 2019 and 2018 were non-cash charges of $12.7 million and $11.8 million, respectively, related to the amortization of debt discount and transaction costs of the Convertible Senior Notes. Interest income increased to $4.7 million for 2019, compared to $3.2 million for the comparable prior period, primarily related to higher average interest yields.

Other Income (Expense)

During the fourth quarter of 2019, we determined that our equity investment in Kateeva had indicators of impairment, and as such, we reviewed this investment for impairment. Based on this review, we recorded a non-cash impairment charge of $21.0 million.

Income Taxes

The 2019 income tax expense of $0.8 million is comprised of: (i) a $1.0 million income tax expense attributed to the profitable non-U.S. operations, as well as withholding tax as we now expect to repatriate certain foreign earnings as a result of changes in tax laws under the 2017 Tax Act, (ii) a $0.3 million income tax expense related primarily to U.S. tax amortization of our indefinite-lived intangible assets that is not available to offset existing deferred tax assets, as well as state and local income taxes, which were partially offset by (iii) a $0.5 million income tax benefit related to the amortization and subsequent impairment of certain non-U.S. intangible assets during the year.

The 2018 income tax benefit of $26.7 million is comprised of: (i) a $25.2 million income tax benefit related to the impairment of certain intangible assets during the year, (ii) a $1.7 million income tax benefit recorded in connection with the 2017 Tax Act, (iii) a $0.4 million income tax expense related primarily to U.S. tax amortization of our indefinite-lived intangible assets that is not available to offset existing deferred tax assets, as well as state and local income taxes, and (iv) a $0.2 million income tax benefit from non-U.S. operations and non-U.S. withholding taxes recorded as we expected to repatriate certain foreign earnings as a result of changes in tax laws under the 2017 Tax Act.

32

Liquidity and Capital Resources

Our cash and cash equivalents, restricted cash, and short-term investments are as follows:

	December 31,		December 31,
	2019		2018
	(in thousands)
Cash and cash equivalents	$	129,294	$	212,273
Restricted cash		657		809
Short-term investments		115,252		48,189
Total	$	245,203	$	261,271

A portion of our cash and cash equivalents is held by our subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. At December 31, 2019 and 2018, cash and cash equivalents of $73.0 million and $66.9 million, respectively, were held outside the United States. As of December 31, 2019, we had $9.4 million of accumulated undistributed earnings generated by our non-U.S. subsidiaries for which the U.S. repatriation tax has been provided and did not require the use of cash due to the use of net operating loss carryforwards. Approximately $5.0 million of undistributed earnings would be subject to foreign withholding taxes if distributed back to the United States. We believe that our projected cash flow from operations, combined with our cash and short term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including scheduled interest payments on our Convertible Senior Notes due 2023.

A summary of the cash flow activity for the year ended December 31, 2019 and 2018 is as follows:

Cash Flows from Operating Activities

	For the year ended December 31,
	2019		2018
	(in thousands)
Net income (loss)	$	(78,733)	$	(407,088)
Non-cash items:
Depreciation and amortization		34,399		49,998
Non-cash interest expense		12,676		11,762
Deferred income taxes		360		(27,620)
Share-based compensation expense		15,270		16,074
Asset impairment		4,020		375,172
Impairment of equity investments		20,973		—
Provision for bad debts		392		—
Changes in operating assets and liabilities		(16,773)		(56,036)
Net cash provided by (used in) operating activities	$	(7,416)	$	(37,738)

Net cash used in operating activities was $7.4 million for the year ended December 31, 2019 and was due to the net loss of $78.7 million plus a decline in cash flow from operating activities due to changes in operating assets and liabilities of $16.8 million, partially offset by adjustments for non-cash items of $88.1 million. The changes in operating assets and liabilities was largely attributable to decreases in accounts payable and accrued expenses and customer deposits and deferred revenue, partially offset by decreases in inventories and deferred cost of sales, accounts receivable and contract assets, and prepaid expenses and other current assets.

Net cash used in operating activities was $37.7 million for the year ended December 31, 2018 and was due to the net loss of $407.1 million plus a decline in cash flow from operating activities due to changes in operating assets and liabilities of $56.0 million, partially offset by adjustments for non-cash items of $425.4 million. The changes in operating assets and liabilities was largely attributable to decreases in accounts payable and accrued expenses, customer deposits and deferred

33

revenue, and an increase in inventories and deferred cost of sales, partially offset by decreases in accounts receivable and contract assets, and prepaid expenses and other current assets.

Cash Flows from Investing Activities

	For the year ended December 31,
	2019		2018
	(in thousands)
Acquisitions of businesses, net of cash acquired	$	—	$	(2,662)
Capital expenditures		(10,873)		(12,654)
Changes in investments, net		(65,639)		(2,981)
Proceeds from held for sale assets		645		—
Net cash provided by (used in) investing activities	$	(75,867)	$	(18,297)

The net cash used in investing activities during the year ended December 31, 2019 was attributable to net change in investments as well as capital expenditures. The net cash used in investing activities during the year ended December 31, 2018 was attributable to capital expenditures, net change in investments, and net cash used in the final payout related to the acquisition of Ultratech.

Cash Flows from Financing Activities

	For the year ended December 31,
	2019		2018
	(in thousands)
Settlement of equity awards, net of withholding taxes	$	126	$	(5)
Purchases of common stock		—		(11,457)
Net cash provided by (used in) financing activities	$	126	$	(11,462)

The net cash provided by financing activities for the year ended December 31, 2019 was immaterial. The net cash used in financing activities for the year ended December 31, 2018 was primarily related to the share repurchase program that expired in December 2019.

Convertible Senior Notes

On January 10, 2017, we issued $345.0 million of 2.70% Convertible Senior Notes. We received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior Notes mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted. We believe that we have sufficient capital resources and cash flows from operations to support scheduled interest payments on this debt.

Contractual Obligations and Commitments

We have commitments under certain contractual arrangements to make future payments for goods and services. These contractual arrangements secure the rights to various assets and services to be used in the future in the normal course of business. We expect to fund these contractual arrangements with cash generated from operations in the normal course of business, as well as existing cash and cash equivalents and short-term investments. In addition, we have bank guarantees and letters of credit issued by a financial institution on our behalf as needed. At December 31, 2019, outstanding bank guarantees and letters of credit totaled $10.2 million and unused bank guarantees and letters of credit of $21.6 million were available to be drawn upon.

34

The following table summarizes our contractual arrangements at December 31, 2019 and the timing and effect that those commitments are expected to have on our liquidity and cash flow in future periods.

	Payments due by period
			Less than		1 – 3		3 – 5		More than
	Total		1 year		years		years		5 years
	(in thousands)
Principal payments on long-term debt	$	345,000	$	—	$	—	$	345,000	$	—
Cash interest on debt		28,333		9,315		18,630		388		—
Operating leases		16,064		4,932		10,581		551		—
Purchase commitments(1)		63,258		63,258		—		—		—
Total	$	452,655	$	77,505	$	29,211	$	345,939	$	—

(1)Purchase commitments are generally for inventory used in the manufacturing of our products. We generally do not enter into purchase commitments extending beyond one year. At December 31, 2019, we have $5.9 million of offsetting supplier deposits that will be applied against these purchase commitments.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on our financial condition, changes in financial condition, expenses, results of operations, liquidity, capital expenditures, or capital resources other than bank guarantees and purchase commitments reflected in the preceding “Contractual Obligations and Commitments” table.

Application of Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires a high degree of judgment, either in the application and interpretation of existing accounting literature or in the development of estimates that affect the reported amounts of assets, liabilities, revenues, and expenses. On an ongoing basis, we evaluate our estimates and judgments based on historical experience as well as other factors that we believe to be reasonable under the circumstances. The results of our evaluation form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. These estimates may change in the future if underlying assumptions or factors change, and actual results may differ from these estimates.

We consider the following significant accounting policies to be critical because of their complexity and the high degree of judgment involved in implementing them.

Revenue Recognition

We adopted ASC 606 as of January 1, 2018, using the full retrospective method. Refer to Note 1, “Significant Accounting Policies,” for additional information.

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration we expect to receive in exchange for such product or service. Our contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, we estimate the amount of variable consideration and determine what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. Our contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. We also evaluate whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

35

When there are separate units of accounting, we allocate revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which we separately sell the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, we estimate stand-alone selling prices generally using an expected cost plus margin approach.

Most of our revenue is recognized at a point in time when the performance obligation is satisfied. We consider many facts when evaluating each of our sales arrangements to determine the timing of revenue recognition, including our contractual obligations and the nature of the customer’s post-delivery acceptance provisions. Our system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in our facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When we objectively demonstrate that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or our historical experience of our tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where we cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. We recognize such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases, our contracts with customers contain a billing retention, typically 10% of the sales price, which is billed by us and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

We recognize revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. We recognize revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

We may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, we do not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected performance period is one year or less.

We have elected to treat shipping and handling costs as a fulfillment activity, and we include such costs in cost of services when we recognize revenue for the related goods. Taxes assessed by governmental authorities that are collected by us from a customer are excluded from revenue.

Inventory Valuation

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter we assess the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of our estimated usage requirements is written down to its estimated net realizable value if less than cost. We evaluate usage requirements by analyzing historical usage, anticipated demand alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for our products may require a write down of inventory that could materially affect our operating results.

36

Goodwill and Intangible Assets

Goodwill is tested for impairment at least annually in the beginning of the fourth quarter of our fiscal year. We may first perform a qualitative assessment of whether it is more likely than not that the reporting unit’s fair value is less than its carrying amount, and, if so, we then quantitatively compare the fair value of our reporting unit to its carrying amount. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not impaired. If the carrying amount of the reporting unit exceeds its fair value, we then record an impairment loss equal to the difference, up to the carrying value of goodwill.

We determine the fair value of our reporting unit based on a reconciliation of the aggregate fair value of our reporting unit to our adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of our common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The control premium is estimated using historical transactions in similar industries.

The carrying values of long-lived assets, including identifiable intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability test is performed utilizing undiscounted cash flows expected to be generated by that asset or asset group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals. It is not possible for us to predict the likelihood of any possible future impairments or, if such an impairment were to occur, the magnitude of any impairment.

Intangible assets with finite useful lives, including purchased technology, customer-related intangible assets, patents, trademarks, backlog, and software licenses, are subject to amortization over the expected period of economic benefit to us. We evaluate whether events or circumstances have occurred that warrant a revision to the remaining useful lives of intangible assets. In cases where a revision is deemed appropriate, the remaining carrying amounts of the intangible assets are amortized over the revised remaining useful life.

Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development (“R&D”) efforts. If and when development is complete, the associated assets would be deemed long-lived and would then be amortized based on their respective estimated useful lives at that point in time. Indefinite-lived intangible assets are tested for impairment at least annually in the beginning of the fourth quarter of our fiscal year. In testing indefinite-lived intangible assets for impairment, we may first perform a qualitative assessment of whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, and, if so, we then quantitatively compare the fair value of the indefinite-lived intangible asset to its carrying amount. We determine the fair value of our indefinite-lived intangible assets using a discounted cash flow method.

Income Taxes

We estimate our income taxes in each of the jurisdictions in which we operate. Deferred income taxes reflect the net tax effect of temporary differences between the asset and liability balances recognized for financial reporting purposes and the balances used for income tax purposes, as well as the tax effect of carry forwards. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. Realization of our net deferred tax assets is dependent on future taxable income.

We recognize the effect of income tax positions for only those positions which are estimated to more likely than not be sustained if challenged. We reflect changes in recognition or measurement in the period in which our change in judgment occurs. We record interest and penalties related to uncertain tax positions in income tax expense. Income taxes related to the global intangible low-taxed income (“GILTI”) rules are expensed as incurred.

37

Recent Accounting Pronouncements

We adopted ASC 606 and ASU 2016-01 as of January 1, 2018. We also adopted ASC 842 as of January 1, 2019. Refer to Note 1, “Significant Accounting Policies,” for additional information.

We are also evaluating other pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

Our exposure to market rate risk for changes in interest rates primarily relates to our investment portfolio. We centrally manage our investment portfolios considering investment opportunities and risks, tax consequences, and overall financing strategies. Our investment portfolio includes fixed-income securities with a fair value of approximately $115.3 million at December 31, 2019. These securities are subject to interest rate risk and, based on our investment portfolio at December 31, 2019, a 100 basis point increase in interest rates would result in a decrease in the fair value of the portfolio of $0.3 million. While an increase in interest rates may reduce the fair value of the investment portfolio, we will not realize the losses in the Consolidated Statements of Operations unless the individual fixed-income securities are sold prior to recovery or the loss is determined to be other-than-temporary.

Currency Exchange Risk

We conduct business on a worldwide basis and, as such, a portion of our revenues, earnings, and net investments in foreign affiliates is exposed to changes in currency exchange rates. The economic impact of currency exchange rate movements is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions, and other factors. These changes, if material, could cause us to adjust our financing and operating strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors.

Changes in currency exchange rates could affect our foreign currency denominated monetary assets and liabilities and forecasted cash flows. We may enter into monthly forward derivative contracts with the intent of mitigating a portion of this risk. We only use derivative financial instruments in the context of hedging and not for speculative purposes and have not designated our foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are included in “Other operating expense (income), net” in our Consolidated Statements of Operations. We execute derivative transactions with highly rated financial institutions to mitigate counterparty risk.

Our net sales to customers located outside of the United States represented approximately 70%, 77%, and 80% of our total net sales in 2019, 2018, and 2017, respectively. We expect that net sales to customers outside the United States will continue to represent a large percentage of our total net sales. Our net sales denominated in currencies other than the U.S. dollar represented approximately 4%, 1%, and 1% of total net sales in 2019, 2018, and 2017, respectively.

A 10% change in foreign exchange rates would have an immaterial impact on the consolidated results of operations since most of our sales outside the United States are denominated in U.S. dollars.

Item 8. Financial Statements and Supplementary Data

Our Consolidated Financial Statements are listed in the Index to Consolidated Financial Statements and Financial Statement Schedule filed as part of this Form 10-K.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

38

Item 9A. Controls and Procedures

Management’s Report on Internal Control over Financial Reporting

Our principal executive and financial officers have evaluated and concluded that our disclosure controls and procedures are effective as of December 31, 2019. The disclosure controls and procedures are designed to ensure that the information required to be disclosed in this report filed under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to our principal executive and financial officers as appropriate to allow timely decisions regarding required disclosure.

Our principal executive and financial officers are responsible for establishing and maintaining adequate internal control over financial reporting, which is a process designed and put into effect to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Using the criteria established in the Internal Control — Integrated Framework (2013) published by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), Management has evaluated, assessed, and concluded that internal control over financial reporting is effective as of December 31, 2019.

KPMG LLP, an independent registered public accounting firm, has audited the consolidated financial statements included in this Annual Report on Form 10-K and, as part of their audit, has issued their report, included herein, on the effectiveness of our internal control over financial reporting.

Changes in Internal Control over Financial Reporting

During the quarter ended December 31, 2019, there were no changes in internal control that have materially affected or are reasonably likely to materially affect internal control over financial reporting.

39

Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors

Veeco Instruments Inc.:

Opinion on Internal Control Over Financial Reporting

We have audited Veeco Instruments Inc.’s and subsidiaries’ (the Company) internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2019 and 2018, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2019, and the related notes and financial statement schedule II – valuation and qualifying accounts (collectively, the consolidated financial statements), and our report dated February 21, 2020 expressed an unqualified opinion on those consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become

40

inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP

Melville, New York
February 21, 2020

41

Item 9B. Other Information

None.

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Information required by this Item that will appear under the headings “Governance,” “Executive Officers,” and “Delinquent Section 16(a) Reports” in the definitive proxy statement to be filed with the SEC relating to our 2020 Annual Meeting of Stockholders is incorporated herein by reference.

We have adopted a Code of Ethics for Senior Officers (the “Code”) which applies to our chief executive officer, principal financial officer, principal accounting officer, and persons performing similar functions. A copy of the Code can be found on our website (www.veeco.com). We intend to disclose on our website the nature of any future amendments to and waivers of the Code that apply to the chief executive officer, principal financial officer, principal accounting officer, or persons performing similar functions. We have also adopted a Code of Business Conduct which applies to all of our employees, including those listed above, as well as to our directors. A copy of the Code of Business Conduct can be found on our website (www.veeco.com). The website address above is intended to be an inactive, textual reference only. None of the material on this website is part of this report.

Item 11. Executive Compensation

Information required by this Item that will appear under the heading “Compensation” in the definitive proxy statement to be filed with the SEC relating to our 2020 Annual Meeting of Stockholders is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information required by this Item that will appear under the headings “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information” in the definitive proxy statement to be filed with the SEC relating to our 2020 Annual Meeting of Stockholders is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Information required by this Item that will appear under the headings “Certain Relationships and Related Transactions” and “Independence of Board” in the definitive proxy statement to be filed with the SEC relating to our 2020 Annual Meeting of Stockholders is incorporated herein by reference.

Item 14. Principal Accounting Fees and Services

Information required by this Item that will appear under the heading “Independent Auditor Fees and Other Matters” in the definitive proxy statement to be filed with the SEC relating to our 2020 Annual Meeting of Stockholders is incorporated herein by reference.

42

PART IV

Item 15. Exhibits, Financial Statement Schedules

(a)   (1)  The Registrant’s financial statements together with a separate table of contents are annexed hereto

(2)  Financial Statement Schedules are listed in the separate table of contents annexed hereto.

(3)  Exhibits

Unless otherwise indicated, each of the following exhibits has been previously filed with the Securities and Exchange Commission by the Company under File No. 0-16244.

					Filed or
Exhibit		Incorporated by Reference			Furnished
Number	Exhibit Description	Form	Exhibit	Filing Date	Herewith
3.1	Amended and Restated Certificate of Incorporation of Veeco dated December 1, 1994, as amended June 2, 1997 and July 25, 1997.	10-Q	3.1	8/14/1997
3.2	Amendment to Certificate of Incorporation of Veeco dated May 29, 1998.	10-K	3.2	3/14/2001
3.3	Amendment to Certificate of Incorporation of Veeco dated May 5, 2000.	10-Q	3.1	8/14/2000
3.4	Amendment to Certificate of Incorporation of Veeco dated May 16, 2002.	10-Q	3.1	10/26/2009
3.5	Amendment to Certificate of Incorporation of Veeco dated May 18, 2010.	10-K	3.8	2/24/2011
3.6	Fifth Amended and Restated Bylaws of Veeco effective February 5, 2016.	8-K	3.1	2/10/2016
3.7	Certificate of Designation, Preferences, and Rights of Series A Junior Participating Preferred Stock of Veeco dated March 14, 2001.	10-Q	3.1	5/9/2001
4.1	Indenture, dated as of January 18, 2017, by and between Veeco Instruments Inc. and U.S. Bank National Association, as Trustee (relating to the 2.70% Convertible Notes due 2023).	8-K	4.1	1/18/2017
4.2	First Supplemental Indenture, dated as of January 18, 2017, by and between Veeco Instruments Inc. and U.S. Bank National Association, as Trustee (relating to the 2.70% Convertible Notes due 2023).	8-K	4.2	1/18/2017
4.3	Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934	10-K	4.3		X
10.1*	Veeco Amended and Restated 2010 Stock Incentive Plan, effective May 14, 2010.	Def 14A	Appendix A	11/4/2013
10.2*	Veeco Amended and Restated 2010 Stock Incentive Plan, effective May 5, 2016.	S-8	10.1	6/2/2016
10.3	Veeco Amended and Restated 2010 Stock Incentive Plan, effective March 3, 2017.	10-Q	10.1	11/3/2017
10.4	Veeco Instruments Inc. 2019 Stock Incentive Plan.	S-8	10.1	5/7/2019
10.5	Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan (as Amended and Restated as of May 31, 2011).	S-8	10.1	5/26/2017
10.6*	Form of Notice of Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2015.	10-Q	10.1	8/3/2015

43

					Filed or
Exhibit		Incorporated by Reference			Furnished
Number	Exhibit Description	Form	Exhibit	Filing Date	Herewith
10.7*	Form of Notice of Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2016.	10-Q	10.1	11/1/2016
10.8*	Form of Notice of Critical Priorities Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2016.	10-Q	10.2	11/1/2016
10.9*	Form of Notice of Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2018.	10-Q	10.1	5/7/2018
10.10*	Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2018.	10-Q	10.2	5/7/2018
10.11	Form of Notice of Performance Restricted Stock Unit Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2019.	10-Q	10.1	5/7/2019
10.12	Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2019 (time-based version A)	10-Q	10.2	5/7/2019
10.13	Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2019 (time-based version B)	10-Q	10.3	5/7/2019
10.14*	Veeco 2013 Inducement Stock Incentive Plan, effective September 26, 2013	10-Q	10.1	11/4/2013
10.15*	Veeco Instruments Inc. 2016 Employee Stock Purchase Plan.	S-8	10.9	6/2/2016
10.16	First Amendment to Veeco Instruments Inc. 2016 Employee Stock Purchase Plan.	S-8	10.11	5/7/2019
10.17	Form of Amended and Restated Indemnification Agreement entered into between Veeco and each of its directors and executive officers (August 2017).	10-Q	10.2	8/3/2017
10.18*	Veeco Amended and Restated Senior Executive Change in Control Policy, effective as of January 1, 2014.	10-K	10.22	2/28/2014
10.19*	Letter Agreement dated January 30, 2012 between Veeco and Dr. William J. Miller.	10-K	10.30	2/22/2012
10.20*	Letter Agreement dated August 29, 2018 between Veeco and Dr. William J. Miller.	8-K	10.2	9/4/2018
10.21	Amendment dated March 22, 2019 to the Letter Agreement between Veeco and William J. Miller, Ph.D.	10-Q	10.4	5/7/2019
10.22*	Employment Agreement effective as of July 1, 2007 between Veeco and John R. Peeler.	10-Q	10.3	8/7/2007
10.23*	Amendment effective December 31, 2008 to Employment Agreement between Veeco and John R. Peeler.	10-K	10.38	3/2/2009
10.24*	Second Amendment effective June 11, 2010 to Employment Agreement between Veeco and John R. Peeler.	10-Q	10.1	7/29/2010

44

					Filed or
Exhibit		Incorporated by Reference			Furnished
Number	Exhibit Description	Form	Exhibit	Filing Date	Herewith
10.25*	Third Amendment effective April 25, 2012 to Employment Agreement between Veeco and John R. Peeler.	10-Q	10.2	5/9/2012
10.26*	Amendment dated June 12, 2014 to Employment Agreement between Veeco and John R. Peeler.	10-Q	10.3	7/31/2014
10.27*	Amendment dated June 12, 2017 to Employment Agreement between Veeco and John R. Peeler.	10-Q	10.1	8/3/2017
10.28*	Amendment dated August 29, 2018 to Employment Agreement between Veeco and John R. Peeler.	8-K	10.1	9/4/2018
10.29*	Letter Agreement dated April 8, 2014 between Veeco and Shubham Maheshwari.	10-Q	10.1	7/31/2014
10.30*	Letter Agreement dated August 29, 2018 between Veeco and Shubham Maheshwari.	8-K	10.3	9/4/2018
10.31	Amendment dated March 22, 2019 to the Letter Agreement between Veeco and Shubham Maheshwari.	10-Q	10.5	5/7/2019
10.32*	Letter Agreement dated January 21, 2004 between Veeco and John P. Kiernan.	10-K	10.38	3/12/2004
10.33*	Amendment effective June 9, 2006 to Letter Agreement between Veeco and John P. Kiernan.	10-Q	10.3	8/4/2006
10.34*	Amendment effective December 31, 2008 to Letter Agreement between Veeco and John P. Kiernan.	10-K	10.40	3/2/2009
10.35	Letter dated January 1, 2020 from Veeco to John P. Kiernan.	8-K	99.2	1/2/2020
21.1	Subsidiaries of the Registrant.				X
23.1	Consent of KPMG LLP.				X
31.1	Certification of Chief Executive Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.				X
31.2	Certification of Chief Financial Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.				X
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.				X
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.				X
101.INS	XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.				**
101.XSD	XBRL Schema.				**
101.PRE	XBRL Presentation.				**
101.CAL	XBRL Calculation.				**
101.DEF	XBRL Definition.				**
101.LAB	XBRL Label.				**
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).				**

*    Indicates a management contract or compensatory plan or arrangement, as required by Item 15(a) (3) of Form 10-K.

**  Filed herewith electronically

45

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 21, 2020.

Veeco Instruments Inc.
By:	/S/ WILLIAM J. MILLER, Ph.D.
	William J. Miller, Ph.D.
	Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated, on February 21, 2020.

Signature	Title
/s/ WILLIAM J. MILLER, Ph.D.	Chief Executive Officer and Director
William J. Miller, Ph.D.	(principal executive officer)
/s/ JOHN P. KIERNAN	Senior Vice President and Chief Financial Officer
John P. Kiernan	(principal financial & accounting officer)
/s/ JOHN R. PEELER	Chairman
John R. Peeler
/s/ KATHLEEN A. BAYLESS	Director
Kathleen A. Bayless
/s/ RICHARD A. D’AMORE	Director
Richard A. D’Amore
/s/ GORDON HUNTER	Director
Gordon Hunter
/s/ KEITH D. JACKSON	Director
Keith D. Jackson
/s/ MARY JANE RAYMOND	Director
Mary Jane Raymond
/s/ PETER J. SIMONE	Director
Peter J. Simone
/s/ THOMAS ST. DENNIS	Director
Thomas St. Dennis

46

Veeco Instruments Inc. and Subsidiaries

Index to Consolidated Financial Statements and Financial Statement Schedule

	Page
Report of Independent Registered Public Accounting Firm	F-2
Consolidated Balance Sheets at December 31, 2019 and 2018	F-4
Consolidated Statements of Operations for the years ended December 31, 2019, 2018, and 2017	F-5
Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2019, 2018, and 2017	F-6
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2019, 2018, and 2017	F-7
Consolidated Statements of Cash Flows for the years ended December 31, 2019, 2018, and 2017	F-8
Notes to Consolidated Financial Statements	F-9
Schedule II—Valuation and Qualifying Accounts	S-1

F-1

Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors

Veeco Instruments Inc.:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Veeco Instruments Inc. and subsidiaries (the Company) as of December 31, 2019 and 2018, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2019, and the related notes and financial statement schedule II – valuation and qualifying accounts (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2019, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 21, 2020 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgment. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Assessment of the value of excess and obsolete inventory

As discussed in Note 1 to the consolidated financial statements, the Company assesses the valuation of all inventories, including materials, work-in-process, and finished goods, each reporting period. Obsolete inventory or inventory in excess of the Company’s estimated usage requirement is written down to its estimated net realizable value if less than

F-2

cost. Estimates of usage include the Company’s analysis of anticipated demand, possible alternative uses of its inventory, as well as other qualitative factors. As of December 31, 2019, the Company’s inventories totaled $133.1 million, representing 16.3% of total assets.

We identified the assessment of the value of excess and obsolete inventory as a critical audit matter. Subjective auditor judgment was required to evaluate the Company’s estimates of anticipated demand and possible alternative uses of its inventory, which are affected by market and economic conditions outside the Company’s control.

The primary procedures we performed to address this critical audit matter included the following. We tested certain internal controls over the Company’s inventory valuation process, including controls related to the development of estimates of anticipated demand and possible alternative uses of inventory. We evaluated current year estimates of anticipated demand used to value excess and obsolete inventory when it significantly differed from historical sales volumes and assessed possible alternative uses of inventory. For certain inventory items, we compared the prior year anticipated demand to actual results to assess the Company’s ability to accurately forecast. We compared possible alternative uses of certain inventory determined in the prior year to actual uses in the current year.

/s/ KPMG LLP

We have served as the Company’s auditor since 2015.

Melville, New York

February 21, 2020

F-3

Veeco Instruments Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share amounts)

	December 31,		December 31,
	2019		2018
Assets
Current assets:
Cash and cash equivalents	$	129,294	$	212,273
Restricted cash		657		809
Short-term investments		115,252		48,189
Accounts receivable, net		45,666		66,808
Contract assets		25,351		10,397
Inventories		133,067		156,311
Deferred cost of sales		445		3,072
Prepaid expenses and other current assets		14,966		22,221
Assets held for sale		11,180		—
Total current assets		475,878		520,080
Property, plant, and equipment, net		75,711		80,284
Operating lease right-of-use assets		14,453		—
Intangible assets, net		61,518		85,149
Goodwill		181,943		184,302
Deferred income taxes		1,549		1,869
Other assets		7,036		29,132
Total assets	$	818,088	$	900,816
Liabilities and stockholders' equity
Current liabilities:
Accounts payable	$	21,281	$	39,611
Accrued expenses and other current liabilities		41,243		46,450
Customer deposits and deferred revenue		54,870		72,736
Income taxes payable		830		1,256
Total current liabilities		118,224		160,053
Deferred income taxes		5,648		5,690
Long-term debt		300,068		287,392
Operating lease long-term liabilities		10,300		—
Other liabilities		9,336		9,906
Total liabilities		443,576		463,041
Stockholders' equity:
Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.		—		—
Common stock, $0.01 par value; 120,000,000 shares authorized; 48,994,346 and 48,547,417 shares issued at December 31, 2019 and December 31, 2018, respectively; 48,994,346 and 48,024,685 shares outstanding at December 31, 2019 and December 31, 2018, respectively.		490		485
Additional paid-in capital		1,071,058		1,061,325
Accumulated deficit		(698,930)		(619,983)
Accumulated other comprehensive income		1,894		1,820
Treasury stock, at cost, 522,732 shares at December 31, 2018.		—		(5,872)
Total stockholders' equity		374,512		437,775
Total liabilities and stockholders' equity	$	818,088	$	900,816

See accompanying Notes to the Consolidated Financial Statements.

F-4

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Operations

(in thousands, except per share amounts)

	For the year ended December 31,
	2019		2018		2017
Net sales	$	419,349	$	542,082	$	475,686
Cost of sales		261,155		348,363		299,458
Gross profit		158,194		193,719		176,228
Operating expenses, net:
Research and development		90,557		97,755		81,987
Selling, general, and administrative		79,749		92,060		100,250
Amortization of intangible assets		17,085		32,351		35,475
Restructuring		6,403		8,556		11,851
Acquisition costs		—		2,959		17,786
Asset impairment		4,020		375,172		1,139
Other operating expense (income), net		(42)		368		(392)
Total operating expenses, net		197,772		609,221		248,096
Operating income (loss)		(39,578)		(415,502)		(71,868)
Interest income		4,680		3,186		2,335
Interest expense		(22,085)		(21,518)		(19,457)
Other income (expense), net		(20,973)		—		—
Income (loss) before income taxes		(77,956)		(433,834)		(88,990)
Income tax expense (benefit)		777		(26,746)		(37,594)
Net income (loss)	$	(78,733)	$	(407,088)	$	(51,396)
Income (loss) per common share:
Basic	$	(1.66)	$	(8.63)	$	(1.16)
Diluted	$	(1.66)	$	(8.63)	$	(1.16)
Weighted average number of shares:
Basic		47,482		47,151		44,174
Diluted		47,482		47,151		44,174

See accompanying Notes to the Consolidated Financial Statements.

F-5

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

	For the year ended December 31,
	2019		2018		2017
Net income (loss)	$	(78,733)	$	(407,088)	$	(51,396)
Other comprehensive income (loss), net of tax:
Available-for-sale securities:
Change in net unrealized gains or losses		49		11		(7)
Unrealized gain (loss) on available-for-sale securities		49		11		(7)
Currency translation adjustments:
Change in currency translation adjustments		(19)		5		42
Reclassification adjustments for net (gains) losses included in net income		44		(8)		—
Net changes related to currency translation adjustments		25		(3)		42
Other comprehensive income (loss), net of tax		74		8		35
Total comprehensive income (loss)	$	(78,659)	$	(407,080)	$	(51,361)

See accompanying Notes to the Consolidated Financial Statements.

F-6

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Stockholders' Equity

(in thousands)

												Accumulated
								Additional				Other
	Common Stock			Treasury Stock				Paid-in		Accumulated		Comprehensive
	Shares	Amount		Shares		Amount		Capital		Deficit		Income		Total
Balance at December 31, 2016	40,715		407		127		(2,309)		763,303		(161,474)		1,777	$	601,704
Net loss	—		—		—		—		—		(51,396)		—		(51,396)
Other comprehensive loss, net of tax	—		—		—		—		—		—		35		35
Share-based compensation expense	—		—		—		—		24,396		—		—		24,396
Net issuance under employee stock plans	313		3		(245)		4,043		(9,795)		—		—		(5,749)
Stock issuance for business acquisition	7,201		72		—		—		228,800		—		—		228,872
Convertible Senior Notes, equity component	—		—		—		—		45,249		—		—		45,249
Purchases of common stock	—		—		203		(3,018)		—		—		—		(3,018)
Balance at December 31, 2017	48,229		482		85		(1,284)		1,051,953		(212,870)		1,812		840,093
Net loss	—		—		—		—		—		(407,088)		—		(407,088)
Other comprehensive income, net of tax	—		—		—		—		—		—		8		8
Share-based compensation expense	—		—		—		—		16,074		—		—		16,074
Net issuance under employee stock plans	318		3		(512)		6,721		(6,702)		(25)		—		(3)
Purchases of common stock	—		—		950		(11,309)		—		—		—		(11,309)
Balance at December 31, 2018	48,547		485		523		(5,872)		1,061,325		(619,983)		1,820		437,775
Net loss	—		—		—		—		—		(78,733)		—		(78,733)
Other comprehensive income, net of tax	—		—		—		—		—		—		74		74
Share-based compensation expense	—		—		—		—		15,270		—		—		15,270
Net issuance under employee stock plans	447		5		(523)		5,872		(5,537)		(214)		—		126
Balance at December 31, 2019	48,994	$	490		—	$	—	$	1,071,058	$	(698,930)	$	1,894	$	374,512

See accompanying Notes to the Consolidated Financial Statements.

F-7

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

	For the year ended December 31,
	2019		2018		2017
Cash Flows from Operating Activities
Net income (loss)	$	(78,733)	$	(407,088)	$	(51,396)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		34,399		49,998		50,095
Non-cash interest expense		12,676		11,762		10,446
Deferred income taxes		360		(27,620)		(35,363)
Share-based compensation expense		15,270		16,074		24,396
Asset impairment		4,020		375,172		1,139
Impairment of equity investments		20,973		—		—
Provision for bad debts		392		—		99
Changes in operating assets and liabilities:
Accounts receivable and contract assets		5,796		21,821		10,240
Inventories and deferred cost of sales		14,969		(24,678)		6,244
Prepaid expenses and other current assets		7,520		11,216		(10,204)
Accounts payable and accrued expenses		(26,945)		(19,672)		11,308
Customer deposits and deferred revenue		(17,866)		(39,296)		22,446
Income taxes receivable and payable, net		(655)		(4,800)		775
Long-term income tax liability		—		—		(4,877)
Other, net		408		(627)		(355)
Net cash provided by (used in) operating activities		(7,416)		(37,738)		34,993
Cash Flows from Investing Activities
Acquisitions of businesses, net of cash acquired		—		(2,662)		(401,828)
Capital expenditures		(10,873)		(12,654)		(24,272)
Proceeds from the sale of investments		127,349		90,065		348,927
Payments for purchases of investments		(192,988)		(93,046)		(282,947)
Proceeds from held for sale assets		645		—		2,284
Net cash provided by (used in) investing activities		(75,867)		(18,297)		(357,836)
Cash Flows from Financing Activities
Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan		3,106		3,064		2,992
Restricted stock tax withholdings		(2,980)		(3,069)		(8,741)
Purchases of common stock		—		(11,457)		(2,869)
Proceeds from long-term debt borrowings		—		—		335,752
Principal payments on long-term debt		—		—		(1,194)
Net cash provided by (used in) financing activities		126		(11,462)		325,940
Effect of exchange rate changes on cash and cash equivalents		26		(4)		42
Net increase (decrease) in cash, cash equivalents, and restricted cash		(83,131)		(67,501)		3,139
Cash, cash equivalents, and restricted cash - beginning of period		213,082		280,583		277,444
Cash, cash equivalents, and restricted cash - end of period	$	129,951	$	213,082	$	280,583
Supplemental Disclosure of Cash Flow Information
Interest paid	$	9,408	$	9,708	$	4,675
Income taxes paid		2,931		4,799		1,939
Non-cash operating and financing activities
Net transfer of inventory to property, plant and equipment		4,916		1,479		(97)
Right-of-use assets obtained in exchange for lease obligations		5,576		—		—

See accompanying Notes to the Consolidated Financial Statements.

F-8

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements

Note 1 — Significant Accounting Policies

(a) Description of Business

Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” or the “Company”) operates in a single segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

(b) Basis of Presentation

The accompanying audited Consolidated Financial Statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). The Company reports interim quarters on a 13-week basis ending on the last Sunday of each period, which is determined at the start of each year. The Company’s fourth quarter always ends on the last day of the calendar year, December 31. During 2019 the interim quarters ended on March 31, June 30, and September 29, and during 2018 the interim quarters ended on April 1, July 1, and September 30. The Company reports these interim quarters as March 31, June 30, and September 30 in its interim consolidated financial statements.

(c) Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, these estimates may ultimately differ from actual results. Significant items subject to such estimates and assumptions include: (i) stand-alone selling prices for the Company’s products and services; (ii) allowances for doubtful accounts; (iii) inventory obsolescence; (iv) the useful lives and expected future cash flows of property, plant, and equipment and identifiable intangible assets; (v) the fair value of the Company’s reporting unit and related goodwill; (vi) investment valuations and the valuation of derivatives, deferred tax assets, and assets acquired in business combinations; (vii) the recoverability of long-lived assets; (viii) liabilities for product warranty and legal contingencies; (ix) share-based compensation; (x) lease term and incremental borrowing rates used in determining operating lease assets and liabilities; and (xi) income tax uncertainties.

(d) Principles of Consolidation

The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Companies acquired during each reporting period are reflected in the results of the Company effective from their respective dates of acquisition through the end of the reporting period.

(e) Foreign Currencies

Assets and liabilities of the Company’s foreign subsidiaries that operate using functional currencies other than the U.S. dollar are translated using the exchange rates in effect at the balance sheet date. Results of operations are translated using monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s subsidiaries into U.S. dollars, including intercompany transactions of a long-term nature, are reported as currency translation adjustments in “Accumulated other comprehensive income” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

(f) Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable

F-9

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases, the Company’s contracts with customers contain a billing retention, typically 10% of the sales price, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected performance period is one year or less.

F-10

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in “Cost of sales” in the Consolidated Statements of Operations when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

(g) Warranty Costs

The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance by providing labor and parts necessary to repair the systems during the warranty period. The Company records the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of sales” in the Consolidated Statements of Operations. The estimated warranty cost is based on the Company’s historical experience with its systems and regional labor costs. The Company calculates the average service hours by region and parts expense per system utilizing actual service records to determine the estimated warranty charge. The Company updates its warranty estimates on a quarterly basis when the actual product performance or field expense differs from original estimates.

(h) Shipping and Handling Costs

Shipping and handling costs are expenses incurred to move, package, and prepare the Company’s products for shipment and to move the products to a customer’s designated location. These costs are generally comprised of payments to third-party shippers. Shipping and handling costs are included in “Cost of sales” in the Consolidated Statements of Operations.

(i) Research and Development Costs

Research and development costs are expensed as incurred and include charges for the development of new technology and the transition of existing technology into new products or services.

(j) Advertising Expense

The cost of advertising is expensed as incurred and totaled $0.5 million, $0.9 million, and $0.9 million for the years ended December 31, 2019, 2018, and 2017, respectively.

(k) Accounting for Share-based Compensation

Share-based awards exchanged for employee services are accounted for under the fair value method. Accordingly, share-based compensation cost is measured at the grant date based on the estimated fair value of the award. The expense for awards is recognized over the employee’s requisite service period (generally the vesting period of the award). The Company has elected to treat awards with only service conditions and with graded vesting as one award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date.

In addition to stock options, restricted share awards (“RSAs”) and restricted stock units (“RSUs”) with time-based vesting, the Company grants performance share units and awards (“PSUs” and “PSAs”) that have either performance or market conditions. Compensation cost for PSUs and PSAs with performance conditions is recognized over the requisite service period based on the timing and expected level of achievement of the performance targets. A change in the assessment of performance attainment prior to the conclusion of the performance period is recognized in the period of the change in estimate. Compensation cost for PSUs and PSAs with market conditions is recognized over the requisite service period regardless of the expected level of achievement. For all PSUs and PSAs, the number of shares issued to the employee at the conclusion of the service period may vary from the original target based upon the level of attainment of the performance or market conditions.

F-11

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards and purchase rights under the Employee Stock Purchase Plan. The Company uses a Monte Carlo simulation to compute the estimated fair value of awards with market conditions. The Black-Scholes model and Monte Carlo simulation include assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 15, “Stock Plans,” for additional information.

(l) Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rate is recognized in income in the period that includes the enactment date.

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “2017 Tax Act”), which made broad and complex changes to the U.S. tax code. In response to the 2017 Tax Act, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provided guidance on accounting for the tax effects of 2017 Tax Act, including addressing any uncertainty or diversity of view in applying ASC 740, Income Taxes (“ASC 740”), in the reporting period in which the 2017 Tax Act was enacted. In addition, SAB 118 provided a measurement period that should not extend beyond one year from the 2017 Tax Act enactment date for companies to complete the accounting under ASC 740. During the year ended December 31, 2018, the Company finalized the accounting for the tax effects of 2017 Tax Act.

In January 2018, the FASB released guidance on the accounting for taxes under the global intangible low-taxed income (“GILTI”) provisions of the 2017 Tax Act. The GILTI provisions impose a tax on foreign income in excess of a deemed return on tangible assets of foreign operations. The Company has made a policy election to account for income taxes incurred under GILTI as a period cost.

(m) Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, derivative financial instruments used in hedging activities, and accounts receivable. The Company invests in a variety of financial instruments and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. Historically, the Company has not experienced any material credit losses on its investments.

The Company maintains an allowance reserve for potentially uncollectible accounts for estimated losses resulting from the inability of its customers to make required payments. The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount reasonably expected to be collected. The Company also provides allowances based on its write-off history. The allowance for doubtful accounts totaled $0.6 million and $0.3 million at December 31, 2019 and 2018, respectively.

To further mitigate the Company’s exposure to uncollectable accounts, the Company may request certain customers provide a negotiable irrevocable letter of credit drawn on a reputable financial institution. These irrevocable letters of credit are typically issued to mature between zero and 90 days from the date the documentation requirements are met, typically when a system ships or upon receipt of final acceptance from the customer. The Company, at its discretion, may monetize these letters of credit on a non-recourse basis after they become negotiable but before maturity. The fees associated with the monetization are included in “Selling, general, and administrative” in the Consolidated Statements of Operations and were immaterial for the years ended December 31, 2019, 2018, and 2017.

F-12

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(n) Fair Value of Financial Instruments

The carrying amounts of financial instruments, including cash equivalents, accounts receivable, accounts payable, and accrued expenses reflected in the consolidated financial statements approximate fair value due to their short-term maturities. The fair value of debt for footnote disclosure purposes, including current maturities, if any, is estimated using recently quoted market prices of the instrument, or if not available, a discounted cash flow analysis based on the estimated current incremental borrowing rates for similar types of instruments.

(o) Cash, Cash Equivalents, and Short-term Investments

All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market funds, certificate of deposit and time deposit accounts, U.S. treasuries, government agency securities, and corporate debt. Investments that are classified as cash equivalents are carried at cost, which approximates fair value. The Company’s cash and cash equivalents includes $78.5 million and $69.6 million of cash equivalents at December 31, 2019 and 2018, respectively.

A portion of the Company’s cash and cash equivalents is held by its subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. Approximately 56% and 32% of cash and cash equivalents were maintained outside the United States at December 31, 2019 and 2018, respectively.

Short-term investments consist of marketable debt securities, and are generally classified as available-for-sale for use in current operations, if required, and are reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” on the Consolidated Balance Sheets. These securities can include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations. The specific identification method is used to determine the realized gains and losses on investments.

Non-marketable equity securities are equity securities without readily observable market prices and are included in “Other assets” in the Consolidated Balance Sheets. Non-marketable securities are measured at cost, adjusted for changes in observable prices minus impairment. Changes in fair value are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

(p) Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition. See Note 5, “Acquisitions and Dispositions,” for additional information.

(q) Business Combinations

The Company allocates the fair value of the purchase consideration of the Company’s acquisitions to the tangible assets, intangible assets, including in-process research and development (“IPR&D”), if any, and liabilities assumed, based on

F-13

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. See Note 5, “Acquisitions and Dispositions,” for additional information.

(r) Goodwill and Indefinite-Lived Intangible Assets

Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is measured as the excess of the consideration transferred over the net fair value of identifiable assets acquired and liabilities assumed. Intangible assets with indefinite useful lives are measured at their respective fair values on the acquisition date. Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development (“R&D”) efforts. If and when development is complete, the associated assets would be deemed long-lived and would then be amortized based on their respective estimated useful lives at that point in time. Goodwill and indefinite-lived intangibles are not amortized into results of operations but instead are evaluated for impairment. The Company performs the evaluation in the beginning of the fourth quarter of each year or more frequently if impairment indicators arise.

In testing goodwill for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the reporting unit’s fair value is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the reporting unit to its carrying amount. If the fair value exceeds the carrying amount, goodwill is not impaired. If the carrying amount exceeds fair value, the Company then records an impairment loss equal to the difference, up to the carrying value of goodwill.

The Company determines the fair value of its reporting unit based on a reconciliation of the fair value of the reporting unit to the Company’s adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of the Company’s common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The control premium is estimated using historical transactions in similar industries.

In testing indefinite-lived intangible assets for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the indefinite-lived intangible asset to its carrying amount. The Company determines the fair value of its indefinite-lived intangible assets using a discounted cash flow method.

(s) Long-lived Assets

Long-lived intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, and backlog and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or straight-lined if such pattern cannot be reliably determined.

Property, plant, and equipment are recorded at cost. Depreciation expense is calculated based on the estimated useful lives of the assets by using the straight-line method. Amortization of leasehold improvements is recognized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements.

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability test is performed utilizing undiscounted cash flows expected to be generated by that asset or asset group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent the carrying amount exceeds

F-14

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals.

(t) Leases

Upon the adoption of ASC Topic 842, Leases (“ASC 842”) as of January 1, 2019, the Company determines at contract inception if an arrangement is a lease, or contains a lease, of an identified asset for which the Company has the right to obtain substantially all of the economic benefits from its use and the right to direct its use. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term, while lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. The implicit discount rate in the Company’s leases generally cannot readily be determined, and therefore the Company uses its incremental borrowing rate based on information available at lease commencement date in determining the present value of future payments. The Company has options to renew or terminate certain leases. These options are included in the determination of lease term when it is reasonably certain that the Company will exercise such options. The Company does not separate lease and non-lease components in determining ROU assets or lease liabilities for real estate leases. Additionally, the Company does not recognize ROU assets or lease liabilities for leases with original terms or renewals of one year or less.

(u) Recently Adopted Accounting Standards

The Company adopted ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”), as of January 1, 2018, using the full retrospective method. All amounts and disclosures set forth in this Form 10-K reflect these changes. The most significant financial statement impacts of adopting ASC 606 are the elimination of the constraint on revenue associated with the billing retention related to the receipt of customer final acceptance and the identification of installation services as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, is now generally recognized at the time the Company transfers control of the system to the customer, which is earlier than under the Company’s previous revenue recognition model for certain contracts that were subject to the billing constraint. The performance obligation related to installation services is now recognized as the installation services are performed, which is later than the Company’s previous revenue recognition model. 

The Company adopted ASU 2016-01, Financial Instruments – Overall, as of January 1, 2018. This ASU requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. The Company measures equity investments without readily observable market prices at cost, adjusted for changes in observable prices minus impairment. Changes in measurement are included in “Other income (expense), net” in the Consolidated Statements of Operations. This ASU has not had a material impact on the consolidated financial statements upon adoption, and the Company will monitor its equity investments each reporting period for changes in observable market prices, if any, which may be material in future periods.

The Company adopted ASC Topic 842, Leases (“ASC 842”), as of January 1, 2019. ASC 842 generally requires operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. The new standard offers a transition option whereby companies can recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented. The Company has adopted using this transition method, and therefore prior period balances have not been adjusted. In addition, ASC 842 provides for a number of optional exemptions in transition. The Company has elected certain exemptions whereby prior conclusions regarding lease identification, lease classification, and initial direct costs were not reassessed under the new standard. The adoption of the standard impacted the Company’s Consolidated Balance Sheets through the recognition of ROU assets and lease liabilities of approximately $14.2 million each as of January 1, 2019 but did not have an impact on the Consolidated Statements of Operations, Statements of Comprehensive Income, or Statements of Cash Flows.

F-15

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(v) Recent Accounting Pronouncements Not Yet Adopted

The Company is evaluating pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

Note 2 — Income (Loss) Per Share

Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period. Diluted income per share is calculated by dividing net income by the weighted average number of shares used to calculate basic income per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and non-participating share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share in the periods the performance targets have been achieved.

The computations of basic and diluted income (loss) per share for the years ended December 31, 2019, 2018, and 2017 are as follows:

	For the year ended December 31,
	2019		2018		2017
	(in thousands, except per share amounts)
Net income (loss)	$	(78,733)	$	(407,088)	$	(51,396)
Net income (loss) per common share:
Basic	$	(1.66)	$	(8.63)	$	(1.16)
Diluted	$	(1.66)	$	(8.63)	$	(1.16)
Basic weighted average shares outstanding		47,482		47,151		44,174
Effect of potentially dilutive share-based awards		—		—		—
Diluted weighted average shares outstanding		47,482		47,151		44,174
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive		531		28		239
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		1,689		2,474		1,744
Maximum potential shares to be issued for settlement of the Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive		8,618		8,618		8,618

Note 3 — Fair Value Measurements

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. The Company is required to classify certain assets and liabilities based on the following fair value hierarchy:

● Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

● Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

F-16

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

● Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or estimation methodologies could have a significant effect on the estimated fair value amounts.

The following table presents the Company’s assets that were measured at fair value on a recurring basis at December 31, 2019 and 2018:

	Level 1		Level 2		Level 3		Total
	(in thousands)
December 31, 2019
Cash equivalents
Certificate of deposits and time deposits	$	67,009	$	—	$	—	$	67,009
Commercial paper		—		10,484		—		10,484
Corporate debt		—		1,000		—		1,000
Total	$	67,009	$	11,484	$	—	$	78,493
Short-term investments
U.S. treasuries	$	105,130	$	—	$	—	$	105,130
Government agency securities		—		1,139		—		1,139
Corporate debt		—		6,002		—		6,002
Commercial paper		—		2,981		—		2,981
Total	$	105,130	$	10,122	$	—	$	115,252
December 31, 2018
Cash equivalents
Certificate of deposits and time deposits	$	65,571	$	—	$	—	$	65,571
U.S. treasuries		3,990		—		—		3,990
Total	$	69,561	$	—	$	—	$	69,561
Short-term investments
U.S. treasuries	$	37,184	$	—	$	—	$	37,184
Corporate debt		—		8,516		—		8,516
Commercial paper		—		2,489		—		2,489
Total	$	37,184	$	11,005	$	—	$	48,189

The Company’s investments classified as Level 1 are based on quoted prices that are available in active markets. The Company’s investments classified as Level 2 are valued using observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes, or alternative pricing sources with reasonable levels of price transparency.

F-17

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 4 — Investments

At December 31, 2019 and 2018 the amortized cost and fair value of marketable securities, which are included in “Short-term investments” on the Consolidated Balance Sheets, were as follows:

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
December 31, 2019
U.S. treasuries	$	105,096	$	38	$	(4)	$	105,130
Government agency securities		1,139		—		—		1,139
Corporate debt		6,003		—		(1)		6,002
Commercial paper		2,981		—		—		2,981
Total	$	115,219	$	38	$	(5)	$	115,252
December 31, 2018
U.S. treasuries	$	37,191	$	—	$	(7)	$	37,184
Corporate debt		8,525		—		(9)		8,516
Commercial paper		2,489		—		—		2,489
Total	$	48,205	$	—	$	(16)	$	48,189

Available-for-sale securities in a loss position at December 31, 2019 and 2018 were as follows:

	December 31, 2019				December 31, 2018
			Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses
		(in thousands)
U.S. treasuries	$	22,943	$	(4)	$	37,184	$	(7)
Corporate debt		6,002		(1)		8,516		(9)
Total	$	28,945	$	(5)	$	45,700	$	(16)

At December 31, 2019 and 2018, there were no short-term investments that had been in a continuous loss position for more than 12 months.

The maturities of securities classified as available-for-sale at December 31, 2019 were all due in one year or less. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. The realized gains or losses for the years ended December 31, 2019, 2018, and 2017 were immaterial.

Other Investments

Veeco has an ownership interest of less than 20% in a non-marketable investment, Kateeva, Inc. (“Kateeva”), over which Veeco does not exert significant influence. The carrying value of the investment was $21.0 million at December 31, 2018. Additionally, during the year ended December 31, 2018, the Company made a separate non-marketable investment of $3.5 million in another entity. The Company does not exert significant influence over this investment and its ownership interest is also less than 20%. Neither equity investment has a readily observable market price, and therefore the Company has elected to measure these investments at cost, adjusted for changes in observable market prices minus impairment. The investments are included in “Other assets” on the Consolidated Balance Sheets. There were no changes in observable market prices for either investment for the year ended December 31, 2019. These investments are subject to periodic impairment reviews which require judgment. The analyses include assessments of the

F-18

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

companies’ financial condition, the business outlooks for their products and technologies, their projected results and cash flows, business valuation indications from recent rounds of financing, the likelihood of obtaining subsequent rounds of financing, and the impact of equity preferences held by Veeco relative to other investors. During the quarter ended December 31, 2019, the Company identified impairment indicators on the Company’s investment in Kateeva, and as a result of a valuation analysis, concluded that its investment in Kateeva is fully impaired, and recorded a non-cash impairment charge of $21.0 million, included in “Other income (expense), net” in the Consolidated Statements of Operations. There were no impairment charges recorded for either investment for the years ended December 31, 2018 or 2017.

Note 5 — Acquisitions and Dispositions

Ultratech acquisition

On May 26, 2017, the Company completed its acquisition of Ultratech, Inc. (“Ultratech”). Ultratech develops, manufactures, sells, and supports lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also develops, manufactures, sells, and supports ALD equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, Europe, China, Japan, Taiwan, Singapore, and Korea. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

Ultratech shareholders received (i) $21.75 per share in cash and (ii) 0.2675 of a share of Veeco common stock for each Ultratech common share outstanding on the acquisition date. The acquisition date fair value of the consideration totaled $633.4 million, net of cash acquired, which consisted of the following:

	Acquisition Date
	(May 26, 2017)
	(in thousands)
Cash consideration, net of cash acquired of $229.4 million	$	404,490
Equity consideration (7.2 million shares issued)		228,643
Replacement equity awards attributable to pre-acquisition service		228
Acquisition date fair value	$	633,361

F-19

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

	Acquisition Date
	(May 26, 2017)
	(in thousands)
Short-term investments	$	47,161
Accounts receivable		45,465
Inventories		59,100
Deferred cost of sales		242
Prepaid expense and other current assets		7,217
Property, plant, and equipment		18,152
Intangible assets		346,940
Other assets		6,442
Total identifiable assets acquired		530,719
Accounts payable		24,291
Accrued expenses and other current liabilities		16,356
Customer deposits and deferred revenue		4,834
Deferred income taxes		32,478
Other liabilities		11,622
Total liabilities assumed		89,581
Net identifiable assets acquired		441,138
Goodwill		192,223
Net assets acquired	$	633,361

The gross contractual value of the acquired accounts receivable was approximately $46.0 million. The fair value of the accounts receivables is the amount expected to be collected by the Company. Goodwill generated from the acquisition is primarily attributable to expected synergies from future growth and strategic advantages provided through the expansion of product offerings as well as assembled workforce and is not expected to be deductible for income tax purposes.

The classes of intangible assets acquired and the estimated useful life of each class is presented in the table below:

	Acquisition Date
	(May 26, 2017)
	Amount		Useful life
	(in thousands)
Technology	$	158,390	9	years
Customer relationships		116,710	12	years
Backlog		3,080	6	months
In-process research and development		43,340	*
Trademark and tradenames		25,420	7	years
Intangible assets acquired	$	346,940

* In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project.

The Company determined the estimated fair value of the identifiable intangible assets based on various factors including: cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation.

F-20

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

In-process research and development (“IPR&D”) represents the estimated fair values of incomplete Ultratech research and development projects that had not reached the commercialization stage and met the criteria for recognition as IPR&D as of the date of the acquisition. The fair value of IPR&D was determined using an income approach and costs to complete the project and expected commercialization timelines are considered key assumptions. This valuation approach reflected the present value of the projected cash flows that were expected to be generated by the IPR&D less charges representing the contribution of other assets to those cash flows. The value of the IPR&D was determined to be $43.3 million, approximately half of which was related to Ultratech’s lithography technologies and one-third of which was related to Ultratech’s laser annealing technologies.

During the second quarter of 2018, the Company lowered its projected results for the Ultratech asset group and determined that the revised projections were significantly lower than projected results at the time of the acquisition and that these revised projections required the Company to assess the Ultratech asset group for impairment. See Note 6, “Goodwill and Intangible Assets,” for additional information.

For the year ended December 31, 2018 and 2017, acquisition related costs were approximately $3.0 million and $17.8 million, respectively, including non-cash charges of $4.2 million related to accelerated share-based compensation for employee terminations for the year ended December 31, 2017.

The amounts of net sales and income (loss) from operations before income taxes of Ultratech included in the Company’s Consolidated Statement of Operations for the year ended December 31, 2017 are as follows:

	Year ended
	December 31, 2017
	(in thousands)
Net sales	$	65,280
Loss before income taxes	$	(62,284)

Loss before income taxes of Ultratech for the year ended December 31, 2017 of $62.3 million includes acquisition costs of $17.8 million, release of inventory fair value step-up related to purchase accounting of $9.6 million, amortization expense on intangible assets of $23.9 million, and restructuring charges of $3.3 million.

The following table presents unaudited pro forma financial information for the year ended December 31, 2017, as if the acquisition of Ultratech had occurred on January 1, 2016:

	Year ended December 31, 2017
	(in thousands, except per share amounts)
Net sales	$	546,428
Loss before income taxes		(90,000)
Diluted earnings per share	$	(1.38)

The pro-forma results were calculated by combining the audited results of the Company with the stand-alone unaudited results of Ultratech for the pre-acquisition period, and adjusting for the following:

(i) Additional amortization expense related to identified intangible assets valued as part of the purchase price allocation that would have been incurred starting on January 1, 2016.

(ii) Additional depreciation expense for the property, plant, and equipment fair value adjustments that would have been incurred starting on January 1, 2016.

(iii) All acquisition related costs incurred by the Company as well as by Ultratech pre-acquisition have been removed from the year ended December 31, 2017 and included in the year ended December 31, 2016, as such expenses would have been incurred in the first quarter following the acquisition.

F-21

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(iv) All amortization of inventory step-up has been removed from the year ended December 31, 2017 and recorded in the year ended December 31, 2016, as such costs would have been incurred as the corresponding inventory was sold.

(v) Additional interest expense related to the Convertible Senior Notes (see Note 12, “Debt”) as if they had been issued on January 1, 2016.

(vi) Income tax expense (benefit) was adjusted for the impact of the above adjustments for each period.

(vii) All shares issued in connection with the acquisition were considered outstanding as of January 1, 2016 for purposes of calculating diluted earnings per share.

Dispositions

As of December 31, 2019, the Company determined that one of its non-core product lines (the “disposal group”) met the held for sale criteria, and as such, the related assets are presented as “Assets held for sale” on the Consolidated Balance Sheets. Long-lived assets and definite-lived intangible assets are not depreciated or amortized while classified as held for sale. The potential sale of this disposal group does not represent a strategic shift that will have a material effect on the Company’s operations and financial results, nor is it considered a component of the Company, and as such it did not meet the criteria to be reported as discontinued operations.

For the year ended December 31, 2019, the Company recorded a non-cash impairment charge on these assets held for sale of $4.0 million, included in “Asset impairment” in the Consolidated Statements of Operations, in order to measure the disposal group at the lower of its carrying value or fair value less costs to sell as of December 31, 2019, which resulted in a corresponding held for sale valuation allowance on its assets held for sale in the Consolidated Balance Sheet. The major classes of assets that were classified as held for sale as of December 31, 2019 are as follows:

	December 31, 2019
	(in thousands)
Assets held for sale:
Inventories	$	5,985
Property, plant, and equipment, net		310
Intangible assets, net		6,546
Goodwill		2,359
Impairment		(4,020)
Total Assets held for sale	$	11,180

F-22

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 6 — Goodwill and Intangible Assets

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The following table presents the changes in goodwill balances during the years indicated:

	Gross carrying		Accumulated
	amount		impairment		Net amount
	(in thousands)
Balance at December 31, 2017	$	430,331	$	123,200	$	307,131
Impairment		—		122,829		(122,829)
Balance at December 31, 2018		430,331		246,029		184,302
Allocated to Assets held for sale		—		2,359		(2,359)
Balance at December 31, 2019	$	430,331	$	248,388	$	181,943

The Company performs its annual goodwill impairment test at the beginning of the fourth quarter each year. As the Company maintains a single goodwill reporting unit, it determines the fair value of its reporting unit based upon the Company’s adjusted market capitalization. The annual test performed at the beginning of the fourth quarter of fiscal 2018 and 2019 did not result in any potential impairment as the fair value of the reporting unit was determined to exceed the carrying amount of the reporting unit.

As a result of a significant decline in the Company’s stock price during the fourth quarter of 2018, the Company concluded it was appropriate to perform an interim goodwill impairment test as of the end of fiscal 2018. The fair value of its reporting unit, as calculated using the adjusted market capitalization approach, was determined to be below the carrying value of the reporting unit, and the Company recorded an impairment charge equal to the excess of carrying value over fair value, or $122.8 million, for the year ended December 31, 2018. The impairment charge is included in “Asset impairment” in the Consolidated Statements of Operations. The valuation of goodwill will continue to be subject to changes in the Company’s market capitalization and observable market control premiums. This analysis is sensitive to changes in the Company’s stock price and absent other qualitative factors, the Company may be required to record additional goodwill impairment charges in future periods if the stock price declines and remains depressed for an extended period of time. 

The components of purchased intangible assets were as follows:

		December 31, 2019						December 31, 2018
	Average			Accumulated						Accumulated
	Remaining	Gross		Amortization				Gross		Amortization
	Amortization	Carrying		and		Net		Carrying		and		Net
	Period	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in years)	(in thousands)
Technology	5.0	$	327,908	$	291,766	$	36,142	$	337,218	$	290,808	$	46,410
Customer relationships	9.2		146,465		126,764		19,701		164,595		136,126		28,469
In-process R&D	—		—		—		—		13,710		10,530		3,180
Trademarks and tradenames	4.4		30,910		25,256		5,654		30,910		23,899		7,011
Other	1.1		3,686		3,665		21		3,686		3,607		79
Total	6.3	$	508,969	$	447,451	$	61,518	$	550,119	$	464,970	$	85,149

Other intangible assets primarily consist of patents, licenses, and backlog.

During the second quarter of 2018, the Company lowered its projected results for the Ultratech asset group, which were significantly below the projected results at the time of the acquisition. The reduced projections were based on lower than expected unit volume of certain smartphones, which incorporate advanced packaging methods such as fan-out wafer

F-23

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

level packaging (“FOWLP”), and a delay in the adoption of FOWLP advanced packaging by other electronics manufacturers, both of which slowed orders and reduced revenue projections for the Company’s advanced packaging lithography systems. In addition, there has been a delay in the build out of 28nm facilities by companies in China who were expected to purchase the Company’s Laser Spike Anneal systems. Taken together, the reduced projections identified during the second quarter of 2018 required the Company to assess the Ultratech asset group for impairment. As a result of the analysis, which included projected cash flows that required the use of unobservable inputs, the Company recorded non-cash impairment charges of $216.4 million and $35.9 million related to definite-lived intangible assets and in-process research and development assets, respectively, during the second quarter of 2018. The impairment charge is included in “Asset impairment” in the Consolidated Statement of Operations. Subsequently, certain in-process research and development projects were completed and moved to the “Technology” line in the above table.

Based on the intangible assets recorded at December 31, 2019, and assuming no subsequent additions to or impairment of the underlying assets, the remaining estimated annual amortization expense, is expected to be as follows:

	Amortization
	(in thousands)
2020	$	15,333
2021		12,280
2022		10,018
2023		8,347
2024		6,708
Thereafter		8,832
Total	$	61,518

Note 7 — Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventories consist of the following:

	December 31,		December 31,
	2019		2018
	(in thousands)
Materials	$	82,155	$	90,816
Work-in-process		42,575		42,354
Finished goods		8,337		23,141
Total	$	133,067	$	156,311

F-24

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 8 — Property, Plant, and Equipment

Property and equipment, net, consist of the following:

	December 31,		December 31,
	2019		2018		Average Useful Life
	(in thousands)
Land	$	5,061	$	5,669	N/A
Building and improvements		61,884		61,124	10 – 40 years
Machinery and equipment (1)		137,692		128,385	3 – 10 years
Leasehold improvements		6,703		9,033	3 – 7 years
Gross property, plant, and equipment		211,340		204,211
Less: accumulated depreciation and amortization		135,629		123,927
Net property, plant, and equipment	$	75,711	$	80,284

(1) Machinery and equipment also includes software, furniture, and fixtures

Depreciation expense was $17.3 million, $17.6 million, and $14.6 million for the years ended December 31, 2019, 2018, and 2017, respectively. During the year ended December 31, 2019, the Company classified vacant land in St. Paul, Minnesota as held for sale, and subsequently sold the land for approximately $0.6 million, which approximated its carrying value.

Note 9 — Accrued Expenses and Other Liabilities

The components of accrued expenses and other current liabilities were as follows:

	December 31,		December 31,
	2019		2018
	(in thousands)
Payroll and related benefits	$	15,174	$	20,486
Warranty		7,067		7,852
Operating lease liabilities		4,196		—
Interest		4,321		4,321
Professional fees		2,443		2,897
Sales, use, and other taxes		811		2,670
Restructuring liability		2,841		2,213
Other		4,390		6,011
Total	$	41,243	$	46,450

Customer deposits and deferred revenue

Customer deposits totaled $26.6 million and $28.3 million at December 31, 2019 and 2018, respectively, which are included in “Customer deposits and deferred revenue” in the Consolidated Balance Sheets. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows:

	(in thousands)
Balance - December 31, 2018	$	44,415
Deferral of revenue		5,816
Recognition of previously deferred revenue		(21,982)
Balance - December 31, 2019	$	28,249

F-25

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

As of December 31, 2019, the Company has approximately $38.9 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 87% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Other liabilities

As part of the acquisition of Ultratech, the Company assumed an executive non-qualified deferred compensation plan that allowed qualifying executives to defer cash compensation. The plan was frozen at the time of acquisition and no further contributions have been made. At December 31, 2019 and 2018, plan assets approximated $2.7 million and $3.2 million, respectively, representing the cash surrender value of life insurance policies and is included within “Other assets” in the Consolidated Balance Sheets, while plan liabilities approximated $3.1 million and $3.5 million, respectively and is included within “Other liabilities” in the Consolidated Balance Sheets. Other liabilities also included asset retirement obligations of $3.2 million and income tax payables of $1.0 million at both December 31, 2019 and 2018, and medical and dental benefits for former executives of $2.0 million and $2.2 million at December 31, 2019 and 2018, respectively.

Note 10 — Restructuring Charges

During the second quarter of 2018, the Company initiated plans to reduce excess capacity associated with the manufacture and support of the Company’s advanced packaging lithography and 3D wafer inspection systems by consolidating these operations into its San Jose, California facility. As a result of this and other cost saving initiatives, the Company announced headcount reductions of approximately 40 employees. During the year ended December 31, 2019, additional accruals were recognized and payments were made related to these restructuring initiatives.

The Company continued to record restructuring charges during the year ended December 31, 2019 as a result of its efforts to further streamline operations, enhance efficiencies, and reduce costs. In the second half of 2019, the Company executed an initiative to reorganize various functions along product lines and created a central research and development organization to better allocate its resources to the Company’s highest priority projects. In addition, the Company delayered the organization. Collectively, these actions impacted approximately 60 employees.

The following table shows the amounts incurred and paid for restructuring activities during the years ended December 31, 2019, 2018, and 2017 and the remaining accrued balance of restructuring costs at December 31, 2019, which is included in “Accrued expenses and other current liabilities” in the Consolidated Balance Sheets:

	Personnel		Facility
	Severance and		Related Costs
	Related Costs		and Other		Total
	(in thousands)
Balance - December 31, 2016	$	1,796	$	—	$	1,796
Provision		4,714		5,257		9,971
Payments		(4,990)		(5,257)		(10,247)
Balance - December 31, 2017		1,520		—		1,520
Provision		4,681		2,714		7,395
Payments		(4,058)		(2,644)		(6,702)
Balance - December 31, 2018		2,143		70		2,213
Provision		5,803		203		6,006
Payments		(5,105)		(273)		(5,378)
Balance - December 31, 2019	$	2,841	$	—	$	2,841

F-26

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Restructuring expense for the years ended December 31, 2019, 2018, and 2017 included non-cash charges of $0.4 million, $1.2 million, and $1.9 million, respectively, which are excluded from the table above, related to accelerated share-based compensation for employee terminations.

Note 11 — Commitments and Contingencies

Warranty

Changes in the Company’s product warranty reserves were as follows:

	December 31,
	2019		2018		2017
		(in thousands)
Balance, beginning of the year	$	7,852	$	6,532	$	4,217
Warranties issued		5,865		6,737		5,817
Addition from Ultratech acquisition		—		—		1,889
Consumption of reserves		(6,242)		(6,573)		(6,330)
Changes in estimate		(408)		1,156		939
Balance, end of the year	$	7,067	$	7,852	$	6,532

Minimum Lease Commitments

The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease term of the Company’s operating leases as of December 31, 2019 was 3 years, and the weighted average discount rate used in determining the present value of future lease payments was 6.0%.

The following table provides the maturities of lease liabilities at December 31, 2019:

	Operating
	Leases
	(in thousands)
Payments due by period:
2020	$	4,932
2021		5,020
2022		4,428
2023		1,133
2024		551
Thereafter		—
Total future minimum lease payments		16,064
Less: Imputed interest		(1,568)
Total	$	14,496
Reported as of December 31, 2019
Other current liabilities	$	4,196
Operating lease liabilities		10,300
Total	$	14,496

F-27

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Minimum lease commitments at December 31, 2018 for property and equipment under operating lease agreements (exclusive of renewal options) were as follows:

	Operating
	Leases
	(in thousands)
Payments due by period:
2019	$	5,143
2020		5,056
2021		2,432
2022		1,812
2023		1,066
Thereafter		548
Total	$	16,057

Operating lease cost for the year ended December 31, 2019 was $5.5 million. Variable lease cost for the year ended December 31, 2019 was $1.7 million. Additionally, the Company has an immaterial amount of short-term leases. Lease expense was $7.2 million, $6.3 million, and $5.3 million for the years ended December 31, 2019, 2018, and 2017, respectively. In addition, the Company is obligated under such leases for certain other expenses, including real estate taxes and insurance.

Legal Proceedings

On June 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed on behalf of different plaintiffs in the same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the Securities Act of 1933 for, among other things, alleged false/misleading statements in the registration statement and prospectus relating to the Ultratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. Veeco is defending this matter vigorously.

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the Superior Court of the State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Concentrations of Credit Risk

The Company depends on purchases from its ten largest customers, which accounted for 67% and 61% of net accounts receivable at December 31, 2019 and 2018, respectively.

F-28

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Customers who accounted for more than 10% of net accounts receivable or net sales are as follows:

	Accounts Receivable				Net Sales
	December 31,				For the Year Ended December 31,
Customer	2019		2018		2019		2018		2017
Customer A	16	%	22	%	11	%	*		*
Customer B	21	%	*		*		*		*
Customer C	*		*		*		12	%	*
Customer D	*		*		*		*		21	%

* Less than 10% of aggregate accounts receivable or net sales

The Company manufactures and sells its products to companies in different geographic locations. Refer to Note 18, “Segment Reporting and Geographic Information,” for additional information. In certain instances, the Company requires deposits from its customers for a portion of the sales price in advance of shipment and performs periodic credit evaluations on its customers. Where appropriate, the Company requires letters of credit on certain non-U.S. sales arrangements. Receivables generally are due within 30 to 90 days from the date of invoice. In some geographies, receivables may be payable up to 150 days from the date of the invoice.

Suppliers

The Company outsources certain functions to third parties, including the manufacture of several of its systems. While the Company relies on its outsourcing partners to perform their contracted functions, the Company maintains some level of internal manufacturing capability for these systems. In addition, certain of the components and sub-assemblies included in the Company’s products are obtained from a single source or a limited group of suppliers. The failure of the Company’s present outsourcing partners and suppliers to meet their contractual obligations and the Company’s inability to make alternative arrangements or resume the manufacture of these systems could have a material adverse effect on the Company’s revenues, profitability, cash flows, and relationships with its customers.

The Company had deposits with its suppliers of $5.9 million and $12.8 million at December 31, 2019 and 2018, respectively, that were included in “Prepaid expenses and other current assets” on the Consolidated Balance Sheets.

Purchase Commitments

The Company had purchase commitments of $63.3 million at December 31, 2019, substantially all of which will come due within one year. Purchase commitments are primarily for inventory used in manufacturing products and are partially offset by existing deposits with suppliers.

Bank Guarantees

The Company has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At December 31, 2019, outstanding bank guarantees and letters of credit totaled $10.2 million and unused bank guarantees and letters of credit of $21.6 million were available to be drawn upon.

Note 12 — Debt

Convertible Senior Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes (the “Convertible Senior Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The

F-29

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Convertible Senior Notes mature on January 15, 2023 (the “Maturity Date”), unless earlier purchased by the Company, redeemed, or converted.

The Convertible Senior Notes are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Convertible Senior Notes are convertible into cash, shares of the Company’s common stock, or a combination thereof, at the Company’s election, upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rate is 24.9800 shares of the Company’s common stock per $1,000 principal amount of Convertible Senior Notes, representing an initial effective conversion price of $40.03 per share of common stock. The conversion rate may be subject to adjustment upon the occurrence of certain specified events as provided in the indenture governing the Convertible Senior Notes, dated January 18, 2017 between the Company and U.S. Bank National Association, as trustee, but will not be adjusted for accrued but unpaid interest.

Holders may convert all or any portion of their notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022 only under the following circumstances:

(i) During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii) During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

(iii) If the Company calls any or all of the Convertible Senior Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv) Upon the occurrence of specified corporate events.

On or after October 15, 2022, until the close of business on the business day immediately preceding the Maturity Date, holders may convert their notes at any time, regardless of the foregoing circumstances.

Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion option, the Company segregated the liability component of the instrument from the equity component. The liability component was measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Convertible Senior Notes. The calculation of the fair value of the debt component required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Convertible Senior Notes at a discount rate of 7.00%, an interest rate equal to the estimated borrowing rate for similar non-convertible debt. The excess of the aggregate face value of the Convertible Senior Notes over the estimated fair value of the liability component of $72.5 million was recognized as a debt discount and recorded as an increase to additional paid-in capital and will be amortized over the expected life of the

F-30

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Convertible Senior Notes using the effective interest rate method. Amortization of the debt discount is recognized as non-cash interest expense.

The transaction costs of $9.2 million incurred in connection with the issuance of the Convertible Senior Notes were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component are being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected term of the Convertible Senior Notes. Transaction costs allocated to the equity component of $1.9 million reduced the value of the equity component recognized in stockholders' equity.

The carrying value of the Convertible Senior Notes is as follows:

	December 31,		December 31,
	2019		2018
	(in thousands)
Principal amount	$	345,000	$	345,000
Unamortized debt discount		(40,820)		(52,336)
Unamortized transaction costs		(4,112)		(5,272)
Net carrying value	$	300,068	$	287,392

Total interest expense related to the Convertible Senior Notes is as follows:

	For the year ended December 31,
	2019		2018
	(in thousands)
Cash Interest Expense
Coupon interest expense	$	9,315	$	9,315
Non-Cash Interest Expense
Amortization of debt discount		11,516		10,686
Amortization of transaction costs		1,160		1,076
Total Interest Expense	$	21,991	$	21,077

The Company determined the Convertible Senior Notes is a Level 2 liability in the fair value hierarchy and estimated its fair value as $330.3 million at December 31, 2019.

Note 13 — Derivative Financial Instruments

The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rates could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company entered into monthly forward derivative contracts with the intent of mitigating a portion of this risk. The Company only used derivative financial instruments in the context of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts were recorded as “Other operating expense (income), net” in the Company’s Consolidated Statements of Operations. The Company executed derivative transactions with highly rated financial institutions to mitigate counterparty risk.

The Company did not have any outstanding derivative contracts at December 31, 2019 and 2018. The following table shows the gains and (losses) from currency exchange derivatives during the years ended December 31, 2018 and 2017, which are included in “Other operating expense (income), net” in the Consolidated Statements of Operations as well as the weighted average notional amount of derivatives outstanding for each period:

F-31

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

	Year ended December 31,
	2018				2017
		Gains (losses)		Weighted average notional amount		Gains (losses)		Weighted average notional amount
	(in thousands)
Foreign currency exchange forwards	$	327	$	2,869	$	(6)	$	314

Note 14 — Stockholders’ Equity

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2016	$	1,797	$	(20)	$	1,777
Other comprehensive income (loss)		42		(7)		35
Balance - December 31, 2017		1,839		(27)		1,812
Other comprehensive income (loss)		(3)		11		8
Balance - December 31, 2018		1,836		(16)		1,820
Other comprehensive income (loss)		25		49		74
Balance - December 31, 2019	$	1,861	$	33	$	1,894

The Company did not allocate additional tax expense (benefit) to other comprehensive income (loss) for all years presented as the Company is in a full valuation allowance position such that a deferred tax asset related to amounts recognized in other comprehensive income is not regarded as realizable on a more-likely-than-not basis.

Preferred Stock

The Board of Directors has authority under the Company’s Certificate of Incorporation to issue shares of preferred stock, par value $0.01, with voting and economic rights to be determined by the Board of Directors. As of December 31, 2019, no preferred shares have been issued.

Treasury Stock

The share repurchase program authorized by the Company’s Board of Directors in October 2015 expired on October 28, 2017. On December 11, 2017, the Company’s Board of Directors authorized a new program to repurchase up to $100 million of the Company’s common stock to be completed through December 11, 2019. At the end of the program, $14.3 million of the $100 million had been utilized.

The Company records treasury stock purchases under the cost method using the first-in, first-out (“FIFO”) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If the Company reissues treasury stock at an amount below its acquisition cost and if additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is charged to accumulated deficit.

F-32

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 15 — Stock Plans

Share-based incentive awards are provided to employees under the terms of the Company’s equity incentive compensation plans (the “Plans”), which are administered by the Compensation Committee of the Board of Directors. The 2019 Plan originated as the 2010 Stock Incentive Plan and was originally approved by the Company’s shareholders in May 2010. This Plan was subsequently amended, as approved by shareholders, in 2013, 2016, and 2019 (at which time the Plan was renamed the 2019 Stock Incentive Plan (as amended to date, the “2019 Plan”). The Company’s employees, non-employee directors, and consultants are eligible to receive awards under the 2019 Plan, which can include non-qualified stock options, incentive stock options, restricted share awards (“RSAs”), restricted share units (“RSUs”), performance share awards (“PSAs”), performance share units (“PSUs”), share appreciation rights, dividend equivalent rights, or any combination thereof. The Company settles awards under the Plans with newly issued shares or with shares held in treasury.

In 2013, the Board of Directors granted equity awards to certain employees under the Company’s 2013 Inducement Stock Incentive Plan (the “Inducement Plan”). The Company issued 124,500 stock option shares and 87,000 RSUs under this plan. Stock options under this plan vest over a three year period and have a 10-year term, and RSUs under this plan vest over a two or four year period. At December 31, 2013, the Inducement Plan was merged into the 2019 Plan and is considered an inactive plan with no further shares available for grant. At December 31, 2019, there are 2,000 option shares and no RSUs outstanding under the Inducement Plan.

The Company is authorized to issue up to 13.3 million shares under the 2019 Plan. Option awards are granted with an exercise price equal to the closing price of the Company’s common stock on the trading day prior to the date of grant; option awards generally vest over a three year period and have a seven or ten year term. RSAs and RSUs generally vest over one to five years. Certain option and share awards provide for accelerated vesting if there is a change in control, as defined in the 2019 Plan. At December 31, 2019, there are 1.1 million option shares and 0.9 million RSUs and PSUs outstanding under the 2019 Plan.

During 2016, the Company’s Board of Directors approved the 2016 Employee Stock Purchase Plan (“ESPP”). The Company is authorized to issue up to 1.5 million shares under the ESPP, including additional shares authorized under a plan amendment approved by shareholders in 2019. Under the ESPP, substantially all employees in the U.S. may purchase the Company’s common stock through payroll deductions at a price equal to 85 percent of the lower of the fair market value of the Company’s common stock at the beginning or end of each six-month offer period, as defined in the ESPP, and subject to certain limits. The ESPP was approved by the Company’s shareholders.

During 2017, in connection with the acquisition of Ultratech, the Company assumed certain restricted stock units (the “Assumed RSUs”) available and outstanding under the Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan, as amended (the “Ultratech Plan”). The Assumed RSUs remain subject to the terms set forth in the award agreement governing the award and the Ultratech Plan, except that the Assumed RSUs relate to shares of Company common stock and the number of restricted stock units was adjusted pursuant to the terms of the acquisition to reflect the difference in the value of a share of Company common stock and a share of Ultratech common stock prior to closing the acquisition. The Assumed RSUs were converted into 338,144 restricted stock units of the Company and generally vest over 50 months. After the acquisition and notwithstanding any other provisions of the Ultratech Plan, no further grants will be made under the Ultratech Plan, and the Company is solely maintaining the Ultratech Plan with respect to the Assumed RSUs. At December 31, 2019, there are 7,483 RSUs outstanding under the Ultratech Plan.

Shares Reserved for Future Issuance

At December 31, 2019, the Company has 6.0 million shares reserved to cover exercises of outstanding stock options, vesting of RSUs, and additional grants under the 2019 Plan. At December 31, 2019, the Company has 0.5 million shares reserved to cover future issuances under the ESPP Plan.

F-33

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Share-Based Compensation

The Company recognized share-based compensation in the following line items in the Consolidated Statements of Operations for the periods indicated:

	For the year ended December 31,
	2019		2018		2017
	(in thousands)
Cost of sales	$	1,903	$	1,885	$	2,505
Research and development		3,340		3,611		2,957
Selling, general, and administrative		9,630		9,417		12,851
Restructuring		397		1,161		1,880
Acquisition costs		—		—		4,203
Total	$	15,270	$	16,074	$	24,396

The Company did not realize any tax benefits associated with share-based compensation for the years ended December 31, 2019, 2018, and 2017 due to the full valuation allowance on its U.S. deferred tax assets. See Note 17, “Income Taxes” for additional information. The Company capitalized an immaterial amount of share-based compensation into inventory for the years ended December 31, 2019, 2018, and 2017.

Unrecognized share-based compensation costs at December 31, 2019 are summarized below:

	Unrecognized		Weighted
	Share-Based		Average Period
	Compensation		Expected to be
	Costs		Recognized
	(in thousands)		(in years)
Stock option awards	$	—	—
Restricted stock units		1,884	2.4
Restricted stock awards		15,431	2.5
Performance share units		5,464	1.8
Total unrecognized share-based compensation cost	$	22,779	2.3

Stock Option Awards

Stock options are awards issued to employees that entitle the holder to purchase shares of the Company’s stock at a fixed price. At December 31, 2019, options outstanding that have vested and are expected to vest are as follows:

				Weighted
	Number	Weighted		Average	Aggregate
	of	Average		Remaining	Intrinsic
	Shares	Exercise Price		Contractual Life	Value
	(in thousands)			(in years)	(in thousands)
Vested	1,119	$	34.88	2.0	—
Expected to vest	—		—	—	—
Total	1,119		34.88	2.0	—

The aggregate intrinsic value represents the difference between the option exercise price and $14.69, the closing price of the Company’s common stock on December 31, 2019, the last trading day of the Company’s fiscal year as reported on the NASDAQ Global Select Market.

F-34

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Additional information with respect to stock option activity:

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2016	1,576	$	35.18
Exercised	(18)		30.03
Expired or forfeited	(164)		37.47
Balance - December 31, 2017	1,394		34.97
Expired or forfeited	(172)		36.21
Balance - December 31, 2018	1,222		34.80
Expired or forfeited	(103)		33.97
Balance - December 31, 2019	1,119		34.88

The following table summarizes stock option information at December 31, 2019:

	Options Outstanding and Exercisable
				Weighted
		Aggregate		Average	Weighted
		Intrinsic		Remaining	Average
Range of Exercise Prices	Shares	Value		Contractual Life	Exercise Price
	(in thousands)	(in thousands)		(in years)
$20.00 - $30.00	20	$	—	2.6	$	27.83
$30.01 - $40.00	969		—	2.1		32.81
$40.01 - $50.00	10		—	0.8		46.14
$50.01 - $60.00	120		—	1.4		51.70
	1,119	$	—	2.0		34.88

The following table summarizes information on options exercised for the periods indicated:

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Cash received from options exercised	$	—	$	—	$	431
Intrinsic value of options exercised	$	—	$	—	$	51

RSAs, RSUs, PSAs, PSUs

RSAs are stock awards issued to employees that are subject to specified restrictions and a risk of forfeiture. RSUs are stock awards issued to employees that entitle the holder to receive shares of common stock as the awards vest. PSAs and PSUs are awards that result in an issuance of shares of common stock to employees if certain performance or market conditions are achieved. All of these awards typically vest over one to five years and vesting is subject to the employee's continued service with the Company and, in the case of performance awards, meeting certain performance or market conditions. The fair value of the awards is determined and fixed based on the closing price of the Company’s common stock on the trading day prior to the date of grant, or, in the case of performance awards with market conditions, fair value is determined using a Monte Carlo simulation.

F-35

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The following table summarizes the equity activity of non-vested restricted shares and performance shares:

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2016	1,949	$	23.85
Granted	674		29.22
Performance award adjustments	(25)		20.95
Assumed from Ultratech	338		31.75
Vested	(831)		27.67
Forfeited	(225)		26.29
Balance - December 31, 2017	1,880		25.41
Granted	1,257		17.37
Performance award adjustments	(5)		32.67
Vested	(523)		26.39
Forfeited	(391)		24.66
Balance - December 31, 2018	2,218		20.74
Granted	1,107		11.53
Performance award adjustments	(25)		28.91
Vested	(768)		21.77
Forfeited	(275)		18.48
Balance - December 31, 2019	2,257		16.20

The total fair value of shares that vested during the years ended December 31, 2019, 2018, and 2017 was $8.8 million, $9.1 million, and $22.3 million, respectively. For performance awards, the final number of shares earned will vary depending on the achievement of the actual results relative to the performance or market conditions. Each performance award is included in the table above at the grant date target share amount until the end of the performance period if not previously forfeited.

The fair value of performance awards with market conditions is estimated on the date of grant using a Monte Carlo simulation. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees who receive these awards. The weighted average fair value and the assumptions used in calculating such values during fiscal years 2019 and 2018 for performance awards with market conditions were based on estimates at the date of grant as follows:

	Year ended December 31,
	2019			2018
Weighted average fair value	$	16.45		$	15.58
Dividend yield		0	%		0	%
Expected volatility factor(1)		53	%		49	%
Risk-free interest rate(2)		2.37	%		2.88	%
Expected life (in years)(3)		2.8			3.0

(1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.

(2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.

(3) The expected life is the number of years the Company estimates that the awards will be outstanding prior to exercise.

F-36

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Employee Stock Purchase Plan

For the years ended December 31, 2019, 2018, and 2017 the Company received cash proceeds of $3.1 million, $3.1 million, and $2.6 million, and issued shares of 395,941, 332,096, and 163,000, respectively, under the ESPP Plan. The weighted average estimated values of employee purchase rights as well as the weighted average assumptions that were used in calculating such values during fiscal years 2019, 2018, and 2017 were based on estimates at the date of grant as follows:

		Year ended December 31,
	2019			2018			2017
Weighted average fair value	$	2.96		$	4.94		$	7.09
Dividend yield		0	%		0	%		0	%
Expected volatility factor(1)		60	%		62	%		36	%
Risk-free interest rate(2)		2.41	%		1.81	%		0.99	%
Expected life (in years)(3)		0.5			0.5			0.5

(1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.

(2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.

(3) The expected life is the number of years the Company estimates that the purchase rights will be outstanding prior to exercise.

Note 16 — Retirement Plans

The Company maintains a defined contribution plan for the benefit of its U.S. employees. The plan is intended to be tax qualified and contains a qualified cash or deferred arrangement as described under Section 401(k) of the Internal Revenue Code. Eligible participants may elect to contribute a percentage of their base compensation, and the Company may make matching contributions, generally equal to fifty cents for every dollar employees contribute, up to the lesser of three percent of the employee’s eligible compensation or three percent of the maximum the employee is permitted to contribute under then current Internal Revenue Code limitations. Generally, the plan calls for vesting in the Company contributions over the initial five years of a participant’s employment. In addition, the Company assumed Ultratech’s 401(k) plan as a result of the merger, and Ultratech’s plan was merged into the Company’s existing plan effective January 1, 2018. The Company provided employer contributions associated with these plans of approximately $2.4 million, $2.0 million, and $1.8 million for the years ended December 31, 2019, 2018, and 2017, respectively.

Note 17 — Income Taxes

The amounts of income (loss) before income taxes attributable to domestic and foreign operations were as follows:

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Domestic	$	(78,486)	$	(286,561)	$	(101,573)
Foreign		530		(147,273)		12,583
Total	$	(77,956)	$	(433,834)	$	(88,990)

F-37

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Significant components of the expense (benefit) for income taxes consisted of the following:

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Current:
Federal	$	—	$	(1,682)	$	—
Foreign		304		2,518		(2,246)
State and local		113		38		15
Total current expense (benefit) for income taxes		417		874		(2,231)
Deferred:
Federal		162		205		(35,912)
Foreign		116		(27,932)		1,291
State and local		82		107		(742)
Total deferred expense (benefit) for income taxes		360		(27,620)		(35,363)
Total expense (benefit) for income taxes	$	777	$	(26,746)	$	(37,594)

The income tax expense was reconciled to the tax expense computed at the U.S. federal statutory tax rate as follows:

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Income tax expense (benefit) at U.S. statutory rates	$	(16,396)	$	(91,105)	$	(31,147)
State taxes, net of U.S. federal impact		(835)		(2,848)		(2,523)
Effect of international operations		785		11,847		10,158
Research and development tax credit		(1,692)		(2,230)		620
Net change in valuation allowance		15,098		7,747		1,883
Change in accrual for unrecognized tax benefits		1,232		2,868		(4,772)
Share-based compensation		1,947		1,848		99
Effect of 2017 Tax Act		—		(1,690)		(11,344)
Asset impairment		495		46,872		—
Other		143		(55)		(568)
Total expense (benefit) for income taxes	$	777	$	(26,746)	$	(37,594)

The Company recognized the income tax effects of the 2017 Tax Act in its 2017 financial statements in accordance with SAB 118, which provided SEC staff guidance for the application of ASC 740 in the reporting period in which the 2017 Tax Act was signed into law. As such, the Company’s 2017 financial results included provisional amounts for specific income tax effects of the 2017 Tax Act for which the accounting under ASC 740 was incomplete but for which a reasonable estimate could be determined. During the year ended December 31, 2018, the Company finalized the accounting for the tax effects of 2017 Tax Act based on legislative updates currently available and recorded an additional income tax benefit of $1.7 million for alternative minimum tax credits that became refundable in accordance with the 2017 Tax Act. The Company also reported an increase in deferred tax assets of $6.8 million as a result of adjustments to tax attributes utilized for one-time transition tax, which was offset by a full valuation allowance.

The most significant impacts of the 2017 Tax Act on the Company’s federal income taxes for the year ended December 31, 2017 were as follows:

Reduction of the U.S. Corporate Income Tax Rate

The Company measures deferred tax assets and liabilities using enacted tax rates that will apply in the years in which the temporary differences are expected to be recovered or paid. Accordingly, the Company’s deferred tax assets and liabilities were re-measured as of December 22, 2017 to reflect the reduction in the U.S. corporate income tax rate from

F-38

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

35 percent to 21 percent. The Company recorded an income tax benefit of $4.8 million for the year ended December 31, 2017, as the net deferred tax assets were reduced by $25.6 million with a corresponding valuation allowance reduction of $30.4 million.

One-Time Transition Tax on Foreign Earnings

As of December 31, 2017, the Company had $180.1 million of foreign earnings that was subject to the one-time transition tax. The Company used its 2017 and carryforward net operating losses to offset the impact of the transition tax. As the Company maintains a full valuation allowance against its U.S. deferred tax assets, the Company did not record an income tax expense related to the transition tax for the year ended December 31, 2017.

Valuation Allowance

The 2017 Tax Act modified the Net Operating Loss ("NOL") provisions to provide for an indefinite carryforward of NOLs arising in tax years beginning after December 31, 2017. The 2017 Tax Act also limits the amount of NOL deductions that can be used in any one year to 80 percent of the taxpayer’s taxable income, effective with respect to NOLs arising in tax years beginning after December 31, 2017. The Company recognized an income tax benefit of $6.5 million for the year ended December 31, 2017 related to a reduction in the Company’s valuation allowance as a result of the Company scheduling out the reversals of its net deferred tax assets which resulted in tax amortization on indefinite-lived intangible assets becoming available to offset existing deferred tax assets that are now expected to have an indefinite life.

Deferred income taxes reflect the effect of temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts recognized for tax purposes. The tax effects of the temporary differences were as follows:

	December 31,
	2019		2018
	(in thousands)
Deferred tax assets:
Inventory valuation	$	11,170	$	8,943
Net operating losses		63,342		67,787
Credit carry forwards		55,103		52,592
Warranty and installation accruals		1,391		1,695
Share-based compensation		6,296		6,981
Other		9,496		2,182
Total deferred tax assets		146,798		140,180
Valuation allowance		(130,053)		(114,955)
Net deferred tax assets		16,745		25,225
Deferred tax liabilities:
Purchased intangible assets		9,345		15,401
Convertible Senior Notes		8,831		11,265
Depreciation		2,668		2,380
Total deferred tax liabilities		20,844		29,046
Net deferred taxes	$	(4,099)	$	(3,821)

The Company is no longer permanently reinvesting future earnings from certain foreign jurisdictions and has accrued for foreign tax withholdings of $0.6 million on its unremitted earnings as of December 31, 2019.

F-39

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

At December 31, 2019, the Company had U.S. federal NOL carryforwards of approximately $270.9 million, of which $6.4 million has an indefinite carryforward period, with the remaining expiring in varying amounts between 2033 and 2037, if not utilized. In connection with the Ultratech acquisition, the Company has $120.8 million of historical NOL carryforwards which are subject to an annual limitation. The Company has $3.5 million of capital loss carryforwards that expire in 2021. At December 31, 2019, the Company had U.S. federal research and development credits of $29.8 million that will expire between 2020 and 2039. The Ultratech acquisition resulted in the carryover of $11.4 million of research and development credit carryforwards, which are subject to an annual limitation. The Company also has $9.4 million of foreign tax credits that expire in 2027. Additionally, the Company has state and local NOL carryforwards of approximately $127.5 million (a net deferred tax asset of $8.1 million, net of federal tax benefits and before the valuation allowance) that will expire between 2020 and 2039. Finally, the Company has state credits of $28.4 million, some of which are indefinite and others that will expire between 2020 and 2034.

The Company makes assessments to estimate if sufficient taxable income will be generated in the future to use existing deferred tax assets. As of December 31, 2019, the Company continued to have a cumulative three year loss with respect to its U.S. operations. As such, the Company has recorded a valuation allowance against its U.S. deferred tax assets. During 2019, the Company’s valuation allowance increased by approximately $15.1 million.

A roll-forward of the Company’s uncertain tax positions for all U.S. federal, state, and foreign tax jurisdictions was as follows:

	December 31,
	2019		2018		2017
	(in thousands)
Balance at beginning of year	$	11,137	$	8,269	$	7,452
Additions for tax positions related to current year		3,075		2,154		511
Additions for tax positions related to prior years		21		1,721		3
Reductions for tax positions related to prior years		(1,814)		(934)		(4,877)
Reductions due to the lapse of the statute of limitations		—		(26)		(122)
Settlements		(50)		(47)		(287)
Additions for business combination		—		—		5,589
Balance at end of year	$	12,369	$	11,137	$	8,269

If the amount of unrecognized tax benefits at December 31, 2019 were recognized, the Company’s income tax provision would decrease by $1.5 million. The gross amount of interest and penalties accrued in income tax payable in the Consolidated Balance Sheets was approximately $0.4 million and $0.3 million at December 31, 2019 and 2018, respectively.

The Company, or one of its subsidiaries, files income tax returns in the United States federal jurisdiction, and various state, local, and foreign jurisdictions. All material consolidated federal income tax matters have been concluded for years through 2016 subject to subsequent utilization of NOLs generated in such years. All material state and local income tax matters have been reviewed through 2012. The majority of the Company’s foreign jurisdictions have been reviewed through 2015. The Company’s major foreign jurisdictions’ statutes of limitation remain open with respect to the tax years 2017 and 2018 for China, 2015 through 2018 for Germany and Singapore, and 2018 for Taiwan. The Company does not anticipate that its uncertain tax position will change significantly within the next twelve months subject to the completion of the ongoing tax audits and any resultant settlement.

Note 18 — Segment Reporting and Geographic Information

The Company operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make

F-40

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

electronic devices. The Company’s Chief Operating Decision Maker, the Chief Executive Officer, evaluates performance of the Company and makes decisions regarding the allocation of resources based on total Company results.

Sales by market is as follows:

	For the year ended December 31,
	2019		2018		2017
	(in thousands)
Sales by end-market
Front-End Semiconductor	$	120,128	$	62,582	$	40,319
Advanced Packaging, MEMS & RF Filters		66,909		90,775		67,406
LED Lighting, Display & Compound Semiconductor		72,791		249,974		248,615
Scientific & Industrial		159,521		138,751		119,346
Total	$	419,349	$	542,082	$	475,686

The Company’s significant operations outside the United States include sales and service offices in China, Europe, and Rest of World. For geographic reporting, sales are attributed to the location in which the customer facility is located.

Sales and long-lived tangible assets by geographic region are as follows:

	Net Sales to Unaffiliated Customers						Long-lived Tangible Assets
	2019		2018		2017		2019		2018		2017
	(in thousands)
United States	$	126,160	$	125,659	$	93,433	$	75,187	$	78,503	$	81,046
China		71,078		194,032		106,674		130		81		64
EMEA(1)		57,351		89,102		72,979		143		205		231
Rest of World		164,760		133,289		202,600		251		1,495		3,717
Total	$	419,349	$	542,082	$	475,686	$	75,711	$	80,284	$	85,058

(1) EMEA consists of Europe, the Middle East, and Africa

Note 19 — Selected Quarterly Financial Information (unaudited)

The following table presents selected unaudited financial data for each fiscal quarter of 2019 and 2018. Although unaudited, this information has been prepared on a basis consistent with the Company’s audited Consolidated Financial Statements and, in the opinion of management, reflects all adjustments (consisting only of normal recurring adjustments) that are considered necessary for a fair presentation of this information in accordance with GAAP. Such quarterly results are not necessarily indicative of future results of operations.

	Fiscal 2019								Fiscal 2018
	Q1		Q2		Q3		Q4		Q1		Q2		Q3		Q4
	(in thousands, except per share amounts)
Net sales	$	99,371	$	97,822	$	108,954	$	113,202	$	158,574	$	157,779	$	126,757	$	98,972
Gross profit		34,716		36,285		42,223		44,970		56,680		55,395		46,385		35,259
Net income (loss)		(18,530)		(15,565)		(11,767)		(32,871)		(15,827)		(237,634)		(8,953)		(144,674)
Basic income (loss) per common share		(0.40)		(0.33)		(0.25)		(0.69)		(0.34)		(5.02)		(0.19)		(3.11)
Diluted income (loss) per common share		(0.40)		(0.33)		(0.25)		(0.69)		(0.34)		(5.02)		(0.19)		(3.11)

F-41

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Asset Impairments

During the fourth quarter of 2019, the Company recorded a non-cash impairment charge of $21 million related to its equity investment in Kateeva which is included in “Other income (expense), net” in the Consolidated Statements of Operations, as well as a non-cash impairment charge of $4.0 million related to the classification of a disposal group as held for sale which is included in “Asset impairment” in the Consolidated Statements of Operations. Refer to Note 4, “Investments,” and Note 5, “Acquisitions and Dispositions,” for additional information.

During the second quarter of 2018, the Company recorded non-cash impairment charges related to the Ultratech asset group of $216.4 million and $35.9 million for definite-lived intangible assets and in-process research and development assets, respectively. Additionally, during the fourth quarter of 2018, the Company recorded a non-cash goodwill impairment charge of $122.8 million. Refer to Note 6, “Goodwill and Intangible Assets,” for additional information.

F-42

Schedule II — Valuation and Qualifying Accounts

			Additions
			Charged
	Balance at		(Credited)		Charged to				Balance at
	Beginning		to Costs and		Other				End of
Deducted from asset accounts:	of Period		Expenses		Accounts		Deductions		Period
	(in thousands)
Year ended December 31, 2019
Allowance for doubtful accounts	$	270	$	392	$	—	$	(60)	$	602
Valuation allowance in net deferred tax assets		114,955		15,098		—		—		130,053
	$	115,225	$	15,490	$	—	$	(60)	$	130,655
Year ended December 31, 2018
Allowance for doubtful accounts	$	270	$	—	$	—	$	—	$	270
Valuation allowance in net deferred tax assets		100,456		14,499		—		—		114,955
	$	100,726	$	14,499	$	—	$	—	$	115,225
Year ended December 31, 2017
Allowance for doubtful accounts	$	286	$	99	$	—	$	(115)	$	270
Valuation allowance in net deferred tax assets		104,744		(49,589)		45,301		—		100,456
	$	105,030	$	(49,490)	$	45,301	$	(115)	$	100,726

S-1

EX-4.3

Exhibit 4.3

DESCRIPTION OF THE REGISTRANT’S SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE

SECURITIES EXCHANGE ACT OF 1934

As of December 31, 2019, Veeco Instruments Inc. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, $0.01 par value per share (the “Common Stock”), which is registered under Section 12(b) of the Exchange Act.

Description of Common Stock

The following description of our Common Stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation, as amended on May 29, 1998, May 5, 2000, May 16, 2002, and May 18, 2010 (as amended, the “Certificate of Incorporation”) and our Fifth Amended and Restated Bylaws  (as amended, the “Bylaws”), each of which are incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit 4.3 is a part. We encourage you to read our Certificate of Incorporation, our Bylaws and the applicable provisions of the Delaware General Corporation Law, for additional information.

General

We are authorized to issue 120,000,000 shares of Common Stock. Our Common Stock trades on The NASDAQ Global Select Market under the symbol “VECO”.

Dividend Rights

Subject to the rights of holders of any outstanding shares of Preferred Stock, if any, the holders of Common Stock are entitled to receive dividends, if any, as may be declared from time to time by the Board of Directors in its discretion out of funds legally available for the payment of dividends.

Voting and Other Rights

Holders of our Common Stock are entitled to one vote per share on all matters to be voted upon by the stockholders. Holders of our Common Stock are not entitled to cumulate votes for the election of directors. In general, a majority of votes cast on a matter is sufficient to take action upon routine matters; however, the election of directors requires a plurality of votes cast.

In the event of our liquidation, dissolution or winding up, holders of our Common Stock will be entitled to share ratably in all assets remaining after payment of liabilities, subject to prior distribution rights of any Preferred Stock then outstanding.

Our Common Stock does not have any preemptive rights, redemption privileges, sinking fund privileges, or conversion rights and is not subject to further calls or assessments by the Company. All the outstanding shares of our Common Stock are validly issued, fully paid, and nonassessable.

American Stock Transfer & Trust Company is the transfer agent and registrar for our Common Stock.

Anti-Takeover Provisions

Provisions of Delaware law, our Certificate of Incorporation and our Bylaws may have the effect of delaying, deferring or discouraging another party from acquiring control of us. These provisions include:

•  "blank check" Preferred Stock,

• a classified board of directors, and

• certain Certificate of Incorporation and Bylaw provisions.

Exhibit 4.3

Our board of directors has the authority to issue up to 500,000 shares of Preferred Stock and to fix the rights (including voting rights), preferences and privileges of these shares ("blank check" preferred). Such Preferred Stock may have rights, including economic rights, senior to our Common Stock. As a result, the issuance of the Preferred Stock could have a material adverse effect on the price of our Common Stock and could make it more difficult for a third party to acquire a majority of our outstanding Common Stock.

Our board of directors is divided into three classes with each class serving a staggered three-year term. The existence of a classified board will make it more difficult for our shareholders to change the composition (and therefore the policies) of our board of directors in a relatively short period of time.

We have adopted certain Certificate of Incorporation and Bylaw provisions which may have anti-takeover effects. These include: (a) requiring certain actions to be taken at a meeting of shareholders rather than by written consent, (b) requiring a super-majority of shareholders to approve certain amendments to our bylaws, (c) limiting the maximum number of directors, and (d) providing that directors may be removed only for "cause." These measures and those described above may have the effect of delaying, deferring or preventing a takeover or other change in control of the Company that a holder of our Common Stock might consider in its best interest.

In addition, we are subject to the provisions of Section 203 of the General Corporation Law of the State of Delaware, which prohibits a Delaware corporation from engaging in any business combination, including mergers and asset sales, with an interested stockholder (generally, a 15% or greater stockholder) for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. The operation of Section 203 may have anti-takeover effects, which could delay, defer or prevent a takeover attempt that a holder of our Common Stock might consider in its best interest.

EX-21.1

Exhibit 21.1

Subsidiaries of the Registrant

Subsidiary	Jurisdiction of Organization	Percentage Ownership(A)
U.S. Subsidiaries
Ultratech International Inc.	DE	100%
Veeco APAC LLC	DE	100%
Veeco Process Equipment Inc.	DE	100%
Foreign Subsidiaries
Veeco Asia Pte. Ltd.	Singapore	100%
Veeco GmbH	Germany	100%
Veeco Instruments Limited	England	100%
Veeco Instruments (Shanghai) Co. Ltd.	China	100%
Veeco Japan Ltd.	Japan	100%
Veeco Korea LLC	South Korea	100%
Veeco Malaysia Sdn. Bhd.	Malaysia	100%
Veeco Netherlands BV	Netherlands	100%
Veeco Taiwan Inc.	Taiwan	100%
Ultra-Tech Technologies Israel Ltd.	Israel	100%
Ultratech Thailand Co. Ltd.	Thailand	100%
Ultratech Korea Holdings LLC	Korea	100%

(A) Includes direct and indirect ownership.

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors
Veeco Instruments Inc.:

We consent to the incorporation by reference in the registration statements listed below of Veeco Instruments Inc. (the Company) of our reports, dated February 21, 2020, with respect to the consolidated balance sheets of Veeco Instruments Inc. and subsidiaries as of December 31, 2019 and 2018, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2019, and the related notes and financial statement schedule II – valuation and qualifying accounts (collectively, the consolidated financial statements), and the effectiveness of internal control over financial reporting as of December 31, 2019, which reports appear in the December 31, 2019 annual report on Form 10‑K of Veeco Instruments Inc. 

Registration No.	Form	Plan
333-166852	S-8	Veeco Instruments Inc. 2010 Stock Incentive Plan
333-194737	S-8	Veeco Instruments Inc. 2010 Stock Incentive Plan, Veeco Instruments Inc. 2013 Inducement Stock Incentive Plan
333-211781	S-8	Veeco Instruments Inc. Amended and Restated 2010 Stock Incentive Plan, Veeco Instruments Inc. 2016 Employee Stock Purchase Plan
333-218256	S-8	Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan as amended and restated May 31, 2017

/s/ KPMG LLP

Melville, New York
February 21, 2020

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULE 13a—14(a) or RULE 15d—14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934

I, William J. Miller, Ph.D., certify that:

1. I have reviewed this annual report on Form 10-K for the year ended December 31, 2019 (the “Report”) of the Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ WILLIAM J. MILLER, Ph.D.

William J. Miller, Ph.D.

Chief Executive Officer and Director

Veeco Instruments Inc.

February 21, 2020

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULE 13a—14(a) or RULE 15d—14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934

I, John P. Kiernan, certify that:

1. I have reviewed this annual report on Form 10-K for the year ended December 31, 2019 (the “Report”) of the Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ John P. Kiernan

John P. Kiernan

Senior Vice President and Chief Financial Officer

Veeco Instruments Inc.

February 21, 2020

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Veeco Instruments Inc. (the “Company”) on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William J. Miller, Ph.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ WILLIAM J. MILLER, Ph.D.

William J. Miller, Ph.D.

Chief Executive Officer and Director

Veeco Instruments Inc.

February 21, 2020

A signed original of this written statement required by Section 906 has been provided to Veeco Instruments Inc. and will be retained by Veeco Instruments Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Veeco Instruments Inc. (the “Company”) on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John P. Kiernan,  Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ John P. Kiernan

John P. Kiernan

Senior Vice President and Chief Financial Officer

Veeco Instruments Inc.

February 21, 2020

A signed original of this written statement required by Section 906 has been provided to Veeco Instruments Inc. and will be retained by Veeco Instruments Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Income (Loss) Per Share - Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income (Loss) Per Share
Net income (loss)	$ (32,871)	$ (11,767)	$ (15,565)	$ (18,530)	$ (144,674)	$ (8,953)	$ (237,634)	$ (15,827)	$ (78,733)	$ (407,088)	$ (51,396)
Net income (loss) per common share:
Basic (in dollars per share)	$ (0.69)	$ (0.25)	$ (0.33)	$ (0.40)	$ (3.11)	$ (0.19)	$ (5.02)	$ (0.34)	$ (1.66)	$ (8.63)	$ (1.16)
Diluted (in dollars per share)	$ (0.69)	$ (0.25)	$ (0.33)	$ (0.40)	$ (3.11)	$ (0.19)	$ (5.02)	$ (0.34)	$ (1.66)	$ (8.63)	$ (1.16)
Weighted average shares reconciliation
Basic weighted average shares outstanding									47,482	47,151	44,174
Diluted weighted average shares outstanding									47,482	47,151	44,174

XML

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Valuation and Qualifying Accounts
Balance at Beginning of Period	$ 115,225	$ 100,726	$ 105,030
Charged (Credited) to Costs and Expenses	15,490	14,499	(49,490)
Charged to Other Accounts			45,301
Deductions	(60)		(115)
Balance at End of Period	130,655	115,225	100,726
Allowance for doubtful accounts
Valuation and Qualifying Accounts
Balance at Beginning of Period	270	270	286
Charged (Credited) to Costs and Expenses	392		99
Deductions	(60)		(115)
Balance at End of Period	602	270	270
Valuation allowance in net deferred tax assets
Valuation and Qualifying Accounts
Balance at Beginning of Period	114,955	100,456	104,744
Charged (Credited) to Costs and Expenses	15,098	14,499	(49,589)
Charged to Other Accounts			45,301
Balance at End of Period	$ 130,053	$ 114,955	$ 100,456

XML

Segment Reporting and Geographic Information - Segment (Details) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019 USD ($)	Sep. 30, 2019 USD ($)	Jun. 30, 2019 USD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Sep. 30, 2018 USD ($)	Jun. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2019 USD ($) segment	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)
Revenue reporting by end-market and geographic region
Number of operating segments | segment									1
Number of reportable segments | segment									1
Net sales	$ 113,202	$ 108,954	$ 97,822	$ 99,371	$ 98,972	$ 126,757	$ 157,779	$ 158,574	$ 419,349	$ 542,082	$ 475,686
Front-End Semiconductor
Revenue reporting by end-market and geographic region
Net sales									120,128	62,582	40,319
Advanced Packaging, MEMS & RF Filters
Revenue reporting by end-market and geographic region
Net sales									66,909	90,775	67,406
LED Lighting, Display & Compound Semiconductor
Revenue reporting by end-market and geographic region
Net sales									72,791	249,974	248,615
Scientific & Industrial
Revenue reporting by end-market and geographic region
Net sales									$ 159,521	$ 138,751	$ 119,346

XML

Significant Accounting Policies - Cash, Cash Equivalents, and Short-Term Investments (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Significant Accounting Policies
Cash equivalents	$ 78.5	$ 69.6
Cash and cash equivalents maintained outside the United States (as a percent)	56.00%	32.00%

XML

Commitments and Contingencies - Lease terms (Details)	Dec. 31, 2019
Leases
Lease Renewal Term	5 years
Remaining lease term	3 years
Weighted average discount rate (as a percent)	6.00%

XML

Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Inventories
Materials	$ 82,155	$ 90,816
Work-in-process	42,575	42,354
Finished goods	8,337	23,141
Total	$ 133,067	$ 156,311

XML

Stock Plans - Stock Option Awards (Details) shares in Thousands	12 Months Ended
	Dec. 31, 2019 $ / shares shares
Vested
Number of Shares | shares	1,119
Weighted Average Exercise Price	$ 34.88
Weighted Average Remaining Contractual Life	2 years
Total
Number of Shares | shares	1,119
Weighted Average Exercise Price	$ 34.88
Weighted Average Remaining Contractual Life	2 years
Closing price	$ 14.69

XML

Stock Plans - RSAs, RSUs, PSAs and PSUs (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
RSAs, RSUs, PSAs and PSUs
Number of Shares
Outstanding at the beginning of the period (in shares)	2,218	1,880	1,949
Granted (in shares)	1,107	1,257	674
Performance award adjustments (in shares)	(25)	(5)	(25)
Assumed from Ultratech (in shares)			338
Vested (in shares)	(768)	(523)	(831)
Forfeited (in shares)	(275)	(391)	(225)
Outstanding at the end of the period (in shares)	2,257	2,218	1,880
Weighted Average Grant Date Fair Value
Outstanding at the beginning of the period (in dollars per share)	$ 20.74	$ 25.41	$ 23.85
Granted (in dollars per share)	11.53	17.37	29.22
Performance award adjustments (in dollars per share)	28.91	32.67	20.95
Assumed from Ultratech (in dollars per share)			31.75
Vested (in dollars per share)	21.77	26.39	27.67
Forfeited (in dollars per share)	18.48	24.66	26.29
Outstanding at the end of the period (in dollars per share)	$ 16.20	$ 20.74	$ 25.41
Total fair value of shares vested	$ 8.8	$ 9.1	$ 22.3
PSAs and PSUs | Minimum
Weighted Average Grant Date Fair Value
Vesting period	1 year
PSAs and PSUs | Maximum
Weighted Average Grant Date Fair Value
Vesting period	5 years

XML

Accrued Expenses and Other Liabilities - Performance Obligation Amount (Details) $ in Millions	Dec. 31, 2019 USD ($)
Accrued Expenses and Other Liabilities
Remaining performance obligations	$ 38.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01
Performance obligations
Percentage of remaining performance obligation expected to be recognized	87.00%

XML

Commitments and Contingencies - Concentration of Credit Risk (Details) - customer	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Ten largest customers
Concentration of Credit Risk
Number of customers	10
Accounts Receivable | Credit Concentration Risk | Ten largest customers
Concentration of Credit Risk
Concentration Risk (as a percent)	67.00%	61.00%
Accounts Receivable | Credit Concentration Risk | Customer A
Concentration of Credit Risk
Concentration Risk (as a percent)	16.00%	22.00%
Accounts Receivable | Credit Concentration Risk | Customer B
Concentration of Credit Risk
Concentration Risk (as a percent)	21.00%
Net Sales | Credit Concentration Risk | Customer A
Concentration of Credit Risk
Concentration Risk (as a percent)	11.00%
Net Sales | Credit Concentration Risk | Customer C
Concentration of Credit Risk
Concentration Risk (as a percent)		12.00%
Net Sales | Credit Concentration Risk | Customer D
Concentration of Credit Risk
Concentration Risk (as a percent)			21.00%

XML

Debt - Convertible Senior Notes (Details) - Convertible Notes	Jan. 10, 2017 USD ($) D $ / shares	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)
Debt
Principal amount	$ 345,000,000.0	$ 345,000,000	$ 345,000,000
Interest rate (as a percent)	2.70%
Proceeds from long-term debt borrowings	$ 335,800,000
Conversion rate	0.0249800
Conversion price (in dollars per share) | $ / shares	$ 40.03
Multiples of principal holders may convert	$ 1,000
Consecutive trading days | D	30
Stock price trigger (as a percent)	130.00%
Trading days	5
Number of consecutive business days	5 days
Maximum percentage of common stock conversion	98.00%
Measurement input	7.00
Long-term Debt, Measurement Input	us-gaap:MeasurementInputDiscountRateMember
Debt discount	$ 72,500,000	$ 40,820,000	$ 52,336,000
Transaction costs	9,200,000
Transaction costs allocated to the equity component	$ 1,900,000
Minimum
Debt
Trading days | D	20

XML

Restructuring Charges - Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Changes in restructuring accrual
Balance at the beginning of the period	$ 2,213	$ 1,520	$ 1,796
Provision	6,006	7,395	9,971
Payments	(5,378)	(6,702)	(10,247)
Balance at the end of the period	2,841	2,213	1,520
Non-cash share based compensation	15,270	16,074	24,396
Non-cash charges related to share based compensation	15,270	16,074	24,396
Personnel severance and related costs
Changes in restructuring accrual
Balance at the beginning of the period	2,143	1,520	1,796
Provision	5,803	4,681	4,714
Payments	(5,105)	(4,058)	(4,990)
Balance at the end of the period	2,841	2,143	1,520
Facility Related Costs and Other
Changes in restructuring accrual
Balance at the beginning of the period	70
Provision	203	2,714	5,257
Payments	(273)	(2,644)	(5,257)
Balance at the end of the period		70
Restructuring
Changes in restructuring accrual
Non-cash share based compensation	$ 397	$ 1,161	$ 1,880

XML

Commitments and Contingencies

12 Months Ended

Dec. 31, 2019

Commitments and Contingencies

Commitments and Contingencies

Note 11 — Commitments and Contingencies

Warranty

Changes in the Company’s product warranty reserves were as follows:

	December 31,
	2019		2018		2017
		(in thousands)
Balance, beginning of the year	$	7,852	$	6,532	$	4,217
Warranties issued		5,865		6,737		5,817
Addition from Ultratech acquisition		—		—		1,889
Consumption of reserves		(6,242)		(6,573)		(6,330)
Changes in estimate		(408)		1,156		939
Balance, end of the year	$	7,067	$	7,852	$	6,532

Minimum Lease Commitments

The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease term of the Company’s operating leases as of December 31, 2019 was 3 years, and the weighted average discount rate used in determining the present value of future lease payments was 6.0%.

The following table provides the maturities of lease liabilities at December 31, 2019:

	Operating
	Leases
	(in thousands)
Payments due by period:
2020	$	4,932
2021		5,020
2022		4,428
2023		1,133
2024		551
Thereafter		—
Total future minimum lease payments		16,064
Less: Imputed interest		(1,568)
Total	$	14,496
Reported as of December 31, 2019
Other current liabilities	$	4,196
Operating lease liabilities		10,300
Total	$	14,496

Minimum lease commitments at December 31, 2018 for property and equipment under operating lease agreements (exclusive of renewal options) were as follows:

	Operating
	Leases
	(in thousands)
Payments due by period:
2019	$	5,143
2020		5,056
2021		2,432
2022		1,812
2023		1,066
Thereafter		548
Total	$	16,057

Operating lease cost for the year ended December 31, 2019 was $5.5 million. Variable lease cost for the year ended December 31, 2019 was $1.7 million. Additionally, the Company has an immaterial amount of short-term leases. Lease expense was $7.2 million, $6.3 million, and $5.3 million for the years ended December 31, 2019, 2018, and 2017, respectively. In addition, the Company is obligated under such leases for certain other expenses, including real estate taxes and insurance.

Legal Proceedings

On June 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed on behalf of different plaintiffs in the same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the Securities Act of 1933 for, among other things, alleged false/misleading statements in the registration statement and prospectus relating to the Ultratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. Veeco is defending this matter vigorously.

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the Superior Court of the State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Concentrations of Credit Risk

The Company depends on purchases from its ten largest customers, which accounted for 67% and 61% of net accounts receivable at December 31, 2019 and 2018, respectively.

Customers who accounted for more than 10% of net accounts receivable or net sales are as follows:

	Accounts Receivable				Net Sales
	December 31,				For the Year Ended December 31,
Customer	2019		2018		2019		2018		2017
Customer A	16	%	22	%	11	%	*		*
Customer B	21	%	*		*		*		*
Customer C	*		*		*		12	%	*
Customer D	*		*		*		*		21	%

* Less than 10% of aggregate accounts receivable or net sales

The Company manufactures and sells its products to companies in different geographic locations. Refer to Note 18, “Segment Reporting and Geographic Information,” for additional information. In certain instances, the Company requires deposits from its customers for a portion of the sales price in advance of shipment and performs periodic credit evaluations on its customers. Where appropriate, the Company requires letters of credit on certain non-U.S. sales arrangements. Receivables generally are due within 30 to 90 days from the date of invoice. In some geographies, receivables may be payable up to 150 days from the date of the invoice.

Suppliers

The Company outsources certain functions to third parties, including the manufacture of several of its systems. While the Company relies on its outsourcing partners to perform their contracted functions, the Company maintains some level of internal manufacturing capability for these systems. In addition, certain of the components and sub-assemblies included in the Company’s products are obtained from a single source or a limited group of suppliers. The failure of the Company’s present outsourcing partners and suppliers to meet their contractual obligations and the Company’s inability to make alternative arrangements or resume the manufacture of these systems could have a material adverse effect on the Company’s revenues, profitability, cash flows, and relationships with its customers.

The Company had deposits with its suppliers of $5.9 million and $12.8 million at December 31, 2019 and 2018, respectively, that were included in “Prepaid expenses and other current assets” on the Consolidated Balance Sheets.

Purchase Commitments

The Company had purchase commitments of $63.3 million at December 31, 2019, substantially all of which will come due within one year. Purchase commitments are primarily for inventory used in manufacturing products and are partially offset by existing deposits with suppliers.

Bank Guarantees

The Company has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At December 31, 2019, outstanding bank guarantees and letters of credit totaled $10.2 million and unused bank guarantees and letters of credit of $21.6 million were available to be drawn upon.

XML

Inventories

12 Months Ended

Dec. 31, 2019

Inventories

Inventories

Note 7 — Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventories consist of the following:

	December 31,		December 31,
	2019		2018
	(in thousands)
Materials	$	82,155	$	90,816
Work-in-process		42,575		42,354
Finished goods		8,337		23,141
Total	$	133,067	$	156,311

XML

Fair Value Measurements

12 Months Ended

Dec. 31, 2019

Fair Value Measurements

Fair Value Measurements

Note 3 — Fair Value Measurements

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. The Company is required to classify certain assets and liabilities based on the following fair value hierarchy:

● Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

● Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

● Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or estimation methodologies could have a significant effect on the estimated fair value amounts.

The following table presents the Company’s assets that were measured at fair value on a recurring basis at December 31, 2019 and 2018:

	Level 1		Level 2		Level 3		Total
	(in thousands)
December 31, 2019
Cash equivalents
Certificate of deposits and time deposits	$	67,009	$	—	$	—	$	67,009
Commercial paper		—		10,484		—		10,484
Corporate debt		—		1,000		—		1,000
Total	$	67,009	$	11,484	$	—	$	78,493
Short-term investments
U.S. treasuries	$	105,130	$	—	$	—	$	105,130
Government agency securities		—		1,139		—		1,139
Corporate debt		—		6,002		—		6,002
Commercial paper		—		2,981		—		2,981
Total	$	105,130	$	10,122	$	—	$	115,252
December 31, 2018
Cash equivalents
Certificate of deposits and time deposits	$	65,571	$	—	$	—	$	65,571
U.S. treasuries		3,990		—		—		3,990
Total	$	69,561	$	—	$	—	$	69,561
Short-term investments
U.S. treasuries	$	37,184	$	—	$	—	$	37,184
Corporate debt		—		8,516		—		8,516
Commercial paper		—		2,489		—		2,489
Total	$	37,184	$	11,005	$	—	$	48,189

The Company’s investments classified as Level 1 are based on quoted prices that are available in active markets. The Company’s investments classified as Level 2 are valued using observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes, or alternative pricing sources with reasonable levels of price transparency.

XML

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Consolidated Statements of Operations
Net sales	$ 419,349	$ 542,082	$ 475,686
Cost of sales	261,155	348,363	299,458
Gross profit	158,194	193,719	176,228
Operating expenses, net:
Research and development	90,557	97,755	81,987
Selling, general, and administrative	79,749	92,060	100,250
Amortization of intangible assets	17,085	32,351	35,475
Restructuring	6,403	8,556	11,851
Acquisition costs		2,959	17,786
Asset impairment	4,020	375,172	1,139
Other operating expense (income), net	(42)	368	(392)
Total operating expenses, net	197,772	609,221	248,096
Operating income (loss)	(39,578)	(415,502)	(71,868)
Interest income	4,680	3,186	2,335
Interest expense	(22,085)	(21,518)	(19,457)
Other income (expense), net	(20,973)
Income (loss) before income taxes	(77,956)	(433,834)	(88,990)
Income tax expense (benefit)	777	(26,746)	(37,594)
Net income (loss)	$ (78,733)	$ (407,088)	$ (51,396)
Income (loss) per common share:
Basic (in dollars per share)	$ (1.66)	$ (8.63)	$ (1.16)
Diluted (in dollars per share)	$ (1.66)	$ (8.63)	$ (1.16)
Weighted average number of shares:
Basic (in shares)	47,482	47,151	44,174
Diluted (in shares)	47,482	47,151	44,174

XML

Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2019

Goodwill and Intangible Assets

Schedule of changes in goodwill

	Gross carrying		Accumulated
	amount		impairment		Net amount
	(in thousands)
Balance at December 31, 2017	$	430,331	$	123,200	$	307,131
Impairment		—		122,829		(122,829)
Balance at December 31, 2018		430,331		246,029		184,302
Allocated to Assets held for sale		—		2,359		(2,359)
Balance at December 31, 2019	$	430,331	$	248,388	$	181,943

Schedule of intangible assets excluding goodwill

		December 31, 2019						December 31, 2018
	Average			Accumulated						Accumulated
	Remaining	Gross		Amortization				Gross		Amortization
	Amortization	Carrying		and		Net		Carrying		and		Net
	Period	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in years)	(in thousands)
Technology	5.0	$	327,908	$	291,766	$	36,142	$	337,218	$	290,808	$	46,410
Customer relationships	9.2		146,465		126,764		19,701		164,595		136,126		28,469
In-process R&D	—		—		—		—		13,710		10,530		3,180
Trademarks and tradenames	4.4		30,910		25,256		5,654		30,910		23,899		7,011
Other	1.1		3,686		3,665		21		3,686		3,607		79
Total	6.3	$	508,969	$	447,451	$	61,518	$	550,119	$	464,970	$	85,149

Schedule of estimated annual amortization expense, excluding in-process R&D for intangible assets with definite useful lives

	Amortization
	(in thousands)
2020	$	15,333
2021		12,280
2022		10,018
2023		8,347
2024		6,708
Thereafter		8,832
Total	$	61,518

XML

Significant Accounting Policies

12 Months Ended

Dec. 31, 2019

Significant Accounting Policies

Significant Accounting Policies

Note 1 — Significant Accounting Policies

(a) Description of Business

Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” or the “Company”) operates in a single segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

(b) Basis of Presentation

The accompanying audited Consolidated Financial Statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). The Company reports interim quarters on a 13-week basis ending on the last Sunday of each period, which is determined at the start of each year. The Company’s fourth quarter always ends on the last day of the calendar year, December 31. During 2019 the interim quarters ended on March 31, June 30, and September 29, and during 2018 the interim quarters ended on April 1, July 1, and September 30. The Company reports these interim quarters as March 31, June 30, and September 30 in its interim consolidated financial statements.

(c) Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, these estimates may ultimately differ from actual results. Significant items subject to such estimates and assumptions include: (i) stand-alone selling prices for the Company’s products and services; (ii) allowances for doubtful accounts; (iii) inventory obsolescence; (iv) the useful lives and expected future cash flows of property, plant, and equipment and identifiable intangible assets; (v) the fair value of the Company’s reporting unit and related goodwill; (vi) investment valuations and the valuation of derivatives, deferred tax assets, and assets acquired in business combinations; (vii) the recoverability of long-lived assets; (viii) liabilities for product warranty and legal contingencies; (ix) share-based compensation; (x) lease term and incremental borrowing rates used in determining operating lease assets and liabilities; and (xi) income tax uncertainties.

(d) Principles of Consolidation

The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Companies acquired during each reporting period are reflected in the results of the Company effective from their respective dates of acquisition through the end of the reporting period.

(e) Foreign Currencies

Assets and liabilities of the Company’s foreign subsidiaries that operate using functional currencies other than the U.S. dollar are translated using the exchange rates in effect at the balance sheet date. Results of operations are translated using monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s subsidiaries into U.S. dollars, including intercompany transactions of a long-term nature, are reported as currency translation adjustments in “Accumulated other comprehensive income” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

(f) Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable

consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases, the Company’s contracts with customers contain a billing retention, typically 10% of the sales price, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected performance period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in “Cost of sales” in the Consolidated Statements of Operations when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

(g) Warranty Costs

The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance by providing labor and parts necessary to repair the systems during the warranty period. The Company records the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of sales” in the Consolidated Statements of Operations. The estimated warranty cost is based on the Company’s historical experience with its systems and regional labor costs. The Company calculates the average service hours by region and parts expense per system utilizing actual service records to determine the estimated warranty charge. The Company updates its warranty estimates on a quarterly basis when the actual product performance or field expense differs from original estimates.

(h) Shipping and Handling Costs

Shipping and handling costs are expenses incurred to move, package, and prepare the Company’s products for shipment and to move the products to a customer’s designated location. These costs are generally comprised of payments to third-party shippers. Shipping and handling costs are included in “Cost of sales” in the Consolidated Statements of Operations.

(i) Research and Development Costs

Research and development costs are expensed as incurred and include charges for the development of new technology and the transition of existing technology into new products or services.

(j) Advertising Expense

The cost of advertising is expensed as incurred and totaled $0.5 million, $0.9 million, and $0.9 million for the years ended December 31, 2019, 2018, and 2017, respectively.

(k) Accounting for Share-based Compensation

Share-based awards exchanged for employee services are accounted for under the fair value method. Accordingly, share-based compensation cost is measured at the grant date based on the estimated fair value of the award. The expense for awards is recognized over the employee’s requisite service period (generally the vesting period of the award). The Company has elected to treat awards with only service conditions and with graded vesting as one award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date.

In addition to stock options, restricted share awards (“RSAs”) and restricted stock units (“RSUs”) with time-based vesting, the Company grants performance share units and awards (“PSUs” and “PSAs”) that have either performance or market conditions. Compensation cost for PSUs and PSAs with performance conditions is recognized over the requisite service period based on the timing and expected level of achievement of the performance targets. A change in the assessment of performance attainment prior to the conclusion of the performance period is recognized in the period of the change in estimate. Compensation cost for PSUs and PSAs with market conditions is recognized over the requisite service period regardless of the expected level of achievement. For all PSUs and PSAs, the number of shares issued to the employee at the conclusion of the service period may vary from the original target based upon the level of attainment of the performance or market conditions.

The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards and purchase rights under the Employee Stock Purchase Plan. The Company uses a Monte Carlo simulation to compute the estimated fair value of awards with market conditions. The Black-Scholes model and Monte Carlo simulation include assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 15, “Stock Plans,” for additional information.

(l) Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rate is recognized in income in the period that includes the enactment date.

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “2017 Tax Act”), which made broad and complex changes to the U.S. tax code. In response to the 2017 Tax Act, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provided guidance on accounting for the tax effects of 2017 Tax Act, including addressing any uncertainty or diversity of view in applying ASC 740, Income Taxes (“ASC 740”), in the reporting period in which the 2017 Tax Act was enacted. In addition, SAB 118 provided a measurement period that should not extend beyond one year from the 2017 Tax Act enactment date for companies to complete the accounting under ASC 740. During the year ended December 31, 2018, the Company finalized the accounting for the tax effects of 2017 Tax Act.

In January 2018, the FASB released guidance on the accounting for taxes under the global intangible low-taxed income (“GILTI”) provisions of the 2017 Tax Act. The GILTI provisions impose a tax on foreign income in excess of a deemed return on tangible assets of foreign operations. The Company has made a policy election to account for income taxes incurred under GILTI as a period cost.

(m) Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, derivative financial instruments used in hedging activities, and accounts receivable. The Company invests in a variety of financial instruments and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. Historically, the Company has not experienced any material credit losses on its investments.

The Company maintains an allowance reserve for potentially uncollectible accounts for estimated losses resulting from the inability of its customers to make required payments. The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount reasonably expected to be collected. The Company also provides allowances based on its write-off history. The allowance for doubtful accounts totaled $0.6 million and $0.3 million at December 31, 2019 and 2018, respectively.

To further mitigate the Company’s exposure to uncollectable accounts, the Company may request certain customers provide a negotiable irrevocable letter of credit drawn on a reputable financial institution. These irrevocable letters of credit are typically issued to mature between zero and 90 days from the date the documentation requirements are met, typically when a system ships or upon receipt of final acceptance from the customer. The Company, at its discretion, may monetize these letters of credit on a non-recourse basis after they become negotiable but before maturity. The fees associated with the monetization are included in “Selling, general, and administrative” in the Consolidated Statements of Operations and were immaterial for the years ended December 31, 2019, 2018, and 2017.

(n) Fair Value of Financial Instruments

The carrying amounts of financial instruments, including cash equivalents, accounts receivable, accounts payable, and accrued expenses reflected in the consolidated financial statements approximate fair value due to their short-term maturities. The fair value of debt for footnote disclosure purposes, including current maturities, if any, is estimated using recently quoted market prices of the instrument, or if not available, a discounted cash flow analysis based on the estimated current incremental borrowing rates for similar types of instruments.

(o) Cash, Cash Equivalents, and Short-term Investments

All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market funds, certificate of deposit and time deposit accounts, U.S. treasuries, government agency securities, and corporate debt. Investments that are classified as cash equivalents are carried at cost, which approximates fair value. The Company’s cash and cash equivalents includes $78.5 million and $69.6 million of cash equivalents at December 31, 2019 and 2018, respectively.

A portion of the Company’s cash and cash equivalents is held by its subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. Approximately 56% and 32% of cash and cash equivalents were maintained outside the United States at December 31, 2019 and 2018, respectively.

Short-term investments consist of marketable debt securities, and are generally classified as available-for-sale for use in current operations, if required, and are reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” on the Consolidated Balance Sheets. These securities can include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations. The specific identification method is used to determine the realized gains and losses on investments.

Non-marketable equity securities are equity securities without readily observable market prices and are included in “Other assets” in the Consolidated Balance Sheets. Non-marketable securities are measured at cost, adjusted for changes in observable prices minus impairment. Changes in fair value are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

(p) Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition. See Note 5, “Acquisitions and Dispositions,” for additional information.

(q) Business Combinations

The Company allocates the fair value of the purchase consideration of the Company’s acquisitions to the tangible assets, intangible assets, including in-process research and development (“IPR&D”), if any, and liabilities assumed, based on

estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. See Note 5, “Acquisitions and Dispositions,” for additional information.

(r) Goodwill and Indefinite-Lived Intangible Assets

Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is measured as the excess of the consideration transferred over the net fair value of identifiable assets acquired and liabilities assumed. Intangible assets with indefinite useful lives are measured at their respective fair values on the acquisition date. Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development (“R&D”) efforts. If and when development is complete, the associated assets would be deemed long-lived and would then be amortized based on their respective estimated useful lives at that point in time. Goodwill and indefinite-lived intangibles are not amortized into results of operations but instead are evaluated for impairment. The Company performs the evaluation in the beginning of the fourth quarter of each year or more frequently if impairment indicators arise.

In testing goodwill for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the reporting unit’s fair value is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the reporting unit to its carrying amount. If the fair value exceeds the carrying amount, goodwill is not impaired. If the carrying amount exceeds fair value, the Company then records an impairment loss equal to the difference, up to the carrying value of goodwill.

The Company determines the fair value of its reporting unit based on a reconciliation of the fair value of the reporting unit to the Company’s adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of the Company’s common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The control premium is estimated using historical transactions in similar industries.

In testing indefinite-lived intangible assets for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the indefinite-lived intangible asset to its carrying amount. The Company determines the fair value of its indefinite-lived intangible assets using a discounted cash flow method.

(s) Long-lived Assets

Long-lived intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, and backlog and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or straight-lined if such pattern cannot be reliably determined.

Property, plant, and equipment are recorded at cost. Depreciation expense is calculated based on the estimated useful lives of the assets by using the straight-line method. Amortization of leasehold improvements is recognized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements.

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability test is performed utilizing undiscounted cash flows expected to be generated by that asset or asset group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent the carrying amount exceeds

its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals.

(t) Leases

Upon the adoption of ASC Topic 842, Leases (“ASC 842”) as of January 1, 2019, the Company determines at contract inception if an arrangement is a lease, or contains a lease, of an identified asset for which the Company has the right to obtain substantially all of the economic benefits from its use and the right to direct its use. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term, while lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. The implicit discount rate in the Company’s leases generally cannot readily be determined, and therefore the Company uses its incremental borrowing rate based on information available at lease commencement date in determining the present value of future payments. The Company has options to renew or terminate certain leases. These options are included in the determination of lease term when it is reasonably certain that the Company will exercise such options. The Company does not separate lease and non-lease components in determining ROU assets or lease liabilities for real estate leases. Additionally, the Company does not recognize ROU assets or lease liabilities for leases with original terms or renewals of one year or less.

(u) Recently Adopted Accounting Standards

The Company adopted ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”), as of January 1, 2018, using the full retrospective method. All amounts and disclosures set forth in this Form 10-K reflect these changes. The most significant financial statement impacts of adopting ASC 606 are the elimination of the constraint on revenue associated with the billing retention related to the receipt of customer final acceptance and the identification of installation services as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, is now generally recognized at the time the Company transfers control of the system to the customer, which is earlier than under the Company’s previous revenue recognition model for certain contracts that were subject to the billing constraint. The performance obligation related to installation services is now recognized as the installation services are performed, which is later than the Company’s previous revenue recognition model. 

The Company adopted ASU 2016-01, Financial Instruments – Overall, as of January 1, 2018. This ASU requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. The Company measures equity investments without readily observable market prices at cost, adjusted for changes in observable prices minus impairment. Changes in measurement are included in “Other income (expense), net” in the Consolidated Statements of Operations. This ASU has not had a material impact on the consolidated financial statements upon adoption, and the Company will monitor its equity investments each reporting period for changes in observable market prices, if any, which may be material in future periods.

The Company adopted ASC Topic 842, Leases (“ASC 842”), as of January 1, 2019. ASC 842 generally requires operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. The new standard offers a transition option whereby companies can recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented. The Company has adopted using this transition method, and therefore prior period balances have not been adjusted. In addition, ASC 842 provides for a number of optional exemptions in transition. The Company has elected certain exemptions whereby prior conclusions regarding lease identification, lease classification, and initial direct costs were not reassessed under the new standard. The adoption of the standard impacted the Company’s Consolidated Balance Sheets through the recognition of ROU assets and lease liabilities of approximately $14.2 million each as of January 1, 2019 but did not have an impact on the Consolidated Statements of Operations, Statements of Comprehensive Income, or Statements of Cash Flows.

(v) Recent Accounting Pronouncements Not Yet Adopted

The Company is evaluating pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

XML

Restructuring Charges (Tables)

12 Months Ended

Dec. 31, 2019

Restructuring Charges

Schedule of restructuring accrual activities

	Personnel		Facility
	Severance and		Related Costs
	Related Costs		and Other		Total
	(in thousands)
Balance - December 31, 2016	$	1,796	$	—	$	1,796
Provision		4,714		5,257		9,971
Payments		(4,990)		(5,257)		(10,247)
Balance - December 31, 2017		1,520		—		1,520
Provision		4,681		2,714		7,395
Payments		(4,058)		(2,644)		(6,702)
Balance - December 31, 2018		2,143		70		2,213
Provision		5,803		203		6,006
Payments		(5,105)		(273)		(5,378)
Balance - December 31, 2019	$	2,841	$	—	$	2,841

XML

Selected Quarterly Financial Information (unaudited)

12 Months Ended

Dec. 31, 2019

Selected Quarterly Financial Information (unaudited)

Selected Quarterly Financial Information (unaudited)

Note 19 — Selected Quarterly Financial Information (unaudited)

The following table presents selected unaudited financial data for each fiscal quarter of 2019 and 2018. Although unaudited, this information has been prepared on a basis consistent with the Company’s audited Consolidated Financial Statements and, in the opinion of management, reflects all adjustments (consisting only of normal recurring adjustments) that are considered necessary for a fair presentation of this information in accordance with GAAP. Such quarterly results are not necessarily indicative of future results of operations.

	Fiscal 2019								Fiscal 2018
	Q1		Q2		Q3		Q4		Q1		Q2		Q3		Q4
	(in thousands, except per share amounts)
Net sales	$	99,371	$	97,822	$	108,954	$	113,202	$	158,574	$	157,779	$	126,757	$	98,972
Gross profit		34,716		36,285		42,223		44,970		56,680		55,395		46,385		35,259
Net income (loss)		(18,530)		(15,565)		(11,767)		(32,871)		(15,827)		(237,634)		(8,953)		(144,674)
Basic income (loss) per common share		(0.40)		(0.33)		(0.25)		(0.69)		(0.34)		(5.02)		(0.19)		(3.11)
Diluted income (loss) per common share		(0.40)		(0.33)		(0.25)		(0.69)		(0.34)		(5.02)		(0.19)		(3.11)

Asset Impairments

During the fourth quarter of 2019, the Company recorded a non-cash impairment charge of $21 million related to its equity investment in Kateeva which is included in “Other income (expense), net” in the Consolidated Statements of Operations, as well as a non-cash impairment charge of $4.0 million related to the classification of a disposal group as held for sale which is included in “Asset impairment” in the Consolidated Statements of Operations. Refer to Note 4, “Investments,” and Note 5, “Acquisitions and Dispositions,” for additional information.

During the second quarter of 2018, the Company recorded non-cash impairment charges related to the Ultratech asset group of $216.4 million and $35.9 million for definite-lived intangible assets and in-process research and development assets, respectively. Additionally, during the fourth quarter of 2018, the Company recorded a non-cash goodwill impairment charge of $122.8 million. Refer to Note 6, “Goodwill and Intangible Assets,” for additional information.

XML

Stock Plans

12 Months Ended

Dec. 31, 2019

Stock Plans

Stock Plans

Note 15 — Stock Plans

Share-based incentive awards are provided to employees under the terms of the Company’s equity incentive compensation plans (the “Plans”), which are administered by the Compensation Committee of the Board of Directors. The 2019 Plan originated as the 2010 Stock Incentive Plan and was originally approved by the Company’s shareholders in May 2010. This Plan was subsequently amended, as approved by shareholders, in 2013, 2016, and 2019 (at which time the Plan was renamed the 2019 Stock Incentive Plan (as amended to date, the “2019 Plan”). The Company’s employees, non-employee directors, and consultants are eligible to receive awards under the 2019 Plan, which can include non-qualified stock options, incentive stock options, restricted share awards (“RSAs”), restricted share units (“RSUs”), performance share awards (“PSAs”), performance share units (“PSUs”), share appreciation rights, dividend equivalent rights, or any combination thereof. The Company settles awards under the Plans with newly issued shares or with shares held in treasury.

In 2013, the Board of Directors granted equity awards to certain employees under the Company’s 2013 Inducement Stock Incentive Plan (the “Inducement Plan”). The Company issued 124,500 stock option shares and 87,000 RSUs under this plan. Stock options under this plan vest over a three year period and have a 10-year term, and RSUs under this plan vest over a two or four year period. At December 31, 2013, the Inducement Plan was merged into the 2019 Plan and is considered an inactive plan with no further shares available for grant. At December 31, 2019, there are 2,000 option shares and no RSUs outstanding under the Inducement Plan.

The Company is authorized to issue up to 13.3 million shares under the 2019 Plan. Option awards are granted with an exercise price equal to the closing price of the Company’s common stock on the trading day prior to the date of grant; option awards generally vest over a three year period and have a seven or ten year term. RSAs and RSUs generally vest over one to five years. Certain option and share awards provide for accelerated vesting if there is a change in control, as defined in the 2019 Plan. At December 31, 2019, there are 1.1 million option shares and 0.9 million RSUs and PSUs outstanding under the 2019 Plan.

During 2016, the Company’s Board of Directors approved the 2016 Employee Stock Purchase Plan (“ESPP”). The Company is authorized to issue up to 1.5 million shares under the ESPP, including additional shares authorized under a plan amendment approved by shareholders in 2019. Under the ESPP, substantially all employees in the U.S. may purchase the Company’s common stock through payroll deductions at a price equal to 85 percent of the lower of the fair market value of the Company’s common stock at the beginning or end of each six-month offer period, as defined in the ESPP, and subject to certain limits. The ESPP was approved by the Company’s shareholders.

During 2017, in connection with the acquisition of Ultratech, the Company assumed certain restricted stock units (the “Assumed RSUs”) available and outstanding under the Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan, as amended (the “Ultratech Plan”). The Assumed RSUs remain subject to the terms set forth in the award agreement governing the award and the Ultratech Plan, except that the Assumed RSUs relate to shares of Company common stock and the number of restricted stock units was adjusted pursuant to the terms of the acquisition to reflect the difference in the value of a share of Company common stock and a share of Ultratech common stock prior to closing the acquisition. The Assumed RSUs were converted into 338,144 restricted stock units of the Company and generally vest over 50 months. After the acquisition and notwithstanding any other provisions of the Ultratech Plan, no further grants will be made under the Ultratech Plan, and the Company is solely maintaining the Ultratech Plan with respect to the Assumed RSUs. At December 31, 2019, there are 7,483 RSUs outstanding under the Ultratech Plan.

Shares Reserved for Future Issuance

At December 31, 2019, the Company has 6.0 million shares reserved to cover exercises of outstanding stock options, vesting of RSUs, and additional grants under the 2019 Plan. At December 31, 2019, the Company has 0.5 million shares reserved to cover future issuances under the ESPP Plan.

Share-Based Compensation

The Company recognized share-based compensation in the following line items in the Consolidated Statements of Operations for the periods indicated:

	For the year ended December 31,
	2019		2018		2017
	(in thousands)
Cost of sales	$	1,903	$	1,885	$	2,505
Research and development		3,340		3,611		2,957
Selling, general, and administrative		9,630		9,417		12,851
Restructuring		397		1,161		1,880
Acquisition costs		—		—		4,203
Total	$	15,270	$	16,074	$	24,396

The Company did not realize any tax benefits associated with share-based compensation for the years ended December 31, 2019, 2018, and 2017 due to the full valuation allowance on its U.S. deferred tax assets. See Note 17, “Income Taxes” for additional information. The Company capitalized an immaterial amount of share-based compensation into inventory for the years ended December 31, 2019, 2018, and 2017.

Unrecognized share-based compensation costs at December 31, 2019 are summarized below:

	Unrecognized		Weighted
	Share-Based		Average Period
	Compensation		Expected to be
	Costs		Recognized
	(in thousands)		(in years)
Stock option awards	$	—	—
Restricted stock units		1,884	2.4
Restricted stock awards		15,431	2.5
Performance share units		5,464	1.8
Total unrecognized share-based compensation cost	$	22,779	2.3

Stock Option Awards

Stock options are awards issued to employees that entitle the holder to purchase shares of the Company’s stock at a fixed price. At December 31, 2019, options outstanding that have vested and are expected to vest are as follows:

				Weighted
	Number	Weighted		Average	Aggregate
	of	Average		Remaining	Intrinsic
	Shares	Exercise Price		Contractual Life	Value
	(in thousands)			(in years)	(in thousands)
Vested	1,119	$	34.88	2.0	—
Expected to vest	—		—	—	—
Total	1,119		34.88	2.0	—

The aggregate intrinsic value represents the difference between the option exercise price and $14.69, the closing price of the Company’s common stock on December 31, 2019, the last trading day of the Company’s fiscal year as reported on the NASDAQ Global Select Market.

Additional information with respect to stock option activity:

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2016	1,576	$	35.18
Exercised	(18)		30.03
Expired or forfeited	(164)		37.47
Balance - December 31, 2017	1,394		34.97
Expired or forfeited	(172)		36.21
Balance - December 31, 2018	1,222		34.80
Expired or forfeited	(103)		33.97
Balance - December 31, 2019	1,119		34.88

The following table summarizes stock option information at December 31, 2019:

	Options Outstanding and Exercisable
				Weighted
		Aggregate		Average	Weighted
		Intrinsic		Remaining	Average
Range of Exercise Prices	Shares	Value		Contractual Life	Exercise Price
	(in thousands)	(in thousands)		(in years)
$20.00 - $30.00	20	$	—	2.6	$	27.83
$30.01 - $40.00	969		—	2.1		32.81
$40.01 - $50.00	10		—	0.8		46.14
$50.01 - $60.00	120		—	1.4		51.70
	1,119	$	—	2.0		34.88

The following table summarizes information on options exercised for the periods indicated:

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Cash received from options exercised	$	—	$	—	$	431
Intrinsic value of options exercised	$	—	$	—	$	51

RSAs, RSUs, PSAs, PSUs

RSAs are stock awards issued to employees that are subject to specified restrictions and a risk of forfeiture. RSUs are stock awards issued to employees that entitle the holder to receive shares of common stock as the awards vest. PSAs and PSUs are awards that result in an issuance of shares of common stock to employees if certain performance or market conditions are achieved. All of these awards typically vest over one to five years and vesting is subject to the employee's continued service with the Company and, in the case of performance awards, meeting certain performance or market conditions. The fair value of the awards is determined and fixed based on the closing price of the Company’s common stock on the trading day prior to the date of grant, or, in the case of performance awards with market conditions, fair value is determined using a Monte Carlo simulation.

The following table summarizes the equity activity of non-vested restricted shares and performance shares:

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2016	1,949	$	23.85
Granted	674		29.22
Performance award adjustments	(25)		20.95
Assumed from Ultratech	338		31.75
Vested	(831)		27.67
Forfeited	(225)		26.29
Balance - December 31, 2017	1,880		25.41
Granted	1,257		17.37
Performance award adjustments	(5)		32.67
Vested	(523)		26.39
Forfeited	(391)		24.66
Balance - December 31, 2018	2,218		20.74
Granted	1,107		11.53
Performance award adjustments	(25)		28.91
Vested	(768)		21.77
Forfeited	(275)		18.48
Balance - December 31, 2019	2,257		16.20

The total fair value of shares that vested during the years ended December 31, 2019, 2018, and 2017 was $8.8 million, $9.1 million, and $22.3 million, respectively. For performance awards, the final number of shares earned will vary depending on the achievement of the actual results relative to the performance or market conditions. Each performance award is included in the table above at the grant date target share amount until the end of the performance period if not previously forfeited.

The fair value of performance awards with market conditions is estimated on the date of grant using a Monte Carlo simulation. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees who receive these awards. The weighted average fair value and the assumptions used in calculating such values during fiscal years 2019 and 2018 for performance awards with market conditions were based on estimates at the date of grant as follows:

	Year ended December 31,
	2019			2018
Weighted average fair value	$	16.45		$	15.58
Dividend yield		0	%		0	%
Expected volatility factor(1)		53	%		49	%
Risk-free interest rate(2)		2.37	%		2.88	%
Expected life (in years)(3)		2.8			3.0

(1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.

(2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.

(3) The expected life is the number of years the Company estimates that the awards will be outstanding prior to exercise.

Employee Stock Purchase Plan

For the years ended December 31, 2019, 2018, and 2017 the Company received cash proceeds of $3.1 million, $3.1 million, and $2.6 million, and issued shares of 395,941, 332,096, and 163,000, respectively, under the ESPP Plan. The weighted average estimated values of employee purchase rights as well as the weighted average assumptions that were used in calculating such values during fiscal years 2019, 2018, and 2017 were based on estimates at the date of grant as follows:

		Year ended December 31,
	2019			2018			2017
Weighted average fair value	$	2.96		$	4.94		$	7.09
Dividend yield		0	%		0	%		0	%
Expected volatility factor(1)		60	%		62	%		36	%
Risk-free interest rate(2)		2.41	%		1.81	%		0.99	%
Expected life (in years)(3)		0.5			0.5			0.5

(1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.

(2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.

(3) The expected life is the number of years the Company estimates that the purchase rights will be outstanding prior to exercise.

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2019

Income Taxes

Schedule of income (loss) from continuing operations before income taxes

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Domestic	$	(78,486)	$	(286,561)	$	(101,573)
Foreign		530		(147,273)		12,583
Total	$	(77,956)	$	(433,834)	$	(88,990)

Schedule of components of the expense (benefit) for income taxes

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Current:
Federal	$	—	$	(1,682)	$	—
Foreign		304		2,518		(2,246)
State and local		113		38		15
Total current expense (benefit) for income taxes		417		874		(2,231)
Deferred:
Federal		162		205		(35,912)
Foreign		116		(27,932)		1,291
State and local		82		107		(742)
Total deferred expense (benefit) for income taxes		360		(27,620)		(35,363)
Total expense (benefit) for income taxes	$	777	$	(26,746)	$	(37,594)

Schedule of reconciliation of the income tax expense computed using the Federal statutory rate to actual income tax provision

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Income tax expense (benefit) at U.S. statutory rates	$	(16,396)	$	(91,105)	$	(31,147)
State taxes, net of U.S. federal impact		(835)		(2,848)		(2,523)
Effect of international operations		785		11,847		10,158
Research and development tax credit		(1,692)		(2,230)		620
Net change in valuation allowance		15,098		7,747		1,883
Change in accrual for unrecognized tax benefits		1,232		2,868		(4,772)
Share-based compensation		1,947		1,848		99
Effect of 2017 Tax Act		—		(1,690)		(11,344)
Asset impairment		495		46,872		—
Other		143		(55)		(568)
Total expense (benefit) for income taxes	$	777	$	(26,746)	$	(37,594)

Schedule of deferred tax assets and liabilities

	December 31,
	2019		2018
	(in thousands)
Deferred tax assets:
Inventory valuation	$	11,170	$	8,943
Net operating losses		63,342		67,787
Credit carry forwards		55,103		52,592
Warranty and installation accruals		1,391		1,695
Share-based compensation		6,296		6,981
Other		9,496		2,182
Total deferred tax assets		146,798		140,180
Valuation allowance		(130,053)		(114,955)
Net deferred tax assets		16,745		25,225
Deferred tax liabilities:
Purchased intangible assets		9,345		15,401
Convertible Senior Notes		8,831		11,265
Depreciation		2,668		2,380
Total deferred tax liabilities		20,844		29,046
Net deferred taxes	$	(4,099)	$	(3,821)

Schedule of reconciliation of beginning and ending amount of uncertain tax positions

	December 31,
	2019		2018		2017
	(in thousands)
Balance at beginning of year	$	11,137	$	8,269	$	7,452
Additions for tax positions related to current year		3,075		2,154		511
Additions for tax positions related to prior years		21		1,721		3
Reductions for tax positions related to prior years		(1,814)		(934)		(4,877)
Reductions due to the lapse of the statute of limitations		—		(26)		(122)
Settlements		(50)		(47)		(287)
Additions for business combination		—		—		5,589
Balance at end of year	$	12,369	$	11,137	$	8,269

XML

Significant Accounting Policies - Revenue Recognition (Details)	12 Months Ended
	Dec. 31, 2019
Significant Accounting Policies
Billing retention recognized at time of transfer of control (as a percent)	10.00%
Revenue, Practical Expedient, Incremental Cost of Obtaining Contract	true

XML

Goodwill and Intangible Assets - Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Goodwill
Gross carrying amount, beginning balance		$ 430,331	$ 430,331
Accumulated impairment, beginning balance		(246,029)	(123,200)
Net amount, beginning balance	$ 184,302	181,943	184,302	$ 307,131
Goodwill impairment	122,800		122,829
Allocated to Assets held for sale		2,359
Gross carrying amount, ending balance	430,331	430,331	430,331
Accumulated impairment, ending balance	(246,029)	(248,388)	(246,029)
Net amount, ending balance	$ 184,302	$ 181,943	$ 184,302
Number of trading days used in adjusted market capitalization calculation		10 days

XML

Stock Plans - Ultratech Plan (Details) - Ultratech Plan - shares		12 Months Ended
	May 17, 2017	Dec. 31, 2017	Dec. 31, 2019
Share-based compensation
Shares that may be granted in future under Plan	0
Restricted stock units
Share-based compensation
Awards converted (in shares)		338,144
Vesting period		50 months
Number of awards outstanding (in shares)			7,483

XML

Stockholders' Equity - Preferred Stock (Details) - $ / shares	Dec. 31, 2019	Dec. 31, 2018
Stockholders' Equity
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued	0	0

XML

Income Taxes - Deferred Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Deferred tax assets:
Inventory valuation	$ 11,170	$ 8,943
Net operating losses	63,342	67,787
Credit carry forwards	55,103	52,592
Warranty and installation accruals	1,391	1,695
Share-based compensation	6,296	6,981
Other	9,496	2,182
Total deferred tax assets	146,798	140,180
Valuation allowance	(130,053)	(114,955)
Net deferred tax assets	16,745	25,225
Deferred tax liabilities:
Purchased intangible assets	9,345	15,401
Convertible Senior Notes	8,831	11,265
Depreciation	2,668	2,380
Total deferred tax liabilities	20,844	29,046
Net deferred taxes	(4,099)	$ (3,821)
Undistributed earnings of foreign subsidiaries
Undistributed earnings of foreign subsidiaries	$ 600

XML

Acquisitions and Dispositions - Intangible Assets (Details) - Ultratech $ in Thousands	May 26, 2017 USD ($)
Intangible assets acquired and the estimated weighted-average useful life
Intangible assets acquired, amount	$ 346,940
In-process R&D
Intangible assets acquired and the estimated weighted-average useful life
Intangible assets acquired, amount	43,340
Technology
Intangible assets acquired and the estimated weighted-average useful life
Intangible assets acquired, amount	$ 158,390
Useful life	9 years
Customer relationships
Intangible assets acquired and the estimated weighted-average useful life
Intangible assets acquired, amount	$ 116,710
Useful life	12 years
Backlog
Intangible assets acquired and the estimated weighted-average useful life
Intangible assets acquired, amount	$ 3,080
Useful life	6 months
Trademarks and tradenames
Intangible assets acquired and the estimated weighted-average useful life
Intangible assets acquired, amount	$ 25,420
Useful life	7 years

XML

Investments - Other Investment (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Other Investment
Impairment of equity investments		$ 20,973	$ 0	$ 0
Kateeva
Other Investment
Carrying amount			21,000
Impairment of equity investments	$ 21,000
Kateeva | Other income (expense), net
Other Investment
Impairment of equity investments		$ 21,000
Kateeva | Maximum
Other Investment
Percentage ownership of cost method investee	20.00%	20.00%
Separate non-marketable investment
Other Investment
Amount of investment made			$ 3,500
Separate non-marketable investment | Maximum
Other Investment
Percentage ownership of cost method investee	20.00%	20.00%

XML

Income Taxes - Additional disclosure and 2017 Tax Act (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018 USD ($)
Income Taxes
Additional income tax benefit from effect of Tax Cuts and Jobs Act of 2017	$ 1.7
2017 Tax Act, Amount of increase in gross deferred tax assets	6.8
2017 Tax Act, Increase in deferred tax assets valuation allowance	$ 6.8

XML

Debt - Carrying Value - Convertible Senior Notes (Details) - Convertible Notes - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Jan. 10, 2017
Debt
Principal amount	$ 345,000	$ 345,000	$ 345,000
Unamortized debt discount	(40,820)	(52,336)	$ (72,500)
Unamortized transaction costs	(4,112)	(5,272)
Net carrying value	$ 300,068	$ 287,392

XML

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2019

Schedule II - Valuation and Qualifying Accounts

Schedule II - Valuation and Qualifying Accounts

Schedule II — Valuation and Qualifying Accounts

			Additions
			Charged
	Balance at		(Credited)		Charged to				Balance at
	Beginning		to Costs and		Other				End of
Deducted from asset accounts:	of Period		Expenses		Accounts		Deductions		Period
	(in thousands)
Year ended December 31, 2019
Allowance for doubtful accounts	$	270	$	392	$	—	$	(60)	$	602
Valuation allowance in net deferred tax assets		114,955		15,098		—		—		130,053
	$	115,225	$	15,490	$	—	$	(60)	$	130,655
Year ended December 31, 2018
Allowance for doubtful accounts	$	270	$	—	$	—	$	—	$	270
Valuation allowance in net deferred tax assets		100,456		14,499		—		—		114,955
	$	100,726	$	14,499	$	—	$	—	$	115,225
Year ended December 31, 2017
Allowance for doubtful accounts	$	286	$	99	$	—	$	(115)	$	270
Valuation allowance in net deferred tax assets		104,744		(49,589)		45,301		—		100,456
	$	105,030	$	(49,490)	$	45,301	$	(115)	$	100,726

XML

Retirement Plans

12 Months Ended

Dec. 31, 2019

Retirement Plans

Retirement Plans

Note 16 — Retirement Plans

The Company maintains a defined contribution plan for the benefit of its U.S. employees. The plan is intended to be tax qualified and contains a qualified cash or deferred arrangement as described under Section 401(k) of the Internal Revenue Code. Eligible participants may elect to contribute a percentage of their base compensation, and the Company may make matching contributions, generally equal to fifty cents for every dollar employees contribute, up to the lesser of three percent of the employee’s eligible compensation or three percent of the maximum the employee is permitted to contribute under then current Internal Revenue Code limitations. Generally, the plan calls for vesting in the Company contributions over the initial five years of a participant’s employment. In addition, the Company assumed Ultratech’s 401(k) plan as a result of the merger, and Ultratech’s plan was merged into the Company’s existing plan effective January 1, 2018. The Company provided employer contributions associated with these plans of approximately $2.4 million, $2.0 million, and $1.8 million for the years ended December 31, 2019, 2018, and 2017, respectively.

XML

Stock Plans (Tables)

12 Months Ended

Dec. 31, 2019

Stock Plans

Schedule of share-based compensation expense

	For the year ended December 31,
	2019		2018		2017
	(in thousands)
Cost of sales	$	1,903	$	1,885	$	2,505
Research and development		3,340		3,611		2,957
Selling, general, and administrative		9,630		9,417		12,851
Restructuring		397		1,161		1,880
Acquisition costs		—		—		4,203
Total	$	15,270	$	16,074	$	24,396

Summary of unrecognized share-based compensation costs

	Unrecognized		Weighted
	Share-Based		Average Period
	Compensation		Expected to be
	Costs		Recognized
	(in thousands)		(in years)
Stock option awards	$	—	—
Restricted stock units		1,884	2.4
Restricted stock awards		15,431	2.5
Performance share units		5,464	1.8
Total unrecognized share-based compensation cost	$	22,779	2.3

Schedule of options, vested and expected to vest

				Weighted
	Number	Weighted		Average	Aggregate
	of	Average		Remaining	Intrinsic
	Shares	Exercise Price		Contractual Life	Value
	(in thousands)			(in years)	(in thousands)
Vested	1,119	$	34.88	2.0	—
Expected to vest	—		—	—	—
Total	1,119		34.88	2.0	—

Summary of stock option activity

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2016	1,576	$	35.18
Exercised	(18)		30.03
Expired or forfeited	(164)		37.47
Balance - December 31, 2017	1,394		34.97
Expired or forfeited	(172)		36.21
Balance - December 31, 2018	1,222		34.80
Expired or forfeited	(103)		33.97
Balance - December 31, 2019	1,119		34.88

Summary of information about stock option information

	Options Outstanding and Exercisable
				Weighted
		Aggregate		Average	Weighted
		Intrinsic		Remaining	Average
Range of Exercise Prices	Shares	Value		Contractual Life	Exercise Price
	(in thousands)	(in thousands)		(in years)
$20.00 - $30.00	20	$	—	2.6	$	27.83
$30.01 - $40.00	969		—	2.1		32.81
$40.01 - $50.00	10		—	0.8		46.14
$50.01 - $60.00	120		—	1.4		51.70
	1,119	$	—	2.0		34.88

Summary of information on options exercised

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Cash received from options exercised	$	—	$	—	$	431
Intrinsic value of options exercised	$	—	$	—	$	51

Summary of non-vested restricted and performance shares activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2016	1,949	$	23.85
Granted	674		29.22
Performance award adjustments	(25)		20.95
Assumed from Ultratech	338		31.75
Vested	(831)		27.67
Forfeited	(225)		26.29
Balance - December 31, 2017	1,880		25.41
Granted	1,257		17.37
Performance award adjustments	(5)		32.67
Vested	(523)		26.39
Forfeited	(391)		24.66
Balance - December 31, 2018	2,218		20.74
Granted	1,107		11.53
Performance award adjustments	(25)		28.91
Vested	(768)		21.77
Forfeited	(275)		18.48
Balance - December 31, 2019	2,257		16.20

Summary of valuation assumptions for performance awards

	Year ended December 31,
	2019			2018
Weighted average fair value	$	16.45		$	15.58
Dividend yield		0	%		0	%
Expected volatility factor(1)		53	%		49	%
Risk-free interest rate(2)		2.37	%		2.88	%
Expected life (in years)(3)		2.8			3.0

(1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.

(2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.

(3) The expected life is the number of years the Company estimates that the awards will be outstanding prior to exercise.

Summary of valuation assumptions for employee stock purchase plan

		Year ended December 31,
	2019			2018			2017
Weighted average fair value	$	2.96		$	4.94		$	7.09
Dividend yield		0	%		0	%		0	%
Expected volatility factor(1)		60	%		62	%		36	%
Risk-free interest rate(2)		2.41	%		1.81	%		0.99	%
Expected life (in years)(3)		0.5			0.5			0.5

(1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.

(2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.

(3) The expected life is the number of years the Company estimates that the purchase rights will be outstanding prior to exercise.

XML

Significant Accounting Policies - Description of Business (Details) - segment	3 Months Ended				12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2019
Significant Accounting Policies
Number of Operating Segments					1
Fiscal period duration (in days)	91 days	91 days	91 days	91 days

XML

Stockholders' Equity - Treasury Stock (Details) - USD ($) $ in Thousands	12 Months Ended		13 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 11, 2017
Treasury Stock
Authorized amount of common stock repurchase (in dollars)				$ 100,000
Purchase of common stock	$ 11,309	$ 3,018	$ 14,300

XML

Acquisitions and Dispositions - IPRD and other (Details) - USD ($) $ in Thousands		12 Months Ended
	May 26, 2017	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Business Combinations
Acquisition related costs			$ 2,959	$ 17,786
Non-cash share based compensation		$ 15,270	16,074	24,396
Amortization of intangible assets		17,085	32,351	35,475
Restructuring Charges.		$ 6,403	8,556	11,851
Acquisition costs
Business Combinations
Non-cash share based compensation				4,203
Ultratech
Business Combinations
Intangible assets acquired, amount	$ 346,940
Portion of IPR&D related to lithography technologies (as a percent)	50.00%
Portion of IPR&D related to laser annealing technologies (as a percent)	33.00%
Acquisition related costs			$ 3,000	17,800
Net sales				65,280
Loss before income taxes				(62,284)
Inventory fair value step-up related to purchase accounting				9,600
Amortization of intangible assets				23,900
Restructuring Charges.				3,300
Ultratech | Acquisition costs
Business Combinations
Non-cash share based compensation				$ 4,200
In-process R&D | Ultratech
Business Combinations
Intangible assets acquired, amount	$ 43,340

XML

Income Taxes - Valuation Allowance (Details) - USD ($) $ in Millions		12 Months Ended
	Jan. 01, 2018	Dec. 31, 2017
Income Taxes
Maximum NOL deduction in any year as percentage of taxable income	80.00%
Income tax benefit related to valuation allowance		$ 6.5

XML

Income Taxes - Reconciliation to Statutory Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Taxes
Income tax expense (benefit) at U.S. statutory rates	$ (16,396)	$ (91,105)	$ (31,147)
State taxes, net of U.S. federal impact	(835)	(2,848)	(2,523)
Effect of international operations	785	11,847	10,158
Research and development tax credit	(1,692)	(2,230)	620
Net change in valuation allowance	15,098	7,747	1,883
Change in accrual for unrecognized tax benefits	1,232	2,868	(4,772)
Share-based compensation	1,947	1,848	99
Tax reform impact		(1,690)	(11,344)
Asset impairment	495	46,872
Other	143	(55)	(568)
Total expense (benefit) for income taxes	$ 777	$ (26,746)	$ (37,594)

XML

Acquisitions and Dispositions - Ultratech (Details) - Ultratech $ / shares in Units, $ in Thousands	May 26, 2017 USD ($) $ / shares shares
Business Combinations
Cash received by acquiree (in dollars per share) | $ / shares	$ 21.75
Number of shares received by acquiree | shares	0.2675
Acquisition date fair value, net of cash acquired | $	$ 633,361

XML

Debt - Interest Expense - Convertible Senior Notes (Details) - Convertible Notes - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash Interest Expense
Coupon interest expense	$ 9,315	$ 9,315
Non-Cash Interest Expense
Amortization of debt discount	11,516	10,686
Amortization of transaction costs	1,160	1,076
Total Interest Expense	21,991	$ 21,077
Estimated fair value	$ 330,300
Convertible Debt, Fair Value by Fair Value Hierarchy Level	us-gaap:FairValueInputsLevel2Member

XML

Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2018	Dec. 31, 2019	Dec. 31, 2018
Intangible assets
Average Remaining Amortization Period		6 years 3 months 18 days
Net Amount, Definite-lived intangible assets		$ 61,518
Total Gross Intangible Assets		508,969	$ 550,119
Accumulated Amortization and Impairment		447,451	464,970
Total Net Intangible Assets		$ 61,518	85,149
Impairment charges, Definite-lived intangible assets	$ 216,400
In-process R&D
Intangible assets
Gross Carrying Amount, Indefinite-lived intangible assets			13,710
Accumulated Amortization and Impairment, Indefinite-lived intangible assets			10,530
Net Amount, Indefinite-lived intangible assets			3,180
Impairment charges, Indefinite-lived intangible assets	$ 35,900
Technology
Intangible assets
Average Remaining Amortization Period		5 years
Gross Carrying Amount, Definite-lived intangible assets		$ 327,908	337,218
Accumulated Amortization and Impairment, Definite-lived intangible assets		291,766	290,808
Net Amount, Definite-lived intangible assets		$ 36,142	46,410
Customer relationships
Intangible assets
Average Remaining Amortization Period		9 years 2 months 12 days
Gross Carrying Amount, Definite-lived intangible assets		$ 146,465	164,595
Accumulated Amortization and Impairment, Definite-lived intangible assets		126,764	136,126
Net Amount, Definite-lived intangible assets		$ 19,701	28,469
Trademarks and tradenames
Intangible assets
Average Remaining Amortization Period		4 years 4 months 24 days
Gross Carrying Amount, Definite-lived intangible assets		$ 30,910	30,910
Accumulated Amortization and Impairment, Definite-lived intangible assets		25,256	23,899
Net Amount, Definite-lived intangible assets		$ 5,654	7,011
Other Intangible Assets
Intangible assets
Average Remaining Amortization Period		1 year 1 month 6 days
Gross Carrying Amount, Definite-lived intangible assets		$ 3,686	3,686
Accumulated Amortization and Impairment, Definite-lived intangible assets		3,665	3,607
Net Amount, Definite-lived intangible assets		$ 21	$ 79

XML

Stock Plans - Shares Reserved for Future Issuance (Details) shares in Millions	Dec. 31, 2019 shares
2019 Plan
Shares reserved for future issuance
Total shares reserved	6.0
ESPP
Shares reserved for future issuance
Total shares reserved	0.5

XML

Selected Quarterly Financial Information (unaudited) - Impairments (Details) - USD ($) $ in Thousands	3 Months Ended			12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Future investments
Impairment of equity investments				$ 20,973	$ 0	$ 0
Asset impairment				$ 4,020	375,172	$ 1,139
Impairment charges, Definite-lived intangible assets			$ 216,400
Goodwill impairment		$ 122,800			$ 122,829
In-process R&D
Future investments
Impairment charges, Indefinite-lived intangible assets			$ 35,900
Kateeva
Future investments
Impairment of equity investments	$ 21,000
Business held-for-sale, Not discontinued operations
Future investments
Asset impairment	$ 4,000

XML

Income (Loss) Per Share - Shares Excluded from EPS (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Common share equivalents
Diluted income (loss) per share
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive	531	28	239
Non-participating shares
Diluted income (loss) per share
Securities excluded from the diluted calculation as their effect would be antidilutive	1,689	2,474	1,744
Convertible Notes
Diluted income (loss) per share
Securities excluded from the diluted calculation as their effect would be antidilutive	8,618	8,618	8,618

XML

Significant Accounting Policies - Goodwill and Indefinite-Lived Intangibles (Details)	12 Months Ended
	Dec. 31, 2019
Significant Accounting Policies
Number of trading days used in adjusted market capitalization calculation	10 days

XML

Income Taxes - Uncertain Tax Positions (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Change in unrecognized tax benefits
Balance at beginning of year	$ 11,137	$ 8,269	$ 7,452
Additions for tax positions related to current year	3,075	2,154	511
Additions for tax positions relating to prior years	21	1,721	3
Reductions for tax positions relating to prior years	(1,814)	(934)	(4,877)
Reductions due to the lapse of the applicable statute of limitations		(26)	(122)
Settlements	(50)	(47)	(287)
Additions for business combination			5,589
Balance at end of year	12,369	11,137	$ 8,269
Unrecognized tax benefits that would impact effective tax rate if recognized	1,500
Accrued interest and penalties related to unrecognized tax benefits	$ 400	$ 300

XML

Commitments and Contingencies - Purchase Commitments and Bank Guarantees (Details) $ in Millions	Dec. 31, 2019 USD ($)
Purchase commitments
Purchase commitments due within one year	$ 63.3
Bank guarantees
Bank guarantees and letters of credit outstanding	10.2
Unused bank guarantees and letters of credit	$ 21.6

XML

Restructuring Charges - Information (Details) - Reduce excess capacity - employee	3 Months Ended
	Jun. 30, 2018	Dec. 31, 2019
Restructuring Accruals
Number of employees terminated	40
Number of employees impacted		60

XML

Commitments and Contingencies - Warranty (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Warranty
Balance, beginning of the year	$ 7,852	$ 6,532	$ 4,217
Warranties issued	5,865	6,737	5,817
Addition from Ultratech acquisition			1,889
Consumption of reserves	(6,242)	(6,573)	(6,330)
Changes in estimate	(408)	1,156	939
Balance, end of the year	$ 7,067	$ 7,852	$ 6,532

XML

Stock Plans - Stock Option Activity (Details) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Number of Shares
Outstanding at the beginning of the period (in shares)	1,222	1,394	1,576
Exercised (in shares)			(18)
Expired or forfeited (in shares)	(103)	(172)	(164)
Outstanding at the end of the period (in shares)	1,119	1,222	1,394
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 34.80	$ 34.97	$ 35.18
Exercised (in dollars per share)			30.03
Expired or forfeited (in dollars per share)	33.97	36.21	37.47
Outstanding at the end of the period (in dollars per share)	$ 34.88	$ 34.80	$ 34.97

XML

Goodwill and Intangible Assets - Amortization (Details) $ in Thousands	Dec. 31, 2019 USD ($)
Estimated aggregate amortization expense
2020	$ 15,333
2021	12,280
2022	10,018
2023	8,347
2024	6,708
Thereafter	8,832
Net Amount, Definite-lived intangible assets	$ 61,518

XML

Accrued Expenses and Other Liabilities - Customer deposits and deferred revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Customer deposits and deferred revenue
Customer deposits and deferred revenue	$ 26,600	$ 28,300
Changes in deferred revenue
Beginning balance	44,415
Deferral of revenue	5,816
Recognition of previously deferred revenue	(21,982)
Ending balance	$ 28,249

XML

Stock Plans - RSAs, RSUs, PSAs and PSUs FV Assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
RSAs, RSUs, PSAs and PSUs
Assumptions
Weighted average fair value (in dollars per share)	$ 11.53	$ 17.37	$ 29.22
Performance share units
Assumptions
Weighted average fair value (in dollars per share)	$ 16.45	$ 15.58
Dividend yield (as a percent)	0.00%	0.00%
Expected volatility factor (as a percent)	53.00%	49.00%
Risk-free interest rate (as a percent)	2.37%	2.88%
Expected life (in years)	2 years 9 months 18 days	3 years

XML

Commitments and Contingencies - Legal Proceedings (Detail)	Aug. 08, 2018 case
Ultratech acquisition litigation
Legal Proceedings
Number of purported class action complaints filed	2

XML

Property, Plant, and Equipment and Assets Held for Sale

12 Months Ended

Dec. 31, 2019

Property, Plant, and Equipment and Assets Held for Sale

Property, Plant, and Equipment and Assets Held for Sale

Note 8 — Property, Plant, and Equipment

Property and equipment, net, consist of the following:

	December 31,		December 31,
	2019		2018		Average Useful Life
	(in thousands)
Land	$	5,061	$	5,669	N/A
Building and improvements		61,884		61,124	10 – 40 years
Machinery and equipment (1)		137,692		128,385	3 – 10 years
Leasehold improvements		6,703		9,033	3 – 7 years
Gross property, plant, and equipment		211,340		204,211
Less: accumulated depreciation and amortization		135,629		123,927
Net property, plant, and equipment	$	75,711	$	80,284

(1) Machinery and equipment also includes software, furniture, and fixtures

Depreciation expense was $17.3 million, $17.6 million, and $14.6 million for the years ended December 31, 2019, 2018, and 2017, respectively. During the year ended December 31, 2019, the Company classified vacant land in St. Paul, Minnesota as held for sale, and subsequently sold the land for approximately $0.6 million, which approximated its carrying value.

XML

Investments

12 Months Ended

Dec. 31, 2019

Investments

Investments

Note 4 — Investments

At December 31, 2019 and 2018 the amortized cost and fair value of marketable securities, which are included in “Short-term investments” on the Consolidated Balance Sheets, were as follows:

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
December 31, 2019
U.S. treasuries	$	105,096	$	38	$	(4)	$	105,130
Government agency securities		1,139		—		—		1,139
Corporate debt		6,003		—		(1)		6,002
Commercial paper		2,981		—		—		2,981
Total	$	115,219	$	38	$	(5)	$	115,252
December 31, 2018
U.S. treasuries	$	37,191	$	—	$	(7)	$	37,184
Corporate debt		8,525		—		(9)		8,516
Commercial paper		2,489		—		—		2,489
Total	$	48,205	$	—	$	(16)	$	48,189

Available-for-sale securities in a loss position at December 31, 2019 and 2018 were as follows:

	December 31, 2019				December 31, 2018
			Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses
		(in thousands)
U.S. treasuries	$	22,943	$	(4)	$	37,184	$	(7)
Corporate debt		6,002		(1)		8,516		(9)
Total	$	28,945	$	(5)	$	45,700	$	(16)

At December 31, 2019 and 2018, there were no short-term investments that had been in a continuous loss position for more than 12 months.

The maturities of securities classified as available-for-sale at December 31, 2019 were all due in one year or less. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. The realized gains or losses for the years ended December 31, 2019, 2018, and 2017 were immaterial.

Other Investments

Veeco has an ownership interest of less than 20% in a non-marketable investment, Kateeva, Inc. (“Kateeva”), over which Veeco does not exert significant influence. The carrying value of the investment was $21.0 million at December 31, 2018. Additionally, during the year ended December 31, 2018, the Company made a separate non-marketable investment of $3.5 million in another entity. The Company does not exert significant influence over this investment and its ownership interest is also less than 20%. Neither equity investment has a readily observable market price, and therefore the Company has elected to measure these investments at cost, adjusted for changes in observable market prices minus impairment. The investments are included in “Other assets” on the Consolidated Balance Sheets. There were no changes in observable market prices for either investment for the year ended December 31, 2019. These investments are subject to periodic impairment reviews which require judgment. The analyses include assessments of the

companies’ financial condition, the business outlooks for their products and technologies, their projected results and cash flows, business valuation indications from recent rounds of financing, the likelihood of obtaining subsequent rounds of financing, and the impact of equity preferences held by Veeco relative to other investors. During the quarter ended December 31, 2019, the Company identified impairment indicators on the Company’s investment in Kateeva, and as a result of a valuation analysis, concluded that its investment in Kateeva is fully impaired, and recorded a non-cash impairment charge of $21.0 million, included in “Other income (expense), net” in the Consolidated Statements of Operations. There were no impairment charges recorded for either investment for the years ended December 31, 2018 or 2017.

XML

Debt

12 Months Ended

Dec. 31, 2019

Debt

Debt

Note 12 — Debt

Convertible Senior Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes (the “Convertible Senior Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The

Convertible Senior Notes mature on January 15, 2023 (the “Maturity Date”), unless earlier purchased by the Company, redeemed, or converted.

The Convertible Senior Notes are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Convertible Senior Notes are convertible into cash, shares of the Company’s common stock, or a combination thereof, at the Company’s election, upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rate is 24.9800 shares of the Company’s common stock per $1,000 principal amount of Convertible Senior Notes, representing an initial effective conversion price of $40.03 per share of common stock. The conversion rate may be subject to adjustment upon the occurrence of certain specified events as provided in the indenture governing the Convertible Senior Notes, dated January 18, 2017 between the Company and U.S. Bank National Association, as trustee, but will not be adjusted for accrued but unpaid interest.

Holders may convert all or any portion of their notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022 only under the following circumstances:

(i) During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii) During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

(iii) If the Company calls any or all of the Convertible Senior Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv) Upon the occurrence of specified corporate events.

On or after October 15, 2022, until the close of business on the business day immediately preceding the Maturity Date, holders may convert their notes at any time, regardless of the foregoing circumstances.

Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion option, the Company segregated the liability component of the instrument from the equity component. The liability component was measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Convertible Senior Notes. The calculation of the fair value of the debt component required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Convertible Senior Notes at a discount rate of 7.00%, an interest rate equal to the estimated borrowing rate for similar non-convertible debt. The excess of the aggregate face value of the Convertible Senior Notes over the estimated fair value of the liability component of $72.5 million was recognized as a debt discount and recorded as an increase to additional paid-in capital and will be amortized over the expected life of the

Convertible Senior Notes using the effective interest rate method. Amortization of the debt discount is recognized as non-cash interest expense.

The transaction costs of $9.2 million incurred in connection with the issuance of the Convertible Senior Notes were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component are being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected term of the Convertible Senior Notes. Transaction costs allocated to the equity component of $1.9 million reduced the value of the equity component recognized in stockholders' equity.

The carrying value of the Convertible Senior Notes is as follows:

	December 31,		December 31,
	2019		2018
	(in thousands)
Principal amount	$	345,000	$	345,000
Unamortized debt discount		(40,820)		(52,336)
Unamortized transaction costs		(4,112)		(5,272)
Net carrying value	$	300,068	$	287,392

Total interest expense related to the Convertible Senior Notes is as follows:

	For the year ended December 31,
	2019		2018
	(in thousands)
Cash Interest Expense
Coupon interest expense	$	9,315	$	9,315
Non-Cash Interest Expense
Amortization of debt discount		11,516		10,686
Amortization of transaction costs		1,160		1,076
Total Interest Expense	$	21,991	$	21,077

The Company determined the Convertible Senior Notes is a Level 2 liability in the fair value hierarchy and estimated its fair value as $330.3 million at December 31, 2019.

XML

Acquisitions and Dispositions (Tables)

12 Months Ended

Dec. 31, 2019

Acquisitions and Dispositions

Schedule of acquisition date fair value of the consideration transferred net of cash acquired

	Acquisition Date
	(May 26, 2017)
	(in thousands)
Cash consideration, net of cash acquired of $229.4 million	$	404,490
Equity consideration (7.2 million shares issued)		228,643
Replacement equity awards attributable to pre-acquisition service		228
Acquisition date fair value	$	633,361

Summary of the estimated fair values of the assets acquired, net of cash acquired, and liabilities assumed

	Acquisition Date
	(May 26, 2017)
	(in thousands)
Short-term investments	$	47,161
Accounts receivable		45,465
Inventories		59,100
Deferred cost of sales		242
Prepaid expense and other current assets		7,217
Property, plant, and equipment		18,152
Intangible assets		346,940
Other assets		6,442
Total identifiable assets acquired		530,719
Accounts payable		24,291
Accrued expenses and other current liabilities		16,356
Customer deposits and deferred revenue		4,834
Deferred income taxes		32,478
Other liabilities		11,622
Total liabilities assumed		89,581
Net identifiable assets acquired		441,138
Goodwill		192,223
Net assets acquired	$	633,361

Schedule of classes of intangible assets acquired and the estimated weighted-average useful life of each class

	Acquisition Date
	(May 26, 2017)
	Amount		Useful life
	(in thousands)
Technology	$	158,390	9	years
Customer relationships		116,710	12	years
Backlog		3,080	6	months
In-process research and development		43,340	*
Trademark and tradenames		25,420	7	years
Intangible assets acquired	$	346,940

* In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project.

Schedule of amounts of revenue and income (loss) from continuing operations before income taxes

	Year ended
	December 31, 2017
	(in thousands)
Net sales	$	65,280
Loss before income taxes	$	(62,284)

Schedule of pro forma financial information

	Year ended December 31, 2017
	(in thousands, except per share amounts)
Net sales	$	546,428
Loss before income taxes		(90,000)
Diluted earnings per share	$	(1.38)

Schedule of assets held for sale

	December 31, 2019
	(in thousands)
Assets held for sale:
Inventories	$	5,985
Property, plant, and equipment, net		310
Intangible assets, net		6,546
Goodwill		2,359
Impairment		(4,020)
Total Assets held for sale	$	11,180

XML

Income (Loss) Per Share

12 Months Ended

Dec. 31, 2019

Income (Loss) Per Share

Income (Loss) Per Share

Note 2 — Income (Loss) Per Share

Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period. Diluted income per share is calculated by dividing net income by the weighted average number of shares used to calculate basic income per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and non-participating share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share in the periods the performance targets have been achieved.

The computations of basic and diluted income (loss) per share for the years ended December 31, 2019, 2018, and 2017 are as follows:

	For the year ended December 31,
	2019		2018		2017
	(in thousands, except per share amounts)
Net income (loss)	$	(78,733)	$	(407,088)	$	(51,396)
Net income (loss) per common share:
Basic	$	(1.66)	$	(8.63)	$	(1.16)
Diluted	$	(1.66)	$	(8.63)	$	(1.16)
Basic weighted average shares outstanding		47,482		47,151		44,174
Effect of potentially dilutive share-based awards		—		—		—
Diluted weighted average shares outstanding		47,482		47,151		44,174
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive		531		28		239
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		1,689		2,474		1,744
Maximum potential shares to be issued for settlement of the Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive		8,618		8,618		8,618

XML

Accrued Expenses and Other Liabilities (Tables)

12 Months Ended

Dec. 31, 2019

Accrued Expenses and Other Liabilities

Schedule of accrued expenses and other current liabilities

	December 31,		December 31,
	2019		2018
	(in thousands)
Payroll and related benefits	$	15,174	$	20,486
Warranty		7,067		7,852
Operating lease liabilities		4,196		—
Interest		4,321		4,321
Professional fees		2,443		2,897
Sales, use, and other taxes		811		2,670
Restructuring liability		2,841		2,213
Other		4,390		6,011
Total	$	41,243	$	46,450

Schedule of changes in deferred revenue

	(in thousands)
Balance - December 31, 2018	$	44,415
Deferral of revenue		5,816
Recognition of previously deferred revenue		(21,982)
Balance - December 31, 2019	$	28,249

XML

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Feb. 14, 2020	Jun. 28, 2019
Document and Entity Information
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2019
Document Transition Report	false
Entity File Number	0-16244
Entity Registrant Name	VEECO INSTRUMENTS INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-2989601
Entity Address, Address Line One	Terminal Drive
Entity Address, City or Town	Plainview
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11803
City Area Code	516
Local Phone Number	677-0200
Title of 12(b) Security	Common Stock
Trading Symbol	VECO
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 584,427,830
Entity Common Stock, Shares Outstanding		49,000,023
Entity Central Index Key	0000103145
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Amendment Flag	false

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Consolidated Statements of Comprehensive Income (Loss)
Net income (loss)	$ (78,733)	$ (407,088)	$ (51,396)
Available-for-sale securities:
Change in net unrealized gains or losses	49	11	(7)
Unrealized gain (loss) on available-for-sale securities	49	11	(7)
Currency translation adjustments:
Change in currency translation adjustments	(19)	5	42
Reclassification adjustments for net (gains) losses included in net income	44	(8)
Net changes related to currency translation adjustments	25	(3)	42
Other comprehensive income (loss), net of tax	74	8	35
Total comprehensive income (loss)	$ (78,659)	$ (407,080)	$ (51,361)

XML

Income (Loss) Per Share (Tables)

12 Months Ended

Dec. 31, 2019

Income (Loss) Per Share

Schedule of basic and diluted income (loss) per share and weighted average shares

	For the year ended December 31,
	2019		2018		2017
	(in thousands, except per share amounts)
Net income (loss)	$	(78,733)	$	(407,088)	$	(51,396)
Net income (loss) per common share:
Basic	$	(1.66)	$	(8.63)	$	(1.16)
Diluted	$	(1.66)	$	(8.63)	$	(1.16)
Basic weighted average shares outstanding		47,482		47,151		44,174
Effect of potentially dilutive share-based awards		—		—		—
Diluted weighted average shares outstanding		47,482		47,151		44,174
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive		531		28		239
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		1,689		2,474		1,744
Maximum potential shares to be issued for settlement of the Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive		8,618		8,618		8,618

XML

Segment Reporting and Geographic Information

12 Months Ended

Dec. 31, 2019

Segment Reporting and Geographic Information

Segment Reporting and Geographic Information

Note 18 — Segment Reporting and Geographic Information

The Company operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make

electronic devices. The Company’s Chief Operating Decision Maker, the Chief Executive Officer, evaluates performance of the Company and makes decisions regarding the allocation of resources based on total Company results.

Sales by market is as follows:

	For the year ended December 31,
	2019		2018		2017
	(in thousands)
Sales by end-market
Front-End Semiconductor	$	120,128	$	62,582	$	40,319
Advanced Packaging, MEMS & RF Filters		66,909		90,775		67,406
LED Lighting, Display & Compound Semiconductor		72,791		249,974		248,615
Scientific & Industrial		159,521		138,751		119,346
Total	$	419,349	$	542,082	$	475,686

The Company’s significant operations outside the United States include sales and service offices in China, Europe, and Rest of World. For geographic reporting, sales are attributed to the location in which the customer facility is located.

Sales and long-lived tangible assets by geographic region are as follows:

	Net Sales to Unaffiliated Customers						Long-lived Tangible Assets
	2019		2018		2017		2019		2018		2017
	(in thousands)
United States	$	126,160	$	125,659	$	93,433	$	75,187	$	78,503	$	81,046
China		71,078		194,032		106,674		130		81		64
EMEA(1)		57,351		89,102		72,979		143		205		231
Rest of World		164,760		133,289		202,600		251		1,495		3,717
Total	$	419,349	$	542,082	$	475,686	$	75,711	$	80,284	$	85,058

(1) EMEA consists of Europe, the Middle East, and Africa

XML

Stockholders' Equity

12 Months Ended

Dec. 31, 2019

Stockholders' Equity

Stockholders' Equity

Note 14 — Stockholders’ Equity

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2016	$	1,797	$	(20)	$	1,777
Other comprehensive income (loss)		42		(7)		35
Balance - December 31, 2017		1,839		(27)		1,812
Other comprehensive income (loss)		(3)		11		8
Balance - December 31, 2018		1,836		(16)		1,820
Other comprehensive income (loss)		25		49		74
Balance - December 31, 2019	$	1,861	$	33	$	1,894

The Company did not allocate additional tax expense (benefit) to other comprehensive income (loss) for all years presented as the Company is in a full valuation allowance position such that a deferred tax asset related to amounts recognized in other comprehensive income is not regarded as realizable on a more-likely-than-not basis.

Preferred Stock

The Board of Directors has authority under the Company’s Certificate of Incorporation to issue shares of preferred stock, par value $0.01, with voting and economic rights to be determined by the Board of Directors. As of December 31, 2019, no preferred shares have been issued.

Treasury Stock

The share repurchase program authorized by the Company’s Board of Directors in October 2015 expired on October 28, 2017. On December 11, 2017, the Company’s Board of Directors authorized a new program to repurchase up to $100 million of the Company’s common stock to be completed through December 11, 2019. At the end of the program, $14.3 million of the $100 million had been utilized.

The Company records treasury stock purchases under the cost method using the first-in, first-out (“FIFO”) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If the Company reissues treasury stock at an amount below its acquisition cost and if additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is charged to accumulated deficit.

XML

Stock Plans - ESPP (Details) - ESPP	12 Months Ended
	Dec. 31, 2016 shares
Share-based compensation
Number of shares authorized	1.5
Share price (as a percent)	85.00%
Offer period	6 months

XML

Income Taxes - Reduction of U.S. Corporate Tax Rate (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Taxes
U.S. federal statutory rate (as a percent)	21.00%	35.00%
Income tax benefit		$ (4.8)
Amount of reduction in net deferred tax assets		25.6
Reduction in valuation allowance		$ 30.4

XML

Acquisitions and Dispositions - Dispositions (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Dispositions
Asset impairment		$ 4,020	$ 375,172	$ 1,139
Assets held for sale:
Total Assets held for sale	$ 11,180	11,180
Business held-for-sale, Not discontinued operations
Dispositions
Asset impairment	4,000
One non-core product line | Business held-for-sale, Not discontinued operations
Dispositions
Asset impairment		4,000
Assets held for sale:
Inventories	5,985	5,985
Property, plant, and equipment, net	310	310
Intangible assets, net	6,546	6,546
Goodwill	2,359	2,359
Impairment	(4,020)	(4,020)
Total Assets held for sale	$ 11,180	$ 11,180

XML

Acquisitions and Dispositions - Fair value of assets acquired and liabilities assumed (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	May 26, 2017
Summary of estimated fair values of the assets acquired and liabilities assumed
Goodwill	$ 181,943	$ 184,302	$ 307,131
Ultratech
Summary of estimated fair values of the assets acquired and liabilities assumed
Short-term investments				$ 47,161
Account receivable				45,465
Inventories				59,100
Deferred cost of sales				242
Prepaid expense and other current assets				7,217
Property, plant, and equipment				18,152
Intangible assets				346,940
Other assets				6,442
Total identifiable assets acquired				530,719
Accounts payable				24,291
Accrued expenses and other current liabilities				16,356
Customer deposits and deferred revenue				4,834
Deferred income taxes				32,478
Other liabilities				11,622
Total liabilities assumed				89,581
Net identifiable assets acquired				441,138
Goodwill				192,223
Net assets acquired				633,361
Gross contractual value of accounts receivable				$ 46,000

XML

Income Taxes - Income Attributable to Domestic and Foreign Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income (loss) from continuing operations before income taxes
Domestic	$ (78,486)	$ (286,561)	$ (101,573)
Foreign	530	(147,273)	12,583
Income (loss) before income taxes	$ (77,956)	$ (433,834)	$ (88,990)

XML

Stockholders' Equity - AOCI Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Changes in the balances of each component of AOCI
Balance at the beginning of the period	$ 437,775	$ 840,093	$ 601,704
Other comprehensive income (loss), net of tax	74	8	35
Balance at the end of the period	374,512	437,775	840,093
Accumulated Other Comprehensive Income
Changes in the balances of each component of AOCI
Balance at the beginning of the period	1,820	1,812	1,777
Other comprehensive income (loss), net of tax	74	8	35
Balance at the end of the period	1,894	1,820	1,812
Foreign Currency Translation
Changes in the balances of each component of AOCI
Balance at the beginning of the period	1,836	1,839	1,797
Other comprehensive income (loss), net of tax	25	(3)	42
Balance at the end of the period	1,861	1,836	1,839
Unrealized Gains (Losses) on Available for Sale Securities
Changes in the balances of each component of AOCI
Balance at the beginning of the period	(16)	(27)	(20)
Other comprehensive income (loss), net of tax	49	11	(7)
Balance at the end of the period	$ 33	$ (16)	$ (27)

XML

Income Taxes - Operating Loss Carryforwards (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Operating loss carryforwards disclosures
Net deferred tax asset	$ 63,342	$ 67,787
Domestic
Operating loss carryforwards disclosures
Net operating loss carryforwards	270,900
Net operating loss carryforwards, Indefinite carryforward period	6,400
Domestic | Ultratech
Operating loss carryforwards disclosures
Net operating loss carryforwards	120,800
State and local
Operating loss carryforwards disclosures
Net operating loss carryforwards	127,500
Net deferred tax asset	$ 8,100

XML

Derivative Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2019

Derivative Financial Instruments

Schedule of gains and (losses) and weighted average notional amount of derivatives

	Year ended December 31,
	2018				2017
		Gains (losses)		Weighted average notional amount		Gains (losses)		Weighted average notional amount
	(in thousands)
Foreign currency exchange forwards	$	327	$	2,869	$	(6)	$	314

XML

Segment Reporting and Geographic Information (Tables)

12 Months Ended

Dec. 31, 2019

Segment Reporting and Geographic Information

Schedule of sales by end-market

	For the year ended December 31,
	2019		2018		2017
	(in thousands)
Sales by end-market
Front-End Semiconductor	$	120,128	$	62,582	$	40,319
Advanced Packaging, MEMS & RF Filters		66,909		90,775		67,406
LED Lighting, Display & Compound Semiconductor		72,791		249,974		248,615
Scientific & Industrial		159,521		138,751		119,346
Total	$	419,349	$	542,082	$	475,686

Schedule of sales by geographic region

	Net Sales to Unaffiliated Customers						Long-lived Tangible Assets
	2019		2018		2017		2019		2018		2017
	(in thousands)
United States	$	126,160	$	125,659	$	93,433	$	75,187	$	78,503	$	81,046
China		71,078		194,032		106,674		130		81		64
EMEA(1)		57,351		89,102		72,979		143		205		231
Rest of World		164,760		133,289		202,600		251		1,495		3,717
Total	$	419,349	$	542,082	$	475,686	$	75,711	$	80,284	$	85,058

(1) EMEA consists of Europe, the Middle East, and Africa

XML

Significant Accounting Policies - Warranty Costs (Details)	12 Months Ended
	Dec. 31, 2019
Significant Accounting Policies
Warranty period	1 year

XML

Retirement Plans - Defined Contribution Plan (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Defined contribution plan disclosures
Employer's matching contribution for every dollar the employees contribute (as a percent)	50.00%
Employer's matching contribution, vesting period (in years)	5 years
Aggregate employer's contribution to pension plans	$ 2.4	$ 2.0	$ 1.8
Maximum
Defined contribution plan disclosures
Employer's contribution as a percentage of employee's eligible compensation	3.00%
Employer's contribution as a percentage of the maximum an employee is permitted to contribute under IRS limits	3.00%

XML

Commitments and Contingencies - Minimum lease commitments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Minimum lease commitments, Payments due by period:
2020	$ 4,932
2021	5,020
2022	4,428
2023	1,133
2024	551
Total future minimum lease payments	16,064
Less: Imputed interest	(1,568)
Total operating lease liabilities	14,496
Operating lease liability, current	$ 4,196
Operating Lease, Liability, Current, Statement of Financial Position	veco:AccruedAndOtherLiabilitiesCurrent
Operating lease liability, noncurrent	$ 10,300
Total operating lease liabilities	$ 14,496
Operating Lease, Liability, Statement of Financial Position	veco:AccruedAndOtherLiabilitiesCurrent us-gaap:OperatingLeaseLiabilityNoncurrent
Operating lease cost	$ 5,500
Variable lease cost	1,700
Lease expense - 2019	$ 7,200
Lease expense		$ 6,300	$ 5,300

XML

Property, Plant, and Equipment - Property and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Property, plant, and equipment
Gross property, plant and equipment	$ 211,340	$ 204,211
Less: accumulated depreciation and amortization	135,629	123,927
Net property, plant, and equipment	75,711	80,284	$ 85,058
Depreciation expense	17,300	17,600	$ 14,600
Proceeds from sale of land	600
Land
Property, plant, and equipment
Gross property, plant and equipment	5,061	5,669
Building and improvements
Property, plant, and equipment
Gross property, plant and equipment	$ 61,884	61,124
Building and improvements | Minimum
Property, plant, and equipment
Average Useful Life	10 years
Building and improvements | Maximum
Property, plant, and equipment
Average Useful Life	40 years
Machinery and equipment
Property, plant, and equipment
Gross property, plant and equipment	$ 137,692	128,385
Machinery and equipment | Minimum
Property, plant, and equipment
Average Useful Life	3 years
Machinery and equipment | Maximum
Property, plant, and equipment
Average Useful Life	10 years
Leaseholds improvements
Property, plant, and equipment
Gross property, plant and equipment	$ 6,703	$ 9,033
Leaseholds improvements | Minimum
Property, plant, and equipment
Average Useful Life	3 years
Leaseholds improvements | Maximum
Property, plant, and equipment
Average Useful Life	7 years

XML

Stock Plans - Unrecognized Share-based Compensation Costs (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019 USD ($)
Unrecognized share-based compensation costs
Unrecognized Share-Based Compensation Costs	$ 22,779
Weighted Average Period Expected to be Recognized	2 years 3 months 18 days
Restricted stock units
Unrecognized share-based compensation costs
Unrecognized Share-Based Compensation Costs	$ 1,884
Weighted Average Period Expected to be Recognized	2 years 4 months 24 days
Restricted stock awards
Unrecognized share-based compensation costs
Unrecognized Share-Based Compensation Costs	$ 15,431
Weighted Average Period Expected to be Recognized	2 years 6 months
Performance share units
Unrecognized share-based compensation costs
Unrecognized Share-Based Compensation Costs	$ 5,464
Weighted Average Period Expected to be Recognized	1 year 9 months 18 days

XML

Stock Plans - Options Exercised (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2017 USD ($)
Stock Plans
Cash received from options exercised	$ 431
Intrinsic value of options exercised	$ 51

XML

Accrued Expenses and Other Liabilities - Performance Obligation Timing (Details)	12 Months Ended
	Dec. 31, 2019
Accrued Expenses and Other Liabilities
Revenue, Practical Expedient, Remaining Performance Obligation	true
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01
Performance obligations
Remaining performance obligations, expected timing of satisfaction	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01
Performance obligations
Remaining performance obligations, expected timing of satisfaction	2 years

XML

Commitments and Contingencies - Receivables (Details)	12 Months Ended
	Dec. 31, 2019
Geographic location, Two
Concentration of Credit Risk
Credit period for accounts receivable	150 days
Minimum | Geographic location, One
Concentration of Credit Risk
Credit period for accounts receivable	30 days
Maximum | Geographic location, One
Concentration of Credit Risk
Credit period for accounts receivable	90 days

XML

Investments - Available-For-Sale Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Total available-for-sale securities
Amortized Cost	$ 115,219	$ 48,205
Gross Unrealized Gains	38
Gross Unrealized Losses	(5)	(16)
Estimated Fair Value	115,252	48,189
Available-for-sale securities in a loss position
Estimated Fair Value	28,945	45,700
Gross Unrealized Losses	(5)	(16)
Investments that had been in a continuous loss position for more than 12 months	0	0
U.S. treasuries
Total available-for-sale securities
Amortized Cost	105,096	37,191
Gross Unrealized Gains	38
Gross Unrealized Losses	(4)	(7)
Estimated Fair Value	105,130	37,184
Available-for-sale securities in a loss position
Estimated Fair Value	22,943	37,184
Gross Unrealized Losses	(4)	(7)
Government agency securities
Total available-for-sale securities
Amortized Cost	1,139
Estimated Fair Value	1,139
Corporate debt
Total available-for-sale securities
Amortized Cost	6,003	8,525
Gross Unrealized Losses	(1)	(9)
Estimated Fair Value	6,002	8,516
Available-for-sale securities in a loss position
Estimated Fair Value	6,002	8,516
Gross Unrealized Losses	(1)	(9)
Commercial paper
Total available-for-sale securities
Amortized Cost	2,981	2,489
Estimated Fair Value	$ 2,981	$ 2,489

XML

Significant Accounting Policies - Recent Accounting Pronouncements - ASC 842 Leases (Details) - USD ($) $ in Thousands	Jan. 01, 2019	Dec. 31, 2019	Jan. 01, 2018
Accounting Changes
Operating lease right-of-use assets		$ 14,453
Operating lease liability		$ 14,496
ASU 2016-01 Financial Instruments
Accounting Changes
Change in Accounting Principle, Accounting Standards Update, Adopted			true
ASU 2016-02 Leases
Accounting Changes
Change in Accounting Principle, Accounting Standards Update, Adopted	true
New Accounting Pronouncement or Change in Accounting Principle, Prior Period Not Restated	true
Operating lease right-of-use assets	$ 14,200
Operating lease liability	$ 14,200

XML

Segment Reporting and Geographic Information - Geographic (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Revenue reporting by end-market and geographic region
Net sales	$ 113,202	$ 108,954	$ 97,822	$ 99,371	$ 98,972	$ 126,757	$ 157,779	$ 158,574	$ 419,349	$ 542,082	$ 475,686
Long-lived tangible assets	75,711				80,284				75,711	80,284	85,058
United States
Revenue reporting by end-market and geographic region
Net sales									126,160	125,659	93,433
Long-lived tangible assets	75,187				78,503				75,187	78,503	81,046
China
Revenue reporting by end-market and geographic region
Net sales									71,078	194,032	106,674
Long-lived tangible assets	130				81				130	81	64
EMEA
Revenue reporting by end-market and geographic region
Net sales									57,351	89,102	72,979
Long-lived tangible assets	143				205				143	205	231
Rest Of World
Revenue reporting by end-market and geographic region
Net sales									164,760	133,289	202,600
Long-lived tangible assets	$ 251				$ 1,495				$ 251	$ 1,495	$ 3,717

XML

Significant Accounting Policies - Concentration of Credit Risk (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Significant Accounting Policies
Allowance for doubtful accounts receivable	$ 0.6	$ 0.3
Maturity period of irrevocable letters of credit, minimum	0 days
Maturity period of irrevocable letters of credit, maximum	90 days

XML

Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2019

Fair Value Measurements

Schedule of assets measured on a recurring basis at fair value

	Level 1		Level 2		Level 3		Total
	(in thousands)
December 31, 2019
Cash equivalents
Certificate of deposits and time deposits	$	67,009	$	—	$	—	$	67,009
Commercial paper		—		10,484		—		10,484
Corporate debt		—		1,000		—		1,000
Total	$	67,009	$	11,484	$	—	$	78,493
Short-term investments
U.S. treasuries	$	105,130	$	—	$	—	$	105,130
Government agency securities		—		1,139		—		1,139
Corporate debt		—		6,002		—		6,002
Commercial paper		—		2,981		—		2,981
Total	$	105,130	$	10,122	$	—	$	115,252
December 31, 2018
Cash equivalents
Certificate of deposits and time deposits	$	65,571	$	—	$	—	$	65,571
U.S. treasuries		3,990		—		—		3,990
Total	$	69,561	$	—	$	—	$	69,561
Short-term investments
U.S. treasuries	$	37,184	$	—	$	—	$	37,184
Corporate debt		—		8,516		—		8,516
Commercial paper		—		2,489		—		2,489
Total	$	37,184	$	11,005	$	—	$	48,189

XML

Inventories (Tables)

12 Months Ended

Dec. 31, 2019

Inventories

Schedule of inventories

	December 31,		December 31,
	2019		2018
	(in thousands)
Materials	$	82,155	$	90,816
Work-in-process		42,575		42,354
Finished goods		8,337		23,141
Total	$	133,067	$	156,311

XML

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2019	Dec. 31, 2018
Consolidated Balance Sheets
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized shares	120,000,000	120,000,000
Common stock, shares issued	48,994,346	48,547,417
Common stock, shares outstanding	48,994,346	48,024,685
Treasury stock, shares		522,732

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash Flows from Operating Activities
Net income (loss)	$ (78,733)	$ (407,088)	$ (51,396)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	34,399	49,998	50,095
Non-cash interest expense	12,676	11,762	10,446
Deferred income taxes	360	(27,620)	(35,363)
Share-based compensation expense	15,270	16,074	24,396
Asset impairment	4,020	375,172	1,139
Impairment of equity investments	20,973	0	0
Provision for bad debts	392		99
Changes in operating assets and liabilities:
Accounts receivable and contract assets	5,796	21,821	10,240
Inventories and deferred cost of sales	14,969	(24,678)	6,244
Prepaid expenses and other current assets	7,520	11,216	(10,204)
Accounts payable and accrued expenses	(26,945)	(19,672)	11,308
Customer deposits and deferred revenue	(17,866)	(39,296)	22,446
Income taxes receivable and payable, net	(655)	(4,800)	775
Long-term income tax liability			(4,877)
Other, net	408	(627)	(355)
Net cash provided by (used in) operating activities	(7,416)	(37,738)	34,993
Cash Flows from Investing Activities
Acquisitions of businesses, net of cash acquired		(2,662)	(401,828)
Capital expenditures	(10,873)	(12,654)	(24,272)
Proceeds from the sale of investments	127,349	90,065	348,927
Payments for purchases of investments	(192,988)	(93,046)	(282,947)
Proceeds from held for sale assets	645		2,284
Net cash provided by (used in) investing activities	(75,867)	(18,297)	(357,836)
Cash Flows from Financing Activities
Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan	3,106	3,064	2,992
Restricted stock tax withholdings	(2,980)	(3,069)	(8,741)
Purchases of common stock		(11,457)	(2,869)
Proceeds from long-term debt borrowings			335,752
Principal payments on long-term debt			(1,194)
Net cash provided by (used in) financing activities	126	(11,462)	325,940
Effect of exchange rate changes on cash and cash equivalents	26	(4)	42
Net increase (decrease) in cash, cash equivalents, and restricted cash	(83,131)	(67,501)	3,139
Cash, cash equivalents, and restricted cash - beginning of period	213,082	280,583	277,444
Cash, cash equivalents, and restricted cash - end of period	129,951	213,082	280,583
Supplemental Disclosure of Cash Flow Information
Interest paid	9,408	9,708	4,675
Income taxes paid	2,931	4,799	1,939
Non-cash operating and financing activities
Net transfer of inventory to property, plant and equipment	4,916	$ 1,479	$ (97)
Right-of-use assets obtained in exchange for lease obligations	$ 5,576

XML

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2019

Commitments and Contingencies

Schedule of changes in product warranty reserves

	December 31,
	2019		2018		2017
		(in thousands)
Balance, beginning of the year	$	7,852	$	6,532	$	4,217
Warranties issued		5,865		6,737		5,817
Addition from Ultratech acquisition		—		—		1,889
Consumption of reserves		(6,242)		(6,573)		(6,330)
Changes in estimate		(408)		1,156		939
Balance, end of the year	$	7,067	$	7,852	$	6,532

Schedule of maturities of lease liabilities 2019

	Operating
	Leases
	(in thousands)
Payments due by period:
2020	$	4,932
2021		5,020
2022		4,428
2023		1,133
2024		551
Thereafter		—
Total future minimum lease payments		16,064
Less: Imputed interest		(1,568)
Total	$	14,496
Reported as of December 31, 2019
Other current liabilities	$	4,196
Operating lease liabilities		10,300
Total	$	14,496

Schedule of minimum lease commitments 2018

Minimum lease commitments at December 31, 2018 for property and equipment under operating lease agreements (exclusive of renewal options) were as follows:

	Operating
	Leases
	(in thousands)
Payments due by period:
2019	$	5,143
2020		5,056
2021		2,432
2022		1,812
2023		1,066
Thereafter		548
Total	$	16,057

Schedule of customers who accounted for more than 10% of our aggregate accounts receivable or net sales

	Accounts Receivable				Net Sales
	December 31,				For the Year Ended December 31,
Customer	2019		2018		2019		2018		2017
Customer A	16	%	22	%	11	%	*		*
Customer B	21	%	*		*		*		*
Customer C	*		*		*		12	%	*
Customer D	*		*		*		*		21	%

* Less than 10% of aggregate accounts receivable or net sales

XML

Restructuring Charges

12 Months Ended

Dec. 31, 2019

Restructuring Charges

Restructuring Charges

Note 10 — Restructuring Charges

During the second quarter of 2018, the Company initiated plans to reduce excess capacity associated with the manufacture and support of the Company’s advanced packaging lithography and 3D wafer inspection systems by consolidating these operations into its San Jose, California facility. As a result of this and other cost saving initiatives, the Company announced headcount reductions of approximately 40 employees. During the year ended December 31, 2019, additional accruals were recognized and payments were made related to these restructuring initiatives.

The Company continued to record restructuring charges during the year ended December 31, 2019 as a result of its efforts to further streamline operations, enhance efficiencies, and reduce costs. In the second half of 2019, the Company executed an initiative to reorganize various functions along product lines and created a central research and development organization to better allocate its resources to the Company’s highest priority projects. In addition, the Company delayered the organization. Collectively, these actions impacted approximately 60 employees.

The following table shows the amounts incurred and paid for restructuring activities during the years ended December 31, 2019, 2018, and 2017 and the remaining accrued balance of restructuring costs at December 31, 2019, which is included in “Accrued expenses and other current liabilities” in the Consolidated Balance Sheets:

	Personnel		Facility
	Severance and		Related Costs
	Related Costs		and Other		Total
	(in thousands)
Balance - December 31, 2016	$	1,796	$	—	$	1,796
Provision		4,714		5,257		9,971
Payments		(4,990)		(5,257)		(10,247)
Balance - December 31, 2017		1,520		—		1,520
Provision		4,681		2,714		7,395
Payments		(4,058)		(2,644)		(6,702)
Balance - December 31, 2018		2,143		70		2,213
Provision		5,803		203		6,006
Payments		(5,105)		(273)		(5,378)
Balance - December 31, 2019	$	2,841	$	—	$	2,841

Restructuring expense for the years ended December 31, 2019, 2018, and 2017 included non-cash charges of $0.4 million, $1.2 million, and $1.9 million, respectively, which are excluded from the table above, related to accelerated share-based compensation for employee terminations.

XML

Goodwill and Intangible Assets

12 Months Ended

Dec. 31, 2019

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Note 6 — Goodwill and Intangible Assets

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The following table presents the changes in goodwill balances during the years indicated:

	Gross carrying		Accumulated
	amount		impairment		Net amount
	(in thousands)
Balance at December 31, 2017	$	430,331	$	123,200	$	307,131
Impairment		—		122,829		(122,829)
Balance at December 31, 2018		430,331		246,029		184,302
Allocated to Assets held for sale		—		2,359		(2,359)
Balance at December 31, 2019	$	430,331	$	248,388	$	181,943

The Company performs its annual goodwill impairment test at the beginning of the fourth quarter each year. As the Company maintains a single goodwill reporting unit, it determines the fair value of its reporting unit based upon the Company’s adjusted market capitalization. The annual test performed at the beginning of the fourth quarter of fiscal 2018 and 2019 did not result in any potential impairment as the fair value of the reporting unit was determined to exceed the carrying amount of the reporting unit.

As a result of a significant decline in the Company’s stock price during the fourth quarter of 2018, the Company concluded it was appropriate to perform an interim goodwill impairment test as of the end of fiscal 2018. The fair value of its reporting unit, as calculated using the adjusted market capitalization approach, was determined to be below the carrying value of the reporting unit, and the Company recorded an impairment charge equal to the excess of carrying value over fair value, or $122.8 million, for the year ended December 31, 2018. The impairment charge is included in “Asset impairment” in the Consolidated Statements of Operations. The valuation of goodwill will continue to be subject to changes in the Company’s market capitalization and observable market control premiums. This analysis is sensitive to changes in the Company’s stock price and absent other qualitative factors, the Company may be required to record additional goodwill impairment charges in future periods if the stock price declines and remains depressed for an extended period of time. 

The components of purchased intangible assets were as follows:

		December 31, 2019						December 31, 2018
	Average			Accumulated						Accumulated
	Remaining	Gross		Amortization				Gross		Amortization
	Amortization	Carrying		and		Net		Carrying		and		Net
	Period	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in years)	(in thousands)
Technology	5.0	$	327,908	$	291,766	$	36,142	$	337,218	$	290,808	$	46,410
Customer relationships	9.2		146,465		126,764		19,701		164,595		136,126		28,469
In-process R&D	—		—		—		—		13,710		10,530		3,180
Trademarks and tradenames	4.4		30,910		25,256		5,654		30,910		23,899		7,011
Other	1.1		3,686		3,665		21		3,686		3,607		79
Total	6.3	$	508,969	$	447,451	$	61,518	$	550,119	$	464,970	$	85,149

Other intangible assets primarily consist of patents, licenses, and backlog.

During the second quarter of 2018, the Company lowered its projected results for the Ultratech asset group, which were significantly below the projected results at the time of the acquisition. The reduced projections were based on lower than expected unit volume of certain smartphones, which incorporate advanced packaging methods such as fan-out wafer

level packaging (“FOWLP”), and a delay in the adoption of FOWLP advanced packaging by other electronics manufacturers, both of which slowed orders and reduced revenue projections for the Company’s advanced packaging lithography systems. In addition, there has been a delay in the build out of 28nm facilities by companies in China who were expected to purchase the Company’s Laser Spike Anneal systems. Taken together, the reduced projections identified during the second quarter of 2018 required the Company to assess the Ultratech asset group for impairment. As a result of the analysis, which included projected cash flows that required the use of unobservable inputs, the Company recorded non-cash impairment charges of $216.4 million and $35.9 million related to definite-lived intangible assets and in-process research and development assets, respectively, during the second quarter of 2018. The impairment charge is included in “Asset impairment” in the Consolidated Statement of Operations. Subsequently, certain in-process research and development projects were completed and moved to the “Technology” line in the above table.

Based on the intangible assets recorded at December 31, 2019, and assuming no subsequent additions to or impairment of the underlying assets, the remaining estimated annual amortization expense, is expected to be as follows:

	Amortization
	(in thousands)
2020	$	15,333
2021		12,280
2022		10,018
2023		8,347
2024		6,708
Thereafter		8,832
Total	$	61,518

XML

Commitments and Contingencies - Minimum lease commitments 2018 (Details) $ in Thousands	Dec. 31, 2018 USD ($)
Minimum lease commitments, Payments due by period:
2019	$ 5,143
2020	5,056
2021	2,432
2022	1,812
2023	1,066
Thereafter	548
Total	$ 16,057

XML

Stock Plans - Recognized Share-based Compensation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Recognized share-based compensation
Share based Compensation	$ 15,270	$ 16,074	$ 24,396
Total	15,270	16,074	24,396
Cost of sales
Recognized share-based compensation
Total	1,903	1,885	2,505
Research and development
Recognized share-based compensation
Total	3,340	3,611	2,957
Selling, general and administrative
Recognized share-based compensation
Total	9,630	9,417	12,851
Restructuring
Recognized share-based compensation
Total	$ 397	$ 1,161	1,880
Acquisition costs
Recognized share-based compensation
Total			$ 4,203

XML

Accrued Expenses and Other Liabilities - Components (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Accrued expenses and other current liabilities
Payroll and related benefits	$ 15,174	$ 20,486
Warranty	7,067	7,852
Operating lease liabilities	4,196
Interest	4,321	4,321
Professional fees	2,443	2,897
Sales, use, and other taxes	811	2,670
Restructuring liability	2,841	2,213
Other	4,390	6,011
Total	$ 41,243	$ 46,450

XML

Accrued Expenses and Other Liabilities - Other liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Other Assets
Other liabilities
Deferred compensation plan assets	$ 2.7	$ 3.2
Other Liabilities
Other liabilities
Deferred compensation plan liabilities	3.1	3.5
Asset retirement obligations	3.2	3.2
Income taxes payable	1.0	1.0
Medical and dental benefits	$ 2.0	$ 2.2

XML

Stock Plans - Option Exercise Ranges (Details) shares in Thousands	12 Months Ended
	Dec. 31, 2019 $ / shares shares
Options Outstanding
Options Outstanding, Shares | shares	1,119
Weighted Average Remaining Contractual Life	2 years
Options Outstanding and Exercisable
Weighted Average Exercise Price (in dollars per share)	$ 34.88
$20.00 - $30.00
Stock plans
Exercise price, low end of range (in dollars per share)	20.00
Exercise price, high end of range (in dollars per share)	$ 30.00
Options Outstanding
Weighted Average Remaining Contractual Life	2 years 7 months 6 days
Options Outstanding and Exercisable
Outstanding and Exercisable (in shares) | shares	20
Weighted Average Exercise Price (in dollars per share)	$ 27.83
$30.01 - $40.00
Stock plans
Exercise price, low end of range (in dollars per share)	30.01
Exercise price, high end of range (in dollars per share)	$ 40.00
Options Outstanding and Exercisable
Outstanding and Exercisable (in shares) | shares	969
Weighted Average Remaining Contractual life	2 years 1 month 6 days
Weighted Average Exercise Price (in dollars per share)	$ 32.81
$40.01 - $50.00
Stock plans
Exercise price, low end of range (in dollars per share)	40.01
Exercise price, high end of range (in dollars per share)	$ 50.00
Options Outstanding
Weighted Average Remaining Contractual Life	9 months 18 days
Options Outstanding and Exercisable
Outstanding and Exercisable (in shares) | shares	10
Weighted Average Exercise Price (in dollars per share)	$ 46.14
$50.01 - $60.00
Stock plans
Exercise price, low end of range (in dollars per share)	50.01
Exercise price, high end of range (in dollars per share)	$ 60.00
Options Outstanding
Weighted Average Remaining Contractual Life	1 year 4 months 24 days
Options Outstanding and Exercisable
Outstanding and Exercisable (in shares) | shares	120
Weighted Average Exercise Price (in dollars per share)	$ 51.70

XML

Commitments and Contingencies - Suppliers (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Purchase Commitments
Deposits with suppliers	$ 5.9	$ 12.8

XML

Stock Plans - ESPP FV Assumptions (Details) - ESPP - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Share-based compensation
Cash proceeds	$ 3.1	$ 3.1	$ 2.6
Number of shares issued	395,941	332,096	163,000
Assumptions
Weighted average fair value (in dollars per share)	$ 2.96	$ 4.94	$ 7.09
Dividend yield (as a percent)	0.00%	0.00%	0.00%
Expected volatility factor (as a percent)	60.00%	62.00%	36.00%
Risk-free interest rate (as a percent)	2.41%	1.81%	0.99%
Expected life (in years)	6 months	6 months	6 months

XML

Significant Accounting Policies - Change in Accounting Policy - ASC Topic 606 (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jan. 01, 2018
Accounting Changes
Net sales	$ 113,202	$ 108,954	$ 97,822	$ 99,371	$ 98,972	$ 126,757	$ 157,779	$ 158,574	$ 419,349	$ 542,082	$ 475,686
Cost of sales									261,155	348,363	299,458
Income tax expense (benefit)									777	(26,746)	(37,594)
Net income (loss)	$ (32,871)	$ (11,767)	$ (15,565)	$ (18,530)	$ (144,674)	$ (8,953)	$ (237,634)	$ (15,827)	$ (78,733)	$ (407,088)	$ (51,396)
Diluted earnings (loss) per share (in dollars per share)	$ (0.69)	$ (0.25)	$ (0.33)	$ (0.40)	$ (3.11)	$ (0.19)	$ (5.02)	$ (0.34)	$ (1.66)	$ (8.63)	$ (1.16)
ASU 2014-09, Revenue from Contracts with Customers
Accounting Changes
Change in Accounting Principle, Accounting Standards Update, Adopted												true
Change in Accounting Principle, Accounting Standards Update, Transition Option Elected												Retrospective

XML

Significant Accounting Policies - Accounting for Share-Based Compensation (Details)	Dec. 31, 2019 item
Significant Accounting Policies
Number of awards with which entity has elected to treat awards with only service conditions and with graded vesting	1

XML

Selected Quarterly Financial Information (unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Quarterly Financial Information
Net sales	$ 113,202	$ 108,954	$ 97,822	$ 99,371	$ 98,972	$ 126,757	$ 157,779	$ 158,574	$ 419,349	$ 542,082	$ 475,686
Gross profit	44,970	42,223	36,285	34,716	35,259	46,385	55,395	56,680	158,194	193,719	176,228
Net income (loss)	$ (32,871)	$ (11,767)	$ (15,565)	$ (18,530)	$ (144,674)	$ (8,953)	$ (237,634)	$ (15,827)	$ (78,733)	$ (407,088)	$ (51,396)
Basic income (loss) per common share (in dollars per share)	$ (0.69)	$ (0.25)	$ (0.33)	$ (0.40)	$ (3.11)	$ (0.19)	$ (5.02)	$ (0.34)	$ (1.66)	$ (8.63)	$ (1.16)
Diluted earnings (loss) per share (in dollars per share)	$ (0.69)	$ (0.25)	$ (0.33)	$ (0.40)	$ (3.11)	$ (0.19)	$ (5.02)	$ (0.34)	$ (1.66)	$ (8.63)	$ (1.16)

XML

Fair Value Measurements (Details) - Measured at fair value on a recurring basis - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Cash equivalents
Total Cash equivalents	$ 78,493	$ 69,561
Short-term investments
Total Short-term investments	115,252	48,189
U.S. treasuries
Short-term investments
Total Short-term investments	105,130	37,184
Government agency securities
Short-term investments
Total Short-term investments	1,139
Corporate debt
Short-term investments
Total Short-term investments	6,002	8,516
Commercial paper
Short-term investments
Total Short-term investments	2,981	2,489
Certificate of deposits and time deposits
Cash equivalents
Total Cash equivalents	67,009	65,571
Commercial paper
Cash equivalents
Total Cash equivalents	10,484
Corporate debt
Cash equivalents
Total Cash equivalents	1,000
U.S. treasuries
Cash equivalents
Total Cash equivalents		3,990
Level 1
Cash equivalents
Total Cash equivalents	67,009	69,561
Short-term investments
Total Short-term investments	105,130	37,184
Level 1 | U.S. treasuries
Short-term investments
Total Short-term investments	105,130	37,184
Level 1 | Certificate of deposits and time deposits
Cash equivalents
Total Cash equivalents	67,009	65,571
Level 1 | U.S. treasuries
Cash equivalents
Total Cash equivalents		3,990
Level 2
Cash equivalents
Total Cash equivalents	11,484
Short-term investments
Total Short-term investments	10,122	11,005
Level 2 | Government agency securities
Short-term investments
Total Short-term investments	1,139
Level 2 | Corporate debt
Short-term investments
Total Short-term investments	6,002	8,516
Level 2 | Commercial paper
Short-term investments
Total Short-term investments	2,981	$ 2,489
Level 2 | Commercial paper
Cash equivalents
Total Cash equivalents	10,484
Level 2 | Corporate debt
Cash equivalents
Total Cash equivalents	$ 1,000

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 129,294	$ 212,273
Restricted cash	657	809
Short-term investments	115,252	48,189
Accounts receivable, net	45,666	66,808
Contract assets	25,351	10,397
Inventories	133,067	156,311
Deferred cost of sales	445	3,072
Prepaid expenses and other current assets	14,966	22,221
Assets held for sale	11,180
Total current assets	475,878	520,080
Property, plant, and equipment, net	75,711	80,284
Operating lease right-of-use assets	14,453
Intangible assets, net	61,518	85,149
Goodwill	181,943	184,302
Deferred income taxes	1,549	1,869
Other assets	7,036	29,132
Total assets	818,088	900,816
Current liabilities:
Accounts payable	21,281	39,611
Accrued expenses and other current liabilities	41,243	46,450
Customer deposits and deferred revenue	54,870	72,736
Income taxes payable	830	1,256
Total current liabilities	118,224	160,053
Deferred income taxes	5,648	5,690
Long-term debt	300,068	287,392
Operating lease long-term liabilities	10,300
Other liabilities	9,336	9,906
Total liabilities	443,576	463,041
Stockholders' equity:
Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.
Common stock, $0.01 par value; 120,000,000 shares authorized; 48,994,346 and 48,547,417 shares issued at December 31, 2019 and December 31, 2018, respectively; 48,994,346 and 48,024,685 shares outstanding at December 31, 2019 and December 31, 2018, respectively	490	485
Additional paid-in capital	1,071,058	1,061,325
Accumulated deficit	(698,930)	(619,983)
Accumulated other comprehensive income	1,894	1,820
Treasury stock, at cost, 522,732 shares at December 31, 2018.		(5,872)
Total stockholders' equity	374,512	437,775
Total liabilities and stockholders' equity	$ 818,088	$ 900,816

XML

Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balance at the beginning of the period at Dec. 31, 2016	$ 407	$ (2,309)	$ 763,303	$ (161,474)	$ 1,777	$ 601,704
Balance (in shares) at Dec. 31, 2016	40,715	127
Increase (Decrease) in Stockholders' Equity
Net loss				(51,396)		(51,396)
Other comprehensive income (loss), net of tax					35	35
Share-based compensation expense			24,396			24,396
Net issuance under employee stock plans	$ 3	$ 4,043	(9,795)			(5,749)
Net issuance under employee stock plans (in shares)	313	(245)
Stock issuance for business acquisition	$ 72		228,800			228,872
Stock issuance for business acquisition (in shares)	7,201
Convertible Senior Notes, equity component			45,249			45,249
Purchases of common stock		$ (3,018)				(3,018)
Purchase of common stock (in shares)		203
Balance at the end of the period at Dec. 31, 2017	$ 482	$ (1,284)	1,051,953	(212,870)	1,812	840,093
Balance (in shares) at Dec. 31, 2017	48,229	85
Increase (Decrease) in Stockholders' Equity
Net loss				(407,088)		(407,088)
Other comprehensive income (loss), net of tax					8	8
Share-based compensation expense			16,074			16,074
Net issuance under employee stock plans	$ 3	$ 6,721	(6,702)	(25)		(3)
Net issuance under employee stock plans (in shares)	318	(512)
Purchases of common stock		$ (11,309)				(11,309)
Purchase of common stock (in shares)		950
Balance at the end of the period at Dec. 31, 2018	$ 485	$ (5,872)	1,061,325	(619,983)	1,820	437,775
Balance (in shares) at Dec. 31, 2018	48,547	523
Increase (Decrease) in Stockholders' Equity
Net loss				(78,733)		(78,733)
Other comprehensive income (loss), net of tax					74	74
Share-based compensation expense			15,270			15,270
Net issuance under employee stock plans	$ 5	$ 5,872	(5,537)	(214)		126
Net issuance under employee stock plans (in shares)	447	(523)
Balance at the end of the period at Dec. 31, 2019	$ 490		$ 1,071,058	$ (698,930)	$ 1,894	$ 374,512
Balance (in shares) at Dec. 31, 2019	48,994

XML

Debt (Tables)

12 Months Ended

Dec. 31, 2019

Debt

Schedule of carrying value of Convertible Senior Notes

	December 31,		December 31,
	2019		2018
	(in thousands)
Principal amount	$	345,000	$	345,000
Unamortized debt discount		(40,820)		(52,336)
Unamortized transaction costs		(4,112)		(5,272)
Net carrying value	$	300,068	$	287,392

Schedule of interest expense related to Convertible Senior Notes

	For the year ended December 31,
	2019		2018
	(in thousands)
Cash Interest Expense
Coupon interest expense	$	9,315	$	9,315
Non-Cash Interest Expense
Amortization of debt discount		11,516		10,686
Amortization of transaction costs		1,160		1,076
Total Interest Expense	$	21,991	$	21,077

XML

Investments (Tables)

12 Months Ended

Dec. 31, 2019

Investments

Schedule of amortized cost and fair value of available-for-sale securities

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
December 31, 2019
U.S. treasuries	$	105,096	$	38	$	(4)	$	105,130
Government agency securities		1,139		—		—		1,139
Corporate debt		6,003		—		(1)		6,002
Commercial paper		2,981		—		—		2,981
Total	$	115,219	$	38	$	(5)	$	115,252
December 31, 2018
U.S. treasuries	$	37,191	$	—	$	(7)	$	37,184
Corporate debt		8,525		—		(9)		8,516
Commercial paper		2,489		—		—		2,489
Total	$	48,205	$	—	$	(16)	$	48,189

Schedule of fair value and unrealized losses of available-for-sale securities in a loss position

	December 31, 2019				December 31, 2018
			Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses
		(in thousands)
U.S. treasuries	$	22,943	$	(4)	$	37,184	$	(7)
Corporate debt		6,002		(1)		8,516		(9)
Total	$	28,945	$	(5)	$	45,700	$	(16)

XML

Property, Plant, and Equipment and Assets Held for Sale (Tables)

12 Months Ended

Dec. 31, 2019

Property, Plant, and Equipment and Assets Held for Sale

Schedule of property, plant, and equipment

	December 31,		December 31,
	2019		2018		Average Useful Life
	(in thousands)
Land	$	5,061	$	5,669	N/A
Building and improvements		61,884		61,124	10 – 40 years
Machinery and equipment (1)		137,692		128,385	3 – 10 years
Leasehold improvements		6,703		9,033	3 – 7 years
Gross property, plant, and equipment		211,340		204,211
Less: accumulated depreciation and amortization		135,629		123,927
Net property, plant, and equipment	$	75,711	$	80,284

(1) Machinery and equipment also includes software, furniture, and fixtures

XML

Accrued Expenses and Other Liabilities

12 Months Ended

Dec. 31, 2019

Accrued Expenses and Other Liabilities

Accrued Expenses and Other Liabilities

Note 9 — Accrued Expenses and Other Liabilities

The components of accrued expenses and other current liabilities were as follows:

	December 31,		December 31,
	2019		2018
	(in thousands)
Payroll and related benefits	$	15,174	$	20,486
Warranty		7,067		7,852
Operating lease liabilities		4,196		—
Interest		4,321		4,321
Professional fees		2,443		2,897
Sales, use, and other taxes		811		2,670
Restructuring liability		2,841		2,213
Other		4,390		6,011
Total	$	41,243	$	46,450

Customer deposits and deferred revenue

Customer deposits totaled $26.6 million and $28.3 million at December 31, 2019 and 2018, respectively, which are included in “Customer deposits and deferred revenue” in the Consolidated Balance Sheets. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows:

	(in thousands)
Balance - December 31, 2018	$	44,415
Deferral of revenue		5,816
Recognition of previously deferred revenue		(21,982)
Balance - December 31, 2019	$	28,249

As of December 31, 2019, the Company has approximately $38.9 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 87% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Other liabilities

As part of the acquisition of Ultratech, the Company assumed an executive non-qualified deferred compensation plan that allowed qualifying executives to defer cash compensation. The plan was frozen at the time of acquisition and no further contributions have been made. At December 31, 2019 and 2018, plan assets approximated $2.7 million and $3.2 million, respectively, representing the cash surrender value of life insurance policies and is included within “Other assets” in the Consolidated Balance Sheets, while plan liabilities approximated $3.1 million and $3.5 million, respectively and is included within “Other liabilities” in the Consolidated Balance Sheets. Other liabilities also included asset retirement obligations of $3.2 million and income tax payables of $1.0 million at both December 31, 2019 and 2018, and medical and dental benefits for former executives of $2.0 million and $2.2 million at December 31, 2019 and 2018, respectively.

XML

Acquisitions and Dispositions

12 Months Ended

Dec. 31, 2019

Acquisitions and Dispositions

Acquisitions and Dispositions

Note 5 — Acquisitions and Dispositions

Ultratech acquisition

On May 26, 2017, the Company completed its acquisition of Ultratech, Inc. (“Ultratech”). Ultratech develops, manufactures, sells, and supports lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also develops, manufactures, sells, and supports ALD equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, Europe, China, Japan, Taiwan, Singapore, and Korea. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

Ultratech shareholders received (i) $21.75 per share in cash and (ii) 0.2675 of a share of Veeco common stock for each Ultratech common share outstanding on the acquisition date. The acquisition date fair value of the consideration totaled $633.4 million, net of cash acquired, which consisted of the following:

	Acquisition Date
	(May 26, 2017)
	(in thousands)
Cash consideration, net of cash acquired of $229.4 million	$	404,490
Equity consideration (7.2 million shares issued)		228,643
Replacement equity awards attributable to pre-acquisition service		228
Acquisition date fair value	$	633,361

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

	Acquisition Date
	(May 26, 2017)
	(in thousands)
Short-term investments	$	47,161
Accounts receivable		45,465
Inventories		59,100
Deferred cost of sales		242
Prepaid expense and other current assets		7,217
Property, plant, and equipment		18,152
Intangible assets		346,940
Other assets		6,442
Total identifiable assets acquired		530,719
Accounts payable		24,291
Accrued expenses and other current liabilities		16,356
Customer deposits and deferred revenue		4,834
Deferred income taxes		32,478
Other liabilities		11,622
Total liabilities assumed		89,581
Net identifiable assets acquired		441,138
Goodwill		192,223
Net assets acquired	$	633,361

The gross contractual value of the acquired accounts receivable was approximately $46.0 million. The fair value of the accounts receivables is the amount expected to be collected by the Company. Goodwill generated from the acquisition is primarily attributable to expected synergies from future growth and strategic advantages provided through the expansion of product offerings as well as assembled workforce and is not expected to be deductible for income tax purposes.

The classes of intangible assets acquired and the estimated useful life of each class is presented in the table below:

	Acquisition Date
	(May 26, 2017)
	Amount		Useful life
	(in thousands)
Technology	$	158,390	9	years
Customer relationships		116,710	12	years
Backlog		3,080	6	months
In-process research and development		43,340	*
Trademark and tradenames		25,420	7	years
Intangible assets acquired	$	346,940

* In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project.

The Company determined the estimated fair value of the identifiable intangible assets based on various factors including: cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation.

In-process research and development (“IPR&D”) represents the estimated fair values of incomplete Ultratech research and development projects that had not reached the commercialization stage and met the criteria for recognition as IPR&D as of the date of the acquisition. The fair value of IPR&D was determined using an income approach and costs to complete the project and expected commercialization timelines are considered key assumptions. This valuation approach reflected the present value of the projected cash flows that were expected to be generated by the IPR&D less charges representing the contribution of other assets to those cash flows. The value of the IPR&D was determined to be $43.3 million, approximately half of which was related to Ultratech’s lithography technologies and one-third of which was related to Ultratech’s laser annealing technologies.

During the second quarter of 2018, the Company lowered its projected results for the Ultratech asset group and determined that the revised projections were significantly lower than projected results at the time of the acquisition and that these revised projections required the Company to assess the Ultratech asset group for impairment. See Note 6, “Goodwill and Intangible Assets,” for additional information.

For the year ended December 31, 2018 and 2017, acquisition related costs were approximately $3.0 million and $17.8 million, respectively, including non-cash charges of $4.2 million related to accelerated share-based compensation for employee terminations for the year ended December 31, 2017.

The amounts of net sales and income (loss) from operations before income taxes of Ultratech included in the Company’s Consolidated Statement of Operations for the year ended December 31, 2017 are as follows:

	Year ended
	December 31, 2017
	(in thousands)
Net sales	$	65,280
Loss before income taxes	$	(62,284)

Loss before income taxes of Ultratech for the year ended December 31, 2017 of $62.3 million includes acquisition costs of $17.8 million, release of inventory fair value step-up related to purchase accounting of $9.6 million, amortization expense on intangible assets of $23.9 million, and restructuring charges of $3.3 million.

The following table presents unaudited pro forma financial information for the year ended December 31, 2017, as if the acquisition of Ultratech had occurred on January 1, 2016:

	Year ended December 31, 2017
	(in thousands, except per share amounts)
Net sales	$	546,428
Loss before income taxes		(90,000)
Diluted earnings per share	$	(1.38)

The pro-forma results were calculated by combining the audited results of the Company with the stand-alone unaudited results of Ultratech for the pre-acquisition period, and adjusting for the following:

(i) Additional amortization expense related to identified intangible assets valued as part of the purchase price allocation that would have been incurred starting on January 1, 2016.

(ii) Additional depreciation expense for the property, plant, and equipment fair value adjustments that would have been incurred starting on January 1, 2016.

(iii) All acquisition related costs incurred by the Company as well as by Ultratech pre-acquisition have been removed from the year ended December 31, 2017 and included in the year ended December 31, 2016, as such expenses would have been incurred in the first quarter following the acquisition.

(iv) All amortization of inventory step-up has been removed from the year ended December 31, 2017 and recorded in the year ended December 31, 2016, as such costs would have been incurred as the corresponding inventory was sold.

(v) Additional interest expense related to the Convertible Senior Notes (see Note 12, “Debt”) as if they had been issued on January 1, 2016.

(vi) Income tax expense (benefit) was adjusted for the impact of the above adjustments for each period.

(vii) All shares issued in connection with the acquisition were considered outstanding as of January 1, 2016 for purposes of calculating diluted earnings per share.

Dispositions

As of December 31, 2019, the Company determined that one of its non-core product lines (the “disposal group”) met the held for sale criteria, and as such, the related assets are presented as “Assets held for sale” on the Consolidated Balance Sheets. Long-lived assets and definite-lived intangible assets are not depreciated or amortized while classified as held for sale. The potential sale of this disposal group does not represent a strategic shift that will have a material effect on the Company’s operations and financial results, nor is it considered a component of the Company, and as such it did not meet the criteria to be reported as discontinued operations.

For the year ended December 31, 2019, the Company recorded a non-cash impairment charge on these assets held for sale of $4.0 million, included in “Asset impairment” in the Consolidated Statements of Operations, in order to measure the disposal group at the lower of its carrying value or fair value less costs to sell as of December 31, 2019, which resulted in a corresponding held for sale valuation allowance on its assets held for sale in the Consolidated Balance Sheet. The major classes of assets that were classified as held for sale as of December 31, 2019 are as follows:

	December 31, 2019
	(in thousands)
Assets held for sale:
Inventories	$	5,985
Property, plant, and equipment, net		310
Intangible assets, net		6,546
Goodwill		2,359
Impairment		(4,020)
Total Assets held for sale	$	11,180

XML

Income Taxes

12 Months Ended

Dec. 31, 2019

Income Taxes

Income Taxes

Note 17 — Income Taxes

The amounts of income (loss) before income taxes attributable to domestic and foreign operations were as follows:

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Domestic	$	(78,486)	$	(286,561)	$	(101,573)
Foreign		530		(147,273)		12,583
Total	$	(77,956)	$	(433,834)	$	(88,990)

Significant components of the expense (benefit) for income taxes consisted of the following:

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Current:
Federal	$	—	$	(1,682)	$	—
Foreign		304		2,518		(2,246)
State and local		113		38		15
Total current expense (benefit) for income taxes		417		874		(2,231)
Deferred:
Federal		162		205		(35,912)
Foreign		116		(27,932)		1,291
State and local		82		107		(742)
Total deferred expense (benefit) for income taxes		360		(27,620)		(35,363)
Total expense (benefit) for income taxes	$	777	$	(26,746)	$	(37,594)

The income tax expense was reconciled to the tax expense computed at the U.S. federal statutory tax rate as follows:

	Year ended December 31,
	2019		2018		2017
	(in thousands)
Income tax expense (benefit) at U.S. statutory rates	$	(16,396)	$	(91,105)	$	(31,147)
State taxes, net of U.S. federal impact		(835)		(2,848)		(2,523)
Effect of international operations		785		11,847		10,158
Research and development tax credit		(1,692)		(2,230)		620
Net change in valuation allowance		15,098		7,747		1,883
Change in accrual for unrecognized tax benefits		1,232		2,868		(4,772)
Share-based compensation		1,947		1,848		99
Effect of 2017 Tax Act		—		(1,690)		(11,344)
Asset impairment		495		46,872		—
Other		143		(55)		(568)
Total expense (benefit) for income taxes	$	777	$	(26,746)	$	(37,594)

The Company recognized the income tax effects of the 2017 Tax Act in its 2017 financial statements in accordance with SAB 118, which provided SEC staff guidance for the application of ASC 740 in the reporting period in which the 2017 Tax Act was signed into law. As such, the Company’s 2017 financial results included provisional amounts for specific income tax effects of the 2017 Tax Act for which the accounting under ASC 740 was incomplete but for which a reasonable estimate could be determined. During the year ended December 31, 2018, the Company finalized the accounting for the tax effects of 2017 Tax Act based on legislative updates currently available and recorded an additional income tax benefit of $1.7 million for alternative minimum tax credits that became refundable in accordance with the 2017 Tax Act. The Company also reported an increase in deferred tax assets of $6.8 million as a result of adjustments to tax attributes utilized for one-time transition tax, which was offset by a full valuation allowance.

The most significant impacts of the 2017 Tax Act on the Company’s federal income taxes for the year ended December 31, 2017 were as follows:

Reduction of the U.S. Corporate Income Tax Rate

The Company measures deferred tax assets and liabilities using enacted tax rates that will apply in the years in which the temporary differences are expected to be recovered or paid. Accordingly, the Company’s deferred tax assets and liabilities were re-measured as of December 22, 2017 to reflect the reduction in the U.S. corporate income tax rate from

35 percent to 21 percent. The Company recorded an income tax benefit of $4.8 million for the year ended December 31, 2017, as the net deferred tax assets were reduced by $25.6 million with a corresponding valuation allowance reduction of $30.4 million.

One-Time Transition Tax on Foreign Earnings

As of December 31, 2017, the Company had $180.1 million of foreign earnings that was subject to the one-time transition tax. The Company used its 2017 and carryforward net operating losses to offset the impact of the transition tax. As the Company maintains a full valuation allowance against its U.S. deferred tax assets, the Company did not record an income tax expense related to the transition tax for the year ended December 31, 2017.

Valuation Allowance

The 2017 Tax Act modified the Net Operating Loss ("NOL") provisions to provide for an indefinite carryforward of NOLs arising in tax years beginning after December 31, 2017. The 2017 Tax Act also limits the amount of NOL deductions that can be used in any one year to 80 percent of the taxpayer’s taxable income, effective with respect to NOLs arising in tax years beginning after December 31, 2017. The Company recognized an income tax benefit of $6.5 million for the year ended December 31, 2017 related to a reduction in the Company’s valuation allowance as a result of the Company scheduling out the reversals of its net deferred tax assets which resulted in tax amortization on indefinite-lived intangible assets becoming available to offset existing deferred tax assets that are now expected to have an indefinite life.

Deferred income taxes reflect the effect of temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts recognized for tax purposes. The tax effects of the temporary differences were as follows:

	December 31,
	2019		2018
	(in thousands)
Deferred tax assets:
Inventory valuation	$	11,170	$	8,943
Net operating losses		63,342		67,787
Credit carry forwards		55,103		52,592
Warranty and installation accruals		1,391		1,695
Share-based compensation		6,296		6,981
Other		9,496		2,182
Total deferred tax assets		146,798		140,180
Valuation allowance		(130,053)		(114,955)
Net deferred tax assets		16,745		25,225
Deferred tax liabilities:
Purchased intangible assets		9,345		15,401
Convertible Senior Notes		8,831		11,265
Depreciation		2,668		2,380
Total deferred tax liabilities		20,844		29,046
Net deferred taxes	$	(4,099)	$	(3,821)

The Company is no longer permanently reinvesting future earnings from certain foreign jurisdictions and has accrued for foreign tax withholdings of $0.6 million on its unremitted earnings as of December 31, 2019.

At December 31, 2019, the Company had U.S. federal NOL carryforwards of approximately $270.9 million, of which $6.4 million has an indefinite carryforward period, with the remaining expiring in varying amounts between 2033 and 2037, if not utilized. In connection with the Ultratech acquisition, the Company has $120.8 million of historical NOL carryforwards which are subject to an annual limitation. The Company has $3.5 million of capital loss carryforwards that expire in 2021. At December 31, 2019, the Company had U.S. federal research and development credits of $29.8 million that will expire between 2020 and 2039. The Ultratech acquisition resulted in the carryover of $11.4 million of research and development credit carryforwards, which are subject to an annual limitation. The Company also has $9.4 million of foreign tax credits that expire in 2027. Additionally, the Company has state and local NOL carryforwards of approximately $127.5 million (a net deferred tax asset of $8.1 million, net of federal tax benefits and before the valuation allowance) that will expire between 2020 and 2039. Finally, the Company has state credits of $28.4 million, some of which are indefinite and others that will expire between 2020 and 2034.

The Company makes assessments to estimate if sufficient taxable income will be generated in the future to use existing deferred tax assets. As of December 31, 2019, the Company continued to have a cumulative three year loss with respect to its U.S. operations. As such, the Company has recorded a valuation allowance against its U.S. deferred tax assets. During 2019, the Company’s valuation allowance increased by approximately $15.1 million.

A roll-forward of the Company’s uncertain tax positions for all U.S. federal, state, and foreign tax jurisdictions was as follows:

	December 31,
	2019		2018		2017
	(in thousands)
Balance at beginning of year	$	11,137	$	8,269	$	7,452
Additions for tax positions related to current year		3,075		2,154		511
Additions for tax positions related to prior years		21		1,721		3
Reductions for tax positions related to prior years		(1,814)		(934)		(4,877)
Reductions due to the lapse of the statute of limitations		—		(26)		(122)
Settlements		(50)		(47)		(287)
Additions for business combination		—		—		5,589
Balance at end of year	$	12,369	$	11,137	$	8,269

If the amount of unrecognized tax benefits at December 31, 2019 were recognized, the Company’s income tax provision would decrease by $1.5 million. The gross amount of interest and penalties accrued in income tax payable in the Consolidated Balance Sheets was approximately $0.4 million and $0.3 million at December 31, 2019 and 2018, respectively.

The Company, or one of its subsidiaries, files income tax returns in the United States federal jurisdiction, and various state, local, and foreign jurisdictions. All material consolidated federal income tax matters have been concluded for years through 2016 subject to subsequent utilization of NOLs generated in such years. All material state and local income tax matters have been reviewed through 2012. The majority of the Company’s foreign jurisdictions have been reviewed through 2015. The Company’s major foreign jurisdictions’ statutes of limitation remain open with respect to the tax years 2017 and 2018 for China, 2015 through 2018 for Germany and Singapore, and 2018 for Taiwan. The Company does not anticipate that its uncertain tax position will change significantly within the next twelve months subject to the completion of the ongoing tax audits and any resultant settlement.

XML

Derivative Financial Instruments

12 Months Ended

Dec. 31, 2019

Derivative Financial Instruments

Derivative Financial Instruments

Note 13 — Derivative Financial Instruments

The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rates could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company entered into monthly forward derivative contracts with the intent of mitigating a portion of this risk. The Company only used derivative financial instruments in the context of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts were recorded as “Other operating expense (income), net” in the Company’s Consolidated Statements of Operations. The Company executed derivative transactions with highly rated financial institutions to mitigate counterparty risk.

The Company did not have any outstanding derivative contracts at December 31, 2019 and 2018. The following table shows the gains and (losses) from currency exchange derivatives during the years ended December 31, 2018 and 2017, which are included in “Other operating expense (income), net” in the Consolidated Statements of Operations as well as the weighted average notional amount of derivatives outstanding for each period:

	Year ended December 31,
	2018				2017
		Gains (losses)		Weighted average notional amount		Gains (losses)		Weighted average notional amount
	(in thousands)
Foreign currency exchange forwards	$	327	$	2,869	$	(6)	$	314

XML

Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2019

Significant Accounting Policies

Basis of Presentation

(b) Basis of Presentation

The accompanying audited Consolidated Financial Statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). The Company reports interim quarters on a 13-week basis ending on the last Sunday of each period, which is determined at the start of each year. The Company’s fourth quarter always ends on the last day of the calendar year, December 31. During 2019 the interim quarters ended on March 31, June 30, and September 29, and during 2018 the interim quarters ended on April 1, July 1, and September 30. The Company reports these interim quarters as March 31, June 30, and September 30 in its interim consolidated financial statements.

Use of Estimates

(c) Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, these estimates may ultimately differ from actual results. Significant items subject to such estimates and assumptions include: (i) stand-alone selling prices for the Company’s products and services; (ii) allowances for doubtful accounts; (iii) inventory obsolescence; (iv) the useful lives and expected future cash flows of property, plant, and equipment and identifiable intangible assets; (v) the fair value of the Company’s reporting unit and related goodwill; (vi) investment valuations and the valuation of derivatives, deferred tax assets, and assets acquired in business combinations; (vii) the recoverability of long-lived assets; (viii) liabilities for product warranty and legal contingencies; (ix) share-based compensation; (x) lease term and incremental borrowing rates used in determining operating lease assets and liabilities; and (xi) income tax uncertainties.

Principles of Consolidation

(d) Principles of Consolidation

The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Companies acquired during each reporting period are reflected in the results of the Company effective from their respective dates of acquisition through the end of the reporting period.

Foreign Currencies

(e) Foreign Currencies

Assets and liabilities of the Company’s foreign subsidiaries that operate using functional currencies other than the U.S. dollar are translated using the exchange rates in effect at the balance sheet date. Results of operations are translated using monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s subsidiaries into U.S. dollars, including intercompany transactions of a long-term nature, are reported as currency translation adjustments in “Accumulated other comprehensive income” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

Revenue Recognition

(f) Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable

consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases, the Company’s contracts with customers contain a billing retention, typically 10% of the sales price, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected performance period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in “Cost of sales” in the Consolidated Statements of Operations when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Warranty Costs

(g) Warranty Costs

The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance by providing labor and parts necessary to repair the systems during the warranty period. The Company records the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of sales” in the Consolidated Statements of Operations. The estimated warranty cost is based on the Company’s historical experience with its systems and regional labor costs. The Company calculates the average service hours by region and parts expense per system utilizing actual service records to determine the estimated warranty charge. The Company updates its warranty estimates on a quarterly basis when the actual product performance or field expense differs from original estimates.

Shipping and Handling Costs

(h) Shipping and Handling Costs

Shipping and handling costs are expenses incurred to move, package, and prepare the Company’s products for shipment and to move the products to a customer’s designated location. These costs are generally comprised of payments to third-party shippers. Shipping and handling costs are included in “Cost of sales” in the Consolidated Statements of Operations.

Research and Development Costs

(i) Research and Development Costs

Research and development costs are expensed as incurred and include charges for the development of new technology and the transition of existing technology into new products or services.

Advertising Expense

(j) Advertising Expense

The cost of advertising is expensed as incurred and totaled $0.5 million, $0.9 million, and $0.9 million for the years ended December 31, 2019, 2018, and 2017, respectively.

Accounting for Share-Based Compensation

(k) Accounting for Share-based Compensation

Share-based awards exchanged for employee services are accounted for under the fair value method. Accordingly, share-based compensation cost is measured at the grant date based on the estimated fair value of the award. The expense for awards is recognized over the employee’s requisite service period (generally the vesting period of the award). The Company has elected to treat awards with only service conditions and with graded vesting as one award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date.

In addition to stock options, restricted share awards (“RSAs”) and restricted stock units (“RSUs”) with time-based vesting, the Company grants performance share units and awards (“PSUs” and “PSAs”) that have either performance or market conditions. Compensation cost for PSUs and PSAs with performance conditions is recognized over the requisite service period based on the timing and expected level of achievement of the performance targets. A change in the assessment of performance attainment prior to the conclusion of the performance period is recognized in the period of the change in estimate. Compensation cost for PSUs and PSAs with market conditions is recognized over the requisite service period regardless of the expected level of achievement. For all PSUs and PSAs, the number of shares issued to the employee at the conclusion of the service period may vary from the original target based upon the level of attainment of the performance or market conditions.

The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards and purchase rights under the Employee Stock Purchase Plan. The Company uses a Monte Carlo simulation to compute the estimated fair value of awards with market conditions. The Black-Scholes model and Monte Carlo simulation include assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 15, “Stock Plans,” for additional information.

Income Taxes

(l) Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rate is recognized in income in the period that includes the enactment date.

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “2017 Tax Act”), which made broad and complex changes to the U.S. tax code. In response to the 2017 Tax Act, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provided guidance on accounting for the tax effects of 2017 Tax Act, including addressing any uncertainty or diversity of view in applying ASC 740, Income Taxes (“ASC 740”), in the reporting period in which the 2017 Tax Act was enacted. In addition, SAB 118 provided a measurement period that should not extend beyond one year from the 2017 Tax Act enactment date for companies to complete the accounting under ASC 740. During the year ended December 31, 2018, the Company finalized the accounting for the tax effects of 2017 Tax Act.

In January 2018, the FASB released guidance on the accounting for taxes under the global intangible low-taxed income (“GILTI”) provisions of the 2017 Tax Act. The GILTI provisions impose a tax on foreign income in excess of a deemed return on tangible assets of foreign operations. The Company has made a policy election to account for income taxes incurred under GILTI as a period cost.

Concentration of Credit Risk

(m) Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, derivative financial instruments used in hedging activities, and accounts receivable. The Company invests in a variety of financial instruments and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. Historically, the Company has not experienced any material credit losses on its investments.

The Company maintains an allowance reserve for potentially uncollectible accounts for estimated losses resulting from the inability of its customers to make required payments. The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount reasonably expected to be collected. The Company also provides allowances based on its write-off history. The allowance for doubtful accounts totaled $0.6 million and $0.3 million at December 31, 2019 and 2018, respectively.

To further mitigate the Company’s exposure to uncollectable accounts, the Company may request certain customers provide a negotiable irrevocable letter of credit drawn on a reputable financial institution. These irrevocable letters of credit are typically issued to mature between zero and 90 days from the date the documentation requirements are met, typically when a system ships or upon receipt of final acceptance from the customer. The Company, at its discretion, may monetize these letters of credit on a non-recourse basis after they become negotiable but before maturity. The fees associated with the monetization are included in “Selling, general, and administrative” in the Consolidated Statements of Operations and were immaterial for the years ended December 31, 2019, 2018, and 2017.

Fair Value of Financial Instruments

(n) Fair Value of Financial Instruments

The carrying amounts of financial instruments, including cash equivalents, accounts receivable, accounts payable, and accrued expenses reflected in the consolidated financial statements approximate fair value due to their short-term maturities. The fair value of debt for footnote disclosure purposes, including current maturities, if any, is estimated using recently quoted market prices of the instrument, or if not available, a discounted cash flow analysis based on the estimated current incremental borrowing rates for similar types of instruments.

Cash, Cash Equivalents, and Short-Term Investments

(o) Cash, Cash Equivalents, and Short-term Investments

All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market funds, certificate of deposit and time deposit accounts, U.S. treasuries, government agency securities, and corporate debt. Investments that are classified as cash equivalents are carried at cost, which approximates fair value. The Company’s cash and cash equivalents includes $78.5 million and $69.6 million of cash equivalents at December 31, 2019 and 2018, respectively.

A portion of the Company’s cash and cash equivalents is held by its subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. Approximately 56% and 32% of cash and cash equivalents were maintained outside the United States at December 31, 2019 and 2018, respectively.

Short-term investments consist of marketable debt securities, and are generally classified as available-for-sale for use in current operations, if required, and are reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” on the Consolidated Balance Sheets. These securities can include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations. The specific identification method is used to determine the realized gains and losses on investments.

Non-marketable equity securities are equity securities without readily observable market prices and are included in “Other assets” in the Consolidated Balance Sheets. Non-marketable securities are measured at cost, adjusted for changes in observable prices minus impairment. Changes in fair value are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

Inventories

(p) Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition. See Note 5, “Acquisitions and Dispositions,” for additional information.

Business Combinations

(q) Business Combinations

The Company allocates the fair value of the purchase consideration of the Company’s acquisitions to the tangible assets, intangible assets, including in-process research and development (“IPR&D”), if any, and liabilities assumed, based on

estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. See Note 5, “Acquisitions and Dispositions,” for additional information.

Goodwill and Indefinite-Lived Intangibles

(r) Goodwill and Indefinite-Lived Intangible Assets

Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is measured as the excess of the consideration transferred over the net fair value of identifiable assets acquired and liabilities assumed. Intangible assets with indefinite useful lives are measured at their respective fair values on the acquisition date. Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development (“R&D”) efforts. If and when development is complete, the associated assets would be deemed long-lived and would then be amortized based on their respective estimated useful lives at that point in time. Goodwill and indefinite-lived intangibles are not amortized into results of operations but instead are evaluated for impairment. The Company performs the evaluation in the beginning of the fourth quarter of each year or more frequently if impairment indicators arise.

In testing goodwill for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the reporting unit’s fair value is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the reporting unit to its carrying amount. If the fair value exceeds the carrying amount, goodwill is not impaired. If the carrying amount exceeds fair value, the Company then records an impairment loss equal to the difference, up to the carrying value of goodwill.

The Company determines the fair value of its reporting unit based on a reconciliation of the fair value of the reporting unit to the Company’s adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of the Company’s common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The control premium is estimated using historical transactions in similar industries.

In testing indefinite-lived intangible assets for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the indefinite-lived intangible asset to its carrying amount. The Company determines the fair value of its indefinite-lived intangible assets using a discounted cash flow method.

Long-lived Assets

(s) Long-lived Assets

Long-lived intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, and backlog and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or straight-lined if such pattern cannot be reliably determined.

Property, plant, and equipment are recorded at cost. Depreciation expense is calculated based on the estimated useful lives of the assets by using the straight-line method. Amortization of leasehold improvements is recognized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements.

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability test is performed utilizing undiscounted cash flows expected to be generated by that asset or asset group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent the carrying amount exceeds

its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals.

Leases

(t) Leases

Upon the adoption of ASC Topic 842, Leases (“ASC 842”) as of January 1, 2019, the Company determines at contract inception if an arrangement is a lease, or contains a lease, of an identified asset for which the Company has the right to obtain substantially all of the economic benefits from its use and the right to direct its use. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term, while lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. The implicit discount rate in the Company’s leases generally cannot readily be determined, and therefore the Company uses its incremental borrowing rate based on information available at lease commencement date in determining the present value of future payments. The Company has options to renew or terminate certain leases. These options are included in the determination of lease term when it is reasonably certain that the Company will exercise such options. The Company does not separate lease and non-lease components in determining ROU assets or lease liabilities for real estate leases. Additionally, the Company does not recognize ROU assets or lease liabilities for leases with original terms or renewals of one year or less.

Recently Adopted Accounting Standards

(u) Recently Adopted Accounting Standards

The Company adopted ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”), as of January 1, 2018, using the full retrospective method. All amounts and disclosures set forth in this Form 10-K reflect these changes. The most significant financial statement impacts of adopting ASC 606 are the elimination of the constraint on revenue associated with the billing retention related to the receipt of customer final acceptance and the identification of installation services as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, is now generally recognized at the time the Company transfers control of the system to the customer, which is earlier than under the Company’s previous revenue recognition model for certain contracts that were subject to the billing constraint. The performance obligation related to installation services is now recognized as the installation services are performed, which is later than the Company’s previous revenue recognition model. 

The Company adopted ASU 2016-01, Financial Instruments – Overall, as of January 1, 2018. This ASU requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. The Company measures equity investments without readily observable market prices at cost, adjusted for changes in observable prices minus impairment. Changes in measurement are included in “Other income (expense), net” in the Consolidated Statements of Operations. This ASU has not had a material impact on the consolidated financial statements upon adoption, and the Company will monitor its equity investments each reporting period for changes in observable market prices, if any, which may be material in future periods.

The Company adopted ASC Topic 842, Leases (“ASC 842”), as of January 1, 2019. ASC 842 generally requires operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. The new standard offers a transition option whereby companies can recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented. The Company has adopted using this transition method, and therefore prior period balances have not been adjusted. In addition, ASC 842 provides for a number of optional exemptions in transition. The Company has elected certain exemptions whereby prior conclusions regarding lease identification, lease classification, and initial direct costs were not reassessed under the new standard. The adoption of the standard impacted the Company’s Consolidated Balance Sheets through the recognition of ROU assets and lease liabilities of approximately $14.2 million each as of January 1, 2019 but did not have an impact on the Consolidated Statements of Operations, Statements of Comprehensive Income, or Statements of Cash Flows.

(v) Recent Accounting Pronouncements Not Yet Adopted

The Company is evaluating pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

XML

Income Taxes - Tax Credit Carryforwards (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Valuation allowance
Increase (decrease) in valuation allowance	$ 15.1
2017 Tax Act, Increase in deferred tax assets valuation allowance		$ 6.8
Domestic | Capital loss carryforward
Tax credit carryforward
Tax credit carry forwards	3.5
Domestic | Research and development tax credit carryforward
Tax credit carryforward
Tax credit carry forwards	29.8
Domestic | Research and development tax credit carryforward | Ultratech
Tax credit carryforward
Tax credit carry forwards	11.4
State and local
Tax credit carryforward
Tax credit carry forwards	28.4
Foreign tax
Tax credit carryforward
Tax credit carry forwards	$ 9.4

XML

Stock Plans - 2019 Plan (Details) - shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2013	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Share-based compensation
Number of options outstanding (in shares)	1,119,000		1,222,000	1,394,000	1,576,000
Inducement Plan
Share-based compensation
Common stock available for grant (in shares)		0
2019 Plan
Share-based compensation
Number of shares authorized	13,300,000
Stock options | Inducement Plan
Share-based compensation
Awards granted (in shares)		124,500
Vesting period		3 years
Expiration term		10 years
Number of options outstanding (in shares)	2,000
Stock options | 2019 Plan
Share-based compensation
Vesting period	3 years
Number of options outstanding (in shares)			1,100,000
Stock options | 2019 Plan | Minimum
Share-based compensation
Expiration term	7 years
Stock options | 2019 Plan | Maximum
Share-based compensation
Expiration term	10 years
Restricted stock awards and restricted stock units | 2019 Plan | Minimum
Share-based compensation
Vesting period	1 year
Restricted stock awards and restricted stock units | 2019 Plan | Maximum
Share-based compensation
Vesting period	5 years
Restricted stock units | Inducement Plan
Share-based compensation
Awards granted (in shares)		87,000
Number of awards outstanding (in shares)	0
Restricted stock units | Inducement Plan | Minimum
Share-based compensation
Vesting period		2 years
Restricted stock units | Inducement Plan | Maximum
Share-based compensation
Vesting period		4 years
RSUs and PSUs | 2019 Plan
Share-based compensation
Number of awards outstanding (in shares)	900,000

XML

Acquisitions and Dispositions - ProForma (Details) - Ultratech $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2017 USD ($) $ / shares
Pro forma consolidated statement of operations
Net sales	$ 546,428
Loss before income taxes	$ (90,000)
Diluted earnings per share (in dollars per share) | $ / shares	$ (1.38)

XML

Income Taxes - One-Time Transition Tax (Details) $ in Millions	12 Months Ended
	Dec. 31, 2017 USD ($)
Income Taxes
Accumulated undistributed earnings by foreign subsidiaries	$ 180.1

XML

Income Taxes - Components of Expense (Benefit) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Current:
Federal		$ (1,682)
Foreign	$ 304	2,518	$ (2,246)
State and local	113	38	15
Total current expense (benefit) for income taxes	417	874	(2,231)
Deferred:
Federal	162	205	(35,912)
Foreign	116	(27,932)	1,291
State and local	82	107	(742)
Total deferred expense (benefit) for income taxes	360	(27,620)	(35,363)
Total expense (benefit) for income taxes	$ 777	$ (26,746)	$ (37,594)

XML

Acquisitions and Dispositions - Consideration (Details) - Ultratech $ in Thousands, shares in Millions	May 26, 2017 USD ($) shares
Fair value of the consideration transferred
Cash consideration, net of cash acquired	$ 404,490
Equity consideration (7.2 million shares issued)	228,643
Replacement equity awards attributable to pre-acquisition service	228
Acquisition date fair value	633,361
Cash acquired	$ 229,400
Shares issued (in shares) | shares	7.2

XML

Derivative Financial Instruments (Details) - Not designated as hedges - Foreign currency exchange forwards - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Derivative Financial Instruments
Gains (losses)	$ 327	$ (6)
Weighted average notional amount	$ 2,869	$ 314

XML

Significant Accounting Policies - Advertising Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Significant Accounting Policies
Advertising expense	$ 0.5	$ 0.9	$ 0.9

XML

Stockholders Equity (Tables)

12 Months Ended

Dec. 31, 2019

Stockholders' Equity

Schedule of the changes in the balances of each component of AOCI, net of tax

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2016	$	1,797	$	(20)	$	1,777
Other comprehensive income (loss)		42		(7)		35
Balance - December 31, 2017		1,839		(27)		1,812
Other comprehensive income (loss)		(3)		11		8
Balance - December 31, 2018		1,836		(16)		1,820
Other comprehensive income (loss)		25		49		74
Balance - December 31, 2019	$	1,861	$	33	$	1,894

XML

Selected Quarterly Financial Information (unaudited) (Tables)

12 Months Ended

Dec. 31, 2019

Selected Quarterly Financial Information (unaudited)

Schedule of unaudited quarterly financial data

	Fiscal 2019								Fiscal 2018
	Q1		Q2		Q3		Q4		Q1		Q2		Q3		Q4
	(in thousands, except per share amounts)
Net sales	$	99,371	$	97,822	$	108,954	$	113,202	$	158,574	$	157,779	$	126,757	$	98,972
Gross profit		34,716		36,285		42,223		44,970		56,680		55,395		46,385		35,259
Net income (loss)		(18,530)		(15,565)		(11,767)		(32,871)		(15,827)		(237,634)		(8,953)		(144,674)
Basic income (loss) per common share		(0.40)		(0.33)		(0.25)		(0.69)		(0.34)		(5.02)		(0.19)		(3.11)
Diluted income (loss) per common share		(0.40)		(0.33)		(0.25)		(0.69)		(0.34)		(5.02)		(0.19)		(3.11)